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Muchos pudores y dudas tuve que superar a lo largo de mi carrera profesional sanitaria desde 
la lejana época en que decidí ser un ATS que quería dedicarse a la investigación. Y para super-
arlos ha sido imprescindible el apoyo de muchas personas a lo largo de muchos años, sin cuyo 
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aquellas ocasiones en los que un buen consejo a tiempo resulta fundamental para tomar el 
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brirme por primera vez el método científico. Por su continua e incansable ayuda y por sus 
críticas rigurosas siempre orientadas a hacerme mejor profesional. Por haberme motivado sin 
desmayo y, sobre todo, por creer allá por 1975, que un enfermero podía ser un investigador. 
“Gràcies amic RoRo”, esta tesis también es sin ninguna duda un logro tuyo.
A todo el Centro de Diagnóstico Respiratorio del Hospital Clínic, a los Drs. Joan Albert Barberà e 
Isabel Blanco, gracias a los compañeros del Laboratorio, a los históricos Maite Simó, Teresa Le-
cha, Carmen Argaña y, en especial, a Conxi Gistau, sin cuya comprensión y ayuda nunca hubiera 
sido posible realizar esta tesis. A las compañeras del sótano 4b, Teresa Solé y Maite Carrión. A 
los que estuvieron, Montse Rosell, Anabel Sarsa, Mª Jesús Cañadas, Frank Lopez, Jaume Cardús, 
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Finalizada mi primera formación como profesional 
sanitario en 1973,  tras mi paso por la Escuela de 
Ayudantes Técnicos Sanitarios de la Facultad de 
Medicina, Universidad de Barcelona (hoy llamado 
‘Campus Clínic’), hice una rotación en el Hospital 
Clínic durante un período de 3 años, en calidad de 
estudiante, en la Medica B (Cátedra del Profesor 
Soriano). Después, ya como enfermero contratado 
en los Laboratorios de Bioquímica y Hematología, 
presenté formando parte de este último equipo 
humano, el que fue mi primer resumen en unas 
Jornadas “Evaluación del Coulter modelo “S” Va-
llespí MT, Burgos F, Manat C, Vives Corrons JL.  III 
Jornadas Técnicas de Izasa. 1974”,  participando activamente en la primera automatización del 
Laboratorio con la incorporación de los equipos Technicon® y Coulter-S®, que nos permitieron 
la primera aproximación a la automatización de los análisis clínicos como fue el hemograma. 
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		
En 1974 el Prof. Robert Rodriguez Roisin me propuso participar en el proyecto de Laboratorio 
de Función Pulmonar (LFP) que quería llevar a cabo en la Medica C, bajo la dirección del Prof. C. 
Rozman. Tenía entonces 20 años y un océano de conocimientos por descubrir. Probablemente 
me sedujo el empuje y el entusiasmo del RoRo en aquel ya lejano 1975, años aquellos en 
los que se estaban produciendo grandes cambios en nuestro país acelerados con la muerte 
del dictador.  Inicié en esa época marcada por la esperaza y la ilusión mi andadura en lo que 
fue el embrión de lo que más tarde acabaría siendo el LFP del Clínic. Fue entonces cuando 
aprendí mi primera lección sobre espirometría forzada (EF) con un Vitalograph de fuelle, que 
permitía calcular a mano la Capacidad Vital Forzada (FVC), el volumen espiratorio máximo en 
el primer segundo, los flujos mesoespiratorios, el VEMS. Entonces todavía no hablábamos del 
FEV1,. De inmediato me sumergí en la medición de los gases respiratorios en sangre arterial (la 
gasometría arterial), en la medición de los volúmenes pulmonares por dilución y la capacidad 
de transferencia de CO y, De esta época son mis dos primeras presentaciones en el XI Con-
greso de la SEPAR celebrado en Oviedo en 1978 (¡¡sólo hace 35 años!!) que llevaban por título 
“Curvas de flujo volumen: ¿Osciloscopio versus registro gráfico?“ Burgos F, Añaños F, Gistau C, 
Rodriguez Roisin R, Picado C, Agustí Vidal A.; y  “Funcionalismo pulmonar en trabajadores in-
tensamente expuestos al amianto: estudio comparativo”. Picado C, Rodriguez Roisin R, Burgos 
F, Añaños F, Estopá R, Marin A, Agustí Vidal A. En ese mismo año vio la luz mi primera publi-





cotton. Comparative studies.  Rodriguez Roisin R, Picado C, Añaños F, Burgos F, Agustí Vidal A. 
Bull Europ Physiop Resp 1978;14:55-57”. Y ya en 1980, llegará mi primer artículo como primer 
autor “Curvas de flujo volumen (MEFV). Registro gráfico versus osciloscópico. Burgos F, Rodri-




La década del los 80 fue el de la in-
formatización del LFP. Se adquirió 
en 1978 un equipo Hewlett Packard 
HP9825-A, que permitió entre otras 
actividades el generar los valores de 
referencia de la función pulmonar 
de la población mediterránea: fue 
la tesis doctoral del que ahora es mi 
director de tesis, el Prof. Josep Roca 
(1982). Mi dedicación a este proyecto 
me permitió profundizar intensa-
mente en la metodología científica, en la epidemiología, en la estadística y en la informática. 
Un dato para la memoria histórica, el PC de IBM apareció en el mercado americano en 1981. 
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Mi estancia en 1996 en Harbor-UCLA Medical Center en Los Angeles, CA (USA), bajo la tutela 
del Dr. R. Casaburi me abrirá las puertas al conocimiento de uno de los grandes Laboratorios 
de Función Pulmonar mundiales, y en especial de las pruebas de ejercicio cardio-respiratorio, 
así como a profundizar en el concepto de estandarización. Fue sin duda una experiencia in-
olvidable. Quisiera destacar también mi participación en la task force ATS-ERS sobre la estan-
darización de la función pulmonar en el 2003-2005 que me permitió adentrarme en la cuestión 




Uno de los aspectos que más me “sublevó” durante mucho tiempo, a pesar de que la EF tenía 
un gran recorrido histórico desde que en 1846 el cirujano John Hutchinson describiera la capa-
cidad vital, fue la evidente infrautilización de EF. Era y sigue siendo un enorme reto para la me-
dicina el diagnóstico precoz de enfermedades respiratorias como la EPOC. El Dr. Tomas Petty, a 
quien tuve el honor de conocer en mi estancia en Harbor-UCLA Medical Center en 1996, decía: 
“The vital capacity and the FEV1 must emerge as important as BP, cholesterol tests, and other 
indicators of incipient disease states to alert physicians and the patients that they serve to the 
importance of early treatment for COPD and related disorders”. Pero a menudo la realidad es 
muy tozuda a la hora cambiar, y seguimos con una evidente infrautilización de la espirometría 
forzada, lo que se traduce en una altísima tasa de infradiagnóstico. Un mal que la medicina 
moderna no se puede permitir cuando hay medios para resolverlo. 
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La espirometría forzada es la técnica fundamental para la evaluación de la función respiratoria. 
A pesar de que su metodología está muy bien establecida es bien conocido que su calidad, 
en numerosas ocasiones, deja mucho que desear. Como ya he comentado mi relación con la 
tecnología viene de muy lejos. Conseguí mi primera conexión a la red de Medicina en marzo 
de 1997, el FTP; mi primer email se conectaba utilizando el “elm” “Mailbox”, la utilización de 
programas de comunicación como el Eudora© o el Pegasus©, precursores del actual Outlook y 
lenguajes como el HPLC, Basic, etc. El nacimiento de World Wide Web se me hicieron inmedi-
atamente familiares y siempre me interesó estar “a la última” en este campo.
Gracias a una beca de la Unión Europea “Chronic” “An Information Capture and Processing 
Environment for Chronic Patients in the Information Society”, que en 1999 nos abrió las puer-
tas a la investigación en nuevos modelos asistenciales y a la utilización de la telemedicina en 
nuestro ámbito, entramos en contacto con grupos que empezaban a trabajar en modelos de 
telemedicina. En ese mismo año, el FIS me concedió una beca de investigación en el que por 
primera vez pilotamos un modelo de soporte al diagnóstico usando TIC’s (FIS de 99 “Control 
de calidad y aplicabilidad de la espirometría forzada en diferentes niveles asistenciales”). Fruto 
de esa experiencia fue la extensión a todo el territorio nacional en un proyecto coordinado en 
el que participaron varios Hospitales y 18 centros de atención primaria de varias comunidades 
autónomas, y que fue financiado por el FIS en 2004 como proyecto colaborativo “La espi-
rometría forzada en atención primaria: impacto de un programa de tele-trabajo en la calidad 
de los resultados y en las interacciones entre niveles asistenciales”. Aquí se halla el núcleo 
central de mi investigación que ahora toma cuerpo en la presente tesis doctoral. 
Finalmente la oportunidad de cursar el Master Oficial de Medicina Respiratoria de la Univer-
sidad de Barcelona – Pompeu Fabra, me ha permitido el obtener el grado de Master (MSc), 
abriéndome las puertas a mi mayor sueño como profesional, obtener el grado académico de 
doctor. Todos estos antecedentes han modulado a lo largo de los años mi carrera profesional y, 
gracias al apoyo constante de mi director de tesis, Josep Roca y de mi mentor Robert Rodriguez 
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Population ageing and changes in lifestyle are central factors in explaining the increasing 
prevalence of chronic disorders, a trend that it is expected to continue over the coming 
decades, challenging the sustainability of health care systems worldwide. Non-communicable 
diseases (NCDs) represent close to 70% of the total burden on health care systems in Europe, 
and impact significantly on both morbidity and mortality(1-3). 
There is evidence indicating that the current fragmented care system generates avoidable 
inefficiencies at system level(4), perpetuates a reductionist approach to chronic disorders, 
precluding management of co-morbidities(5) and does not facilitate future predictive and per-
sonalized medicine. 
Thus, there is an urgent need to introduce substantial changes in the way we approach the 
delivery of care for chronic patients, as well as its articulation with social support services. 
This need led the World Health Organization (WHO), in 2002, to launch the Innovative Care 
for Chronic Conditions initiative (ICCC-WHO)(1;6) formulating basic principles and strategies to 
enhance the management of chronic patients. 
This PhD thesis has been generated within the NEXES project (2008-13)(7) conceived to de-
velop the practicalities of the Innovative Care for Chronic Conditions  (ICCC) initiative (1;6) 
acknowledging that Integrated Care Services (ICS) supported by Information and Communica-
tion Technologies (ICS-ICT)(8) constitute pivotal building blocks for the Chronic Care model 
proposed by the World Health Organization.
In NEXES(7), well-articulated innovative ICS-ICTs were proposed as the most efficient way of 
adopting the Chronic Care model by transferring complexity from specialized care to the com-
munity (9-13). 
The NEXES project assessed the deployment of four different modalities of ICS-ICT(14;15), 
namely: i) Wellness and Rehabilitation; ii) Enhanced Care for frail patients; iii) Home Hospital-
ization and Early Discharge; and, iv) Remote Support to primary care for diagnosis and therapy, 
covering a wide spectrum of care coordination with a strong focus on prevention and modula-
tion of the disease progress. 
This PhD thesis specifically focuses on the fourth ICS-ICT of this list. That is, it explores the 
feasibility of all the aspects involved in the transfer of testing procedures for diagnostic and 
follow-up purposes, usually managed by specialists, to primary care professionals and to the 
patient’s home. It must be emphasized that this transfer of complexity requires several major 






Forced Spirometry (FS) is the principal testing procedure for the diagnosis and severity assessment 
of COPD patients, as stated by GOLD(17). It is of note that COPD generates a major burden on health 
systems being a representative entity among the highly prevalent NCDs, the impact of which is ex-
pected to increase to become the third leading cause of death by 2020(18;19) due to the continuous 
increase in smoking rates in developing countries and the ageing of the population. Consequently, 
forced spirometry testing constitutes an outstanding use case for the exploration of the potential 
of novel ICT-supported approaches for functional testing in patients with chronic conditions. The 
transfer of the complexity of diagnostic procedures to primary care professionals will change the 
current paradigm for clinical diagnosis, currently too restricted to hospital-based medical specialists. 
This PhD thesis assesses, in a systematic manner, the relevant aspects of the transfer of high-
quality forced spirometry to non-specialized professionals working at a community level. We 
view FS as a first line test in the clinical assessment of patients with respiratory symptoms. 
Because of its high applicability and information content, FS plays a pivotal role in the diagnosis 
and follow-up of chronic obstructive respiratory diseases. It is of note that relevant clinical 
guidelines indicate the need for widespread use of FS in primary care for the early detection 
and appropriate management of asthma and COPD. 
It is hypothesized that that the rapid increase in the impact of COPD on healthcare can be 





























Both primary care physicians and respiratory specialists agree on the extensive use of high quality 
FS since it clearly has a positive impact on public health(20-26). However, although standard FS 
testing shows high applicability, at present it is difficult to perform as part of conventional day-to-
day healthcare practice in primary care because the procedure requires skilled personnel. There 
is a great deal of controversy(27-29) regarding the quality of the tests performed in primary care 
by non-expert professionals leading to suboptimal deployment of FS in community care. Conse-
quently, effective and sustainable training of non-specialized allied health professionals ensuring 
high quality FS testing in primary care is a crucial component for generating reliable results that 
should be accessible across healthcare tiers to prevent unnecessary test duplications. 
support the continuous training of professionals; iii) interpretative support; iv) interoperability 
among healthcare providers; v) collaborative tools for professionals working at different 
healthcare tiers and between patients and professionals; and, vi) availability of proper user 
interfaces to compare patient testing carried out by different providers over time. 
Although NEXES had a patient-oriented approach focusing mainly on chronic respiratory 
conditions, cardiovascular disorders and diabetes mellitus type II, this PhD thesis only ad-
dresses chronic respiratory disorders. This focus has been chosen mainly due to the ap-
plicant’s background, but also because respiratory diseases are a fundamental part of the 
NCDs group prioritized by WHO since 2001. The scientific respiratory community world-
wide is strongly committed to the shift toward the new health scenario for the manage-
ment of chronic conditions. The Forum of International Respiratory Societies (FIRS), which 
involves major international respiratory societies in all continents, recently prepared a 
document including the most relevant research on lung health together with a description 
of the impact of current respiratory health policies, with the aim of guiding world leaders 
in their debates during the 2014 United Nations meeting that will be devoted to chronic 
lung diseases(16). 
NEXES was designed to assess the impact of five factors that have been classically identified 
as barriers to the extensive deployment of ICS-ICT, namely: i) poor evidence of clinical ben-
efits; ii) technological issues; iii) service reimbursement; iv) regulatory and ethical aspects; 
and, v) organizational factors. The service-focused approach adopted in the project has im-
portant implications on future deployment strategies aimed at ensuring sustainability of the 
proposed ICS-ICT.
As mentioned above, the transfer of complexity from hospital-based specialized care to the 
community necessarily involves the development of collaborative tools for aiding interaction 
among the relevant actors across healthcare tiers, together with accessibility of validated test 
data throughout the health system. These two basic requirements shall be supported by an 
interoperable ICT platform constructed with the appropriate architecture. 
We understand that the deployment of functional testing for chronic respiratory patients in a 
coordinated care scenario must promote developments in three major areas, namely: 
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ences in the underlying mechanisms of airway inflammation in the two conditions, asthma and 
COPD, are beyond the scope of this thesis. Different types of bronchial challenges are used in 
specialized care to document and perform a quantitative assessment of AHR(39). FS testing 
is a key element in most bronchial challenge testing (40), but this should probably be limited 
to specialized units. It is of note, however, that increased spontaneous variability of FEV1 over 
time constitutes a hallmark of AHR that can be assessed with FS only, without the need for 
bronchial challenges. Moreover, assessment of the spontaneous variability of FEV1 comple-
ments the information provided by the standard post-bronchodilator response carried out as 
part of the FS testing. Limitations of the post-bronchodilator response in terms of sensitivity 
are well identified (41;42). In this regard, we would like to stress the importance of high-quality 
FS in patient follow-up in primary care as a tool for assessing AHR in respiratory patients. 
Increased variability of high-quality testing is a valuable tool in the diagnosis of AHR that re-
quires the type of setting put forward in this PhD thesis to be able to contribute effectively to 
enhanced diagnosis and management of chronic respiratory conditions. 
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		.B/ A review of COPD management has recently rec-
ommended that FEV1 after administration of a bronchodilator should be measured repeatedly 
over the course of the disease to define the rate of decline in lung function(43), in order to help 
focus both therapeutic decisions and assessment of prognosis. This implies that spirometry 
should be used on a routine basis, to identify patients with a rapid decline in FEV1 and to 
improve quality of care. These considerations have been well proven in the management of 
asthma(44) and can be reasonably extended to most respiratory conditions. Consequently, it 
can be concluded that high-quality FS testing accessible across the health systems is a valuable 




We have identified the following three major factors limiting the deployment of FS in primary 
care. All of them must be simultaneously tackled to ensure the successful adoption of en-
hanced FS: i) poor availability and suboptimal use of FS; ii) support for high-quality FS; and iii) 
accessibility of testing across healthcare tiers that are analyzed below.
		,&+	
5. Insufficient use of FS, even in hospitals, has been identified as 
one of the most important factors of underdiagnosis of COPD(45;46). Compared with heart fail-
ure patients, COPD patients are less likely to have confirmatory testing, even in those cases in 
which the two conditions, heart failure and COPD, coexist(46;47). Consequently, awareness of 
the relevance of the test and the accessibility of FS carried out by trained primary care profes-
sionals through standardized coaching courses are the two main challenges to be faced.  More-
over, knowledge about existing lung function testing resources both at hospital and primary 
care levels is currently incomplete. To resolve those issues, the Master Plan for Respiratory 
=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As a diagnostic test, spirometry is a reliable, simple, non-invasive, safe and inexpensive proce-
dure for the detection of airflow obstruction. This method is recognized by international clini-
cal guidelines as the essential test for making a diagnosis of COPD(22). Consequently, potential 
benefits of the transferability of FS from specialized diagnostic units to community care are 
acknowledged by both health professionals and managers. However, key organizational and 
technological aspects that would make possible such transferability while ensuring accessibil-
ity of the tests across the health system are not yet in place. Moreover, it is of note that by 
solving the challenges involved in the transfer of FS from specialized to community care, we are 
paving the way for reshaping several other diagnostic and follow-up testing procedures within 
an integrated care scenario. It is assumed that the changes proposed in this PhD thesis could 
have a major clinical impact on the following areas of respiratory medicine.
K	/this is a major problem in all chronic respiratory diseases and particularly in 
COPD(26). Only one third of patients with COPD are informed about their disease(30) and 21% of 
patients hospitalized for COPD exacerbation state that their respiratory problem is not regularly 
monitored by a physician(31). Furthermore, a high percentage of patients with a diagnosis of 
COPD do not have spirometric confirmation of the diagnosis. Walters et al (32) report that in Aus-
tralia 31% of patients diagnosed with COPD lack spirometry and that 56% of supposedly COPD 
patients showed normal spirometric results. All epidemiological studies indicate that COPD has 
a very high rate of occult disease. Moreover, the different studies acknowledge limited progress 
during the last decade in effectively reducing the problem of COPD underdiagnosis (33-35). 
We believe that screening for early diagnosis of COPD is needed to define coherent strategies 
aimed at efficient early disease management allowing the modulation of disease progress. Re-
cently, different health strategies adopted on a national level in Europe (36;37) are recognizing the 
importance of appropriate policies to avoid COPD underdiagnosis. Among the different potential 
initiatives, it is well demonstrated that ensuring effective access to high-quality spirometry at 
community level should be the first priority (26;38), since it can be reasonably hypothesized that 
wider implementation of high-quality forced spirometry should reduce the COPD burden. 
In summary, the use of Information and Communication Technologies (ICT) for the remote 
support of case-finding programs has enormous potential for paving the way in the develop-
ment of novel and efficient approaches in the enhanced early diagnosis of COPD, as well as for 
generating efficiencies in respiratory diagnosis and follow-up in the community by remotely 
supported non-specialized professionals.
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.+3+B	, (AHR): AHR is an intrinsic feature of asthma and it is seen in 




testing procedures have adopted communication standards such as HL7 (Health Level Seven) 
and CDA (Clinical Document Architecture, Release 2) to ensure interoperability throughout the 
healthcare system. 
A standardized CDA for FS contains patient data, information on the testing request and con-
text, outcome variables and flow-volume and volume-time curves, as well as the original signal 
captured by the equipment during the testing procedure. Consequently, this standard creates 
a normalized dataset organized in such a way as to facilitate integration of FS testing into any 
health information system (HIS), and pave the way for accessibility of FS by health profession-
als working with different providers and/or on different healthcare tiers.
The first step required in the design of adequate strategies for paving the way for change is to 
acknowledge those major factors limiting the transfer of lung function testing from specialized 




Despite the international recommendations on the quality of FS (ATS/ERS)(49) for both equip-
ment and tests, it is common to find that adherence to these standards is lower than expected, 
even in specialized environments. The lack of appropriate strategies to enforce the use of those 
recommendations has been pointed out as a main barrier to high-quality FS. The statement 
is fully endorsed by the results of the Platino study (52;53), which used a centralized quality 
control assessment of FS. Moreover, as mentioned above, the problem is most relevant when 
tests are performed by non-expert professionals, notably in primary care centers. 
Recently, Walters JA et al. (54) showed that the percentage of high-quality FS tests carried 
out by trained nurses was approximately 76%, whereas that percentage dropped to 44% in 
non-trained professionals. These results confirm the existing evidence (52;55) indicating that 
external quality assurance needs to be implemented in primary care testing to enhance quality 
of testing and to ensure long-term sustainability of high-quality testing over time. Moreover, in 
an extensive review of FS done in primary care, it was found that general practitioners identi-
fied approximately 90% of their own tests as acceptable; whereas the opinion of an external 
expert decreased the acceptance rate to 64%. All in all, most authors(56;57)  are skeptical 
about the potential of primary care to generate high-quality testing on its own, and they agree 
on the need for transferring well-established quality assurance programs from lung function 
laboratories to the primary care setting to ensure quality of the tests(58). In this regard, differ-
ent reports (52;53;59) indicate the potential of telemedicine to enhance both quality of testing 
and diagnosis of FS carried out by non-expert professionals, but because of technological and/
or logistic limitations precluding scalability, none of these studies show potential for general-
ization across the healthcare system.
Diseases in Catalonia (PDMAR)(36) undertook the initiative of identifying and characterizing 
existing lung function testing units and their territorial distribution. The results of this analysis 
represented a pivotal element in the design of strategies ensuring successful transferability of 
diagnostic tools from specialized care to the community.  
$	B&+	
	
		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highly on adherence to international recommendations (48;49). The American Thoracic Society 
(ATS)/European Respiratory Society (ERS) documents establish well-defined quality control cri-
teria for both equipment and tests, but they do not include indications on strategies to ensure 
sustained quality assurance in clinical settings wherein where non-expert professionals are 
likely to perform the tests. 
In 2008, a survey carried out by the European Respiratory Society (ERS) confirmed that no 
formal training on spirometry testing was taking place in most EU countries(50). It is widely ac-
cepted that training is a pivotal element in achieving high-quality FS performed by non-expert 
professionals. Moreover, recent data (51) indicate that conventional training techniques are 
useful but they do not ensure sustained high-quality testing. Consequently, it can be concluded 
that there is a lack of appropriate training programs directed at non-specialized professionals 
aimed at generating sustainable high-quality FS testing.
0&+	
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 The concept of the Electronic Health Re-
cord (EHR) has been evolving dramatically in recent years. The EHR are currently defined as a sys-
tematic collection of patient health information using a digital support, which should facilitate 
information-sharing across different healthcare levels. The EHR can be set up within a provider’s 
Health Information System (HIS) delivering formal care. Chronic patients often have more than 
one EHR since they are frequently seen by several providers of formal healthcare. Moreover, 
EHRs handled by the patient themselves or by the patients’ relatives are an emergent tool in 
Western countries where the Electronic Personal Record (EPR) or Personal Health Folder (PHF) is 
being increasingly and successfully used for patient empowerment in health self-management. 
This has had a beneficial impact not only in terms of enhancing the patient’s adherence to ther-
apy and preventive strategies, but also as a way of enhancing interoperability among healthcare 
providers and between formal and informal care. Unfortunately, this is not the current situation. 
Interoperability issues at a health system level are a major limitation in the extensive deploy-
ment of ICT-supported healthcare services. Moreover, FS testing is poorly implemented in the 
EHR, which clearly explains why interoperability has not been perceived as an issue for FS so far. 
We believe, however, that accessibility of FS testing across the system is a priority target. 
The FS equipment is a medical device that measures either volume or flow signals during the 
maneuver, generating different parameters that are most often stored in a proprietary for-




story board, from formal (Primary Care) and informal care (Pharmacy Office) scenarios, respec-
tively.  Mario and John’s stories illustrate the potentialities of all seven of the building blocks 
described. Our hypothesis is that putting all the items into operation will significantly enhance 
management of the COPD patient. Moreover, it will pave the way for future developments in 
the testing of chronic patients in a Coordinated Care scenario.  
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Virtually any adult patient attending a primary care visit because of respiratory symptoms such 
as cough, shortness of breath, wheezing, phlegm, etc., with no suspicion of acute infection as 
a causal factor, will be a candidate for forced spirometric testing as a basic approach to assess 
lung function. Usually, FS testing including baseline spirometric curves and post-bronchodilator 
testing will be carried out by a non-specialized nurse. 
Let’s imagine the case of Mario, a 50-year-old man with long history of cigarette smoking (60 
packs/year) seeking medical advice because of a history of chronic cough and shortness of 
breath with no previous history of hospital admissions for severe exacerbations. He is an obvi-
ous candidate for forced spirometry testing and a chest X-ray.  
In a standard care scenario, we may face quality problems with the testing mentioned above 
because of the lack of a coaching program ensuring high-quality testing (Blocks 2-4). Addi-
tional problems are lack of transferability of the testing to other healthcare tiers because of 
non-existing interoperability among health professionals (Block 5) and, also, because of poor 
confidence in the quality of testing (Block 6). Moreover, such poor confidence in the quality of 
the testing does not stimulate the generation of strategies facilitating clinical judgments made 
on the basis of follow-up testing stored in the data systems of the same or different providers. 
In this PhD thesis, we hypothesize that high-quality testing would be significantly reinforced if 
the primary care nurse could upload FS testing onto an ICT platform automatically assessing 
quality and providing feedback to non-specialized professionals  (Blocks 1 and 7). Moreover, 
through the ICT platform, nurses can receive coaching for continuous professional develop-
ment irrespective of their geographical location. The remote support could be designed for use 
by other health professionals and even for patients’ self-empowerment. 
Once the nurse transfers the pre- and post-bronchodilator testing to the general practitioner, he/
she makes the diagnosis. In the case that we are analyzing, Mario’s FS testing shows a moderate ob-
structive defect (post-bronchodilator FEV1 55% reference value) with only moderate but significant 
changes in the bronchodilator response to salbutamol. Mario will get the diagnosis of COPD, GOLD 
II stage, with bronchial hyper-responsiveness. The GP will generate both preventive and therapeu-




The strategies for a successful transfer of the complexities involved in shifting patient testing 
from specialized care to the community with the aim of enhancing healthcare efficiencies re-
quire a combination of changes covering several dimensions, namely: re-design of clinical pro-
cesses toward Integrated Care Services (ICS); organizational and cultural aspects involving all 
actors; regulatory issues; novel reimbursement modalities; and, last but not least, appropriate 
use of Information and Communication Technologies (ICT) as supporting tools. Consequently, 
the transition toward ICS-ICT shall be considered an intervention in a complex system(60-62), 
requiring a building blocks approach to ensure the modularity and flexibility of the transfor-
mational process. It is our understanding that this approach is valid even in the rather simple 
use case of forced spirometry (FS). To this end, we selected the main building blocks to be 
systematically addressed in this PhD thesis in order to shape a successful strategy aiming for 
scalability at a regional level with potential for transferability at a European level. We identified 



























































As a way to illustrate the integration of these building blocks into the clinical processes con-




The lack of a history of frequent severe exacerbations provides positive prognosis to the case, 
but Mario shows AHR and low body mass index (BMI) which justify his stratification as a patient 
with increased risk in terms of natural history of the disease. He will be managed by the general 
practitioner under the supervision of the specialist to assess the systemic effects of the disease 
and advice will be given regarding specific actions. Moreover, his AHR will require additional 
periodical FS testing to assess both variability and rate of decline of FEV1. In these patients, 
the need for high-quality FS testing remotely accessible by different healthcare professionals 
and by the patient himself is particularly important in the design of an efficient strategy for 
successfully modulating disease progress. As mentioned above, it is well accepted that high-
quality, accessible testing across the health system is an asset in enhancing the management 
of chronic respiratory patients. In the case of Mario, FS should be used routinely, as part of the 
overall strategy to modulate the natural history of the disease, reduce lung function variability 
and minimize FEV1 decline. 
Mario may require further visits to the respiratory specialist. In this case, it will be relevant 
that high-quality testing carried out in primary care is available for the specialist to properly 
assess follow-up data and to prevent unnecessary duplications of testing between different 




We have previously illustrated the problem of underdiagnosis of COPD and its potential nega-
tive consequences in two main areas: i) increase of the COPD burden on the health system due 
to preventable hospital admissions; and, ii) delayed  adoption of early prevention strategies 
that may have  positive effects on modulation of the COPD progress. Consequently, the need 
for case-finding programs is accepted to such an extent that several publications(63;64) have 
recently explored different program designs. In this PhD thesis, we hypothesize that an inte-
grated care approach with the support of an ICT platform, but based on informal care (Com-
munity Pharmacy, CPh), could provide the basis for an efficient COPD case-finding program 
without generating an additional burden for the healthcare system (Block 7). 
The setting could be as simple as this: John, a 52-year-old man, active smoker, goes to the 
CPh to get arterial hypertension medication. In the CPh, he sees a banner displaying a short 
advertisement extracted from GOLD guidelines: “Do you cough?; b) Do you bring up phlegm or 
mucus?; c) Do you get short of breath?; d) Are you over 40 years of age?; and e) Are you current 
smoker or an ex-smoker?”. 
John remembers his wife’s frequent complaints about his chronic cough and decides that it is 
time to assess his respiratory condition. The CPh officer will administer the GOLD question-
naire and since it is positive, John will be invited to perform pre-bronchodilator FS testing only. 
After successful quality testing certified by the ICT platform, the CPh officer indicates that 
John’s FEV1/FVC ratio is below 0.7. Consequently, an appointment to the GP is immediately 
generated to formally confirm the COPD diagnosis, to complete FS testing and to get appropri-
ate therapeutic advice following GOLD guidelines. The FS administered by the CPh officer will 
be transferred to John’s EHR in primary care along with information on the questionnaire and 




NEXES developed an open ICT platform, Linkcare®, to support the deployment of the four ICS-
ICTs assessed in the project. Linkcare® has been conceived as a multi-tier health information-
sharing platform to provide organizational interoperability and knowledge-sharing among 
stakeholders involved in coordinated care. In addition, it supports ICS-specific knowledge 
management and allows the integration of clinical decision support tools into the workflow of 
the ICS-ICT.
The Linkcare® platform functions as an Enterprise Application Integration1 (EAI) framework 
to support the NEXES integrated care model. In an EAI perspective, the Linkcare® platform is 
composed of a set of technologies and services to provide the requested functionalities [i.e. 
definition and management of integrated care programs (both by professionals and patients), 
integration of information between the Linkcare® platform and external Hospital Information 
Systems (HIS), call-center capabilities and remote monitoring] for the execution of integrated 
care programs. A detailed description of the architecture and functionalities used in NEXES and 
further developments to support scalability at regional and international levels was reported 
by Cano et al (65). The technology of Linkcare® has been developed by a spin-off company, 
Linkcare Health Services (Linkcare HS), of the Hospital Clínic, Barcelona. 
Linkcare® provides a common basic set of technologies and services grouped by functional 
modules to support Integrated Care Services. It is in a way, similar to the architecture of a 
Microkernel-based Computer Operating System (66;67). The Linkcare® core module provides 
a small set of simple abstractions to support the data model behind integrated care programs 
and use applications called Interoperability Middlewares to provide enhanced functionalities, 
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#In this architecture, the core services of the Linkcare® platform are available as web ser-
vices and support the general structure of the service model, depicted in Figure 2. At a 
high functional level, Linkcare® web services can potentially offer database integration and 
knowledge management, professional and access patient portals, accessibility, support 
and education capabilities, remote monitoring functionalities and services to facilitate the 
deployment of Clinical Decision Support Systems (CDSS). Furthermore, core services can 
be easily extended so that the system is ready to incorporate future resources of ICS-ICT. 
Overall, the Linkcare® platform is able to mediate between external applications that use 
web services to communicate between the Linkcare® core module, which acts as a common 
facade exposing only the relevant information and interfaces of the underlying applications 
to the end-user. 
During 2012, the architecture of the ICT platform has evolved further to support scalability 
of ICS at regional level. Recent developments have focused on enhanced data security and 
privacy, plus, most importantly, achievement multicenter functionalities. The current platform 
covers three major areas. Firstly, it supports patient-centered care through ICS-ICT, as de-
scribed above. Secondly, Linkcare® supports information-sharing across several working teams 
and continues to develop functionalities aimed at supporting knowledge-sharing. Finally, it is 
already providing interoperability at a health system level, among several proprietary health 
information systems, covering the requirements for accessibility of lung function testing de-






The emerging healthcare model facing the challenge imposed by NCD epidemics relies heavily 
on the deployment and adoption of innovative Integrated Care Services supported by Informa-
tion and Communication Technologies (ICS-ICT). 
Re-design of diagnostic and follow-up testing is an important component of the ongoing trans-
fer of complexity from specialized care to the community. We are specifically addressing the 
re-design of forced spirometry as a use case of this scenario.
The introductory section identifies the specific components of the change as seven building 
blocks that will be covered by this PhD thesis. It is assumed that a high degree of transferability 
will be achieved and, consequently, the outcomes of the thesis will mark out the basic elements 




The transfer of functional testing from specialized to primary care within a coordinated care 
scenario will improve the efficiency of care delivery and will generate cross-fertilization be-




























The general hypothesis is that extensive deployment of different, well-articulated ICS-ICTs 
covering the entire spectrum of severity of chronic patients generates efficiencies at a system 
level. This PhD thesis focuses on functional testing and specifically addresses forced spirom-





This PhD thesis aims to identify the key factors that seem to modulate success of the transfer 
of forced spirometry (FS) testing to primary care and to other non-specialized professionals 
and to explore the deployment of services with potential for scalability. 
We aim at achieving two main outcomes from this PhD thesis. Firstly, to generate a program 
for the transfer of FS to primary care and to other non-specialized professionals with potential 
for regional scalability. Secondly, to identify those dimensions of the program that can be gen-











The first objective is to assess the deployment of the transfer of FS in two scenarios, each 
with different purposes. The first manuscript analyzes the sustainability of a service to ensure 
high-quality forced spirometry in primary care. The two other manuscripts under Objective 1 
examine the potential of transferability to pharmacy offices, to generate a COPD case-finding 
program.
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Within objective 2, we performed two clusters of studies. The first two (manuscripts 4 and 5) 
analyze the status and needs of FS testing in Catalonia.  The second cluster includes two stud-
ies (manuscripts 6 and 7) with specific proposals for training programs for deployment in Cata-
lonia and at a European level. All these studies were performed directly under the auspices of 
the Catalan Master Plan of Respiratory Diseases. 
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bres.2012.12.006. [Epub ahead of print].
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In this PhD thesis, two areas were identified in which specific technological contributions were 
needed to ensure the success of the deployment. Firstly, the design and production of a FS-CDA 
for structured data transfer supporting interoperability across healthcare tiers (manuscript 8) 
and, secondly, the development of an automatic tool (algorithm) for remote FS quality control 
(manuscript 9). 
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Telemedicine enhances quality of forced
spirometry in primary care
Felip Burgos*, Carlos Disdier#, Elena Lopez de Santamaria", Batxi Galdiz",
Nu´ria Roger+, Maria Luisa Rivera1, Ramona Herva`s1, Enric Dura´n-Tauleriae,
Judith Garcia-Aymerich** and Josep Roca*, on behalf of e-Spir@p group##
ABSTRACT: Forced spirometry is pivotal for diagnosis and management of respiratory diseases,
but its use in primary care is suboptimal. The aim of the present study was to assess a web-based
application aiming at fostering high-quality spirometry in primary care.
This was a randomised controlled trial with 12 intervention primary care units (PCi) and six
control units (PCc) studied over 12 months. All 34 naı¨ve nurses (PCi and PCc) received identical
training. The PCi units had access to educational material and remote expert support. Quality of
spirometry and usability of the web application were assessed.
We included 4,581 patients (3,383 PCi and 1,198 PCc). At baseline, quality was similar (PCi 71%
and PCc 67% high-quality tests). During the study, PCi showed higher percentage (71.5%) of high-
quality tests than PCc (59.5%) (p,0.0001). PCi had 73% more chance of high-quality performance
than PCc. The web application was better for assessing quality of testing than the automatic
feedback provided by the spirometer. Healthcare professionals’ satisfaction and usability were
high.
The web-based remote support for primary care by specialists generated a sustained positive
impact on quality of testing. The study expands the potential of primary care for diagnosis and
management of patients with pulmonary diseases.
KEYWORDS: Forced spirometry, information technology, primary care, quality control, tele-
medicine
F
orced spirometry (FS) is viewed as a first-
line test for clinical assessment of patients
with respiratory symptoms. Because of its
high applicability and information content [1, 2],
FS plays a pivotal role in the diagnosis and follow-
up of chronic obstructive respiratory diseases [1–
4]. It is of note that relevant clinical guidelines
indicate the need for a widespread use of spiro-
metry in primary care for early detection and
appropriate management of asthma and chronic
obstructive pulmonary disease (COPD). There is,
however, a great deal of controversy [5–8] regard-
ing the quality of the tests performed in primary
care by nonexpert professionals, resulting in sub-
optimal deployment of FS. Consequently, effective
training of healthcare professionals ensuring high
quality of FS in primary care is crucial to generate
reliable results preventing unnecessary test dupli-
cations across the healthcare system.
Quality of FS strongly depends on adherence
to international recommendations [9, 10]. The
American Thoracic Society (ATS)/European
Respiratory Society (ERS) documents establish
well-defined quality control criteria for both
equipment and tests, but they do not include indi-
cations on strategies to ensure sustained quality
assurance in clinical settings wherein nonexpert
professionals are likely to perform the tests. Pre-
vious experiences in remote support of FS [11–14]
seem to indicate both feasibility and positive
outcomes, but none of them shows scalability or
potential for generalisation.
The current randomised controlled study carried
out in five areas of Spain throughout a 1-yr
follow-up period examines efficacy, acceptability
and usefulness of a web-based application [15]
providing remote assistance to nonexpert profes-
sionals for both quality assurance and support to
interpretation of the tests.
MATERIAL AND METHODS
The research was carried out from 2007 to 2008 in
five different areas of Spain that were organised
for the study purposes as independent nodes
located in: Extremadura (south-western region of
Spain), Basque Country (north of Spain) and three
nodes in Catalonia (north-eastern area of Spain).
At baseline, a survey on available resources to
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perform FS and the perceived need of the test in primary care
was administered to the general practitioners (GPs) participat-
ing in the study [16].
Each node (fig. 1) had a reference centre (lung function
laboratory) from a tertiary hospital with a specialised lung
function professional playing the role of coordinator of the
primary care units of the node. They were responsible for
blindly scoring (from A (best score) to F (worse score)) (table 1)
all spirometric tests performed in the area for both intervention
and control groups [17].
In each primary care unit, patients eligible for the study were
selected among those with respiratory symptoms that required
testing based on the GP’s criteria, without any restriction
related to age, sex or clinical status. Forced spirometry was
carried out by naı¨ve nurses. No information on clinical status
of the patients was used for the purposes of the study.
The 18 primary care centres included in the trial were randomly
allocated, within each node, either to one of 12 intervention
primary care centres (PCi) or six control primary care centres
(PCc). Up to 34 nurses, five coordinators, three telecommunica-
tion engineers and ,150 GPs participated in the study.
The research was approved by the Ethical Committee of the
Hospital Clı´nic i Provincial de Barcelona (Barcelona, Spain)
and the corresponding ethical committee of each participating
node. Patient consent was not required for the present study.
The study protocol included a 2-day training course for all
nurses of the two groups (PCi and PCc) using a methodology
close to that applied by the National Institute for Occupational
Safety and Health (Centers for Disease Control, Atlanta, GA,
USA) [18]. The training course was carried out in each node at
the beginning of the study. At the end of the training, all
participants had performed several FS manoeuvres and had
participated in discussions on standardisation of FS [10].
The nurses of the intervention group (PCi) were instructed in
the management of the website and were able to access it
during the whole study period. The educational content was
specifically designed to empower the healthcare professionals
to perform high-quality testing. It included a description of the
spirometers used in the study, international recommendations
on FS and educational videos.
The application provided a forum facilitating communication
among healthcare professionals (GPs and nurses) and with the
node’s coordinator. The nurses were able to generate specific
questions to the coordinator related to quality or interpretation
of the test and they received regular individualised feedback
from the coordinator regarding the quality of the spirometries
loaded into the system.
The coordinator of each node was also responsible for the
evaluation of each test loaded into the system, following the
classification described in table 1, and generated, on a weekly
basis, a report addressed to each PCi nurse including informa-
tion on several aspects of quality control of the tests analysed,
namely: repeatability of the manoeuvres, characteristics of the
curves, and checks for starting (back-extrapolation) and ending
(expiratory time) of those manoeuvres accepted by the primary
care professionals. The quality assessment was based on visual
analysis of both flow–volume and volume–time manoeuvres.
All node coordinators were instructed to follow strictly identical
criteria for grading the tests throughout the study period. There
was a general supervision of the node coordinators’ tasks per-
formed by F. Burgos, assessing for homogeneity of the coordi-
nators grading criteria.
In contrast, the healthcare professionals included in the control
group did not have access to the web application. The 2-day
face-to-face training course was the only support provided to
them throughout the entire study period.
Technical setting
We used two types of spirometric systems conforming to the
ATS/ERS recommendations [9, 10]. In all cases, the system was
connected to a personal computer. In two out of the five nodes,
we used a disposable and pre-calibrated pneumotachograph-
based spirometer (Datospir 110; Sibelmed, Barcelona, Spain),
whereas in the three remaining nodes, an ultrasound transit
time-based spirometer (EasyOne; ndd Medical Technologies,
Barcelona, Spain) was used. The FS equipment had the original
software without any modification except for the potential to
export the data from all tests in XML (Extensible Markup
Language) format. Briefly, each node used the same type of
spirometer independently of being an intervention or control
centre. In all cases, the nurses were instructed to use the
automatic quality messages generated by the equipment.
Although the two systems had a build-in capacity to generate
automatic messages, only those of the EasyOne spirometer
were explicitly for the users. Consequently, the comparison
between remote reviewer and automatic feedback was only
reported for those nodes using EasyOne spirometer.
The application tested in the current study is one of the
modules of the information and communication technology
platform used to support management of chronic patients [15,
19]. Such a platform provided traceability of all the actions
taken during the follow-up period. A VeriSignTM Trust Node
(SymantecTM, Sunnyvale, CA, USA) security system was used
to ensure confidentiality of encrypted data shared through the
Internet. After the end of the follow-up, we assessed accept-
ability of the web-based quality control programme by the GPs






FIGURE 1. Structure of each node. The 12 intervention primary care units (PCi)
had a bidirectional communication with the lung function laboratory playing a role as
a support centre, whereas the six control primary care units (PCc) only transferred
information to the support centre without any feedback. The five nodes were Bilbao
(two PCi and two PCc), Ca´ceres (two PCi and one PCc), Vic (three PCi and one PCc),
Badalona (two PCi and one PCc) and Barcelona (three PCi and one PCc).
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also assessed (Software Usability Measurement Inventory
(SUMI); University College Cork, Cork, Ireland) [20] by the
nurses that performed the tests.
Data analysis
Characteristics of the sample are presented as n (%) for
categorical variables or mean¡SD for continuous variables
(since all of them followed normal distributions). Comparisons
of sociodemographic and lung function variables between the
intervention and control groupweremade using Chi-squared or
ANOVA tests, as appropriate. Effects of the intervention in the
quality of the spirometry were tested by comparing the per-
centage of quality grade A and B spirometries between PCi and
PCc, both at each month and during the whole study period,
using the Chi-squared test. Additionally, multivariate logistic
regression analyses were built with quality of spirometry as the
outcome and intervention as the main exposure, adjusting for
differences between PCi and PCc subjects. Data analysis was
conducted using Stata 10.1 (StataCorp, College Station, TX,
USA). A p-value ,0.05 was considered statistically significant.
RESULTS
Study groups
We examined 4,581 subjects whose main anthropometric
characteristics, age and lung function results are displayed in
table 2. Each subject had been scheduled only once for a visit to
a primary care clinic and FS was performed following the
criteria of the GP.
We observed that subjects in the intervention group were
slightly older and moderately taller than those in the control
group. Mean forced expiratory volume in 1 s % predicted was
moderately abnormal with no differences between groups. In
contrast, forced vital capacity was within the reference interval,
but slightly lower in controls than in the intervention group.
The main results of the self-administered baseline question-
naire [16] to assess the status of FS in primary care are
displayed in table 3. It was answered by 146 (99%) GPs from
the 18 primary care centres participating in the study.
Effects of the intervention
After the first quarter, monthly percentages of high-quality FS
manoeuvres were significantly and consistently higher in the
intervention than in the control group (fig. 2). The intervention
group presented an average of 71.5% high-quality spirometries
throughout the whole study period, with no differences be-
tween months 1 and 12. In contrast, the control group showed a
lower mean percentage (59.5%) (p,0.001) of high-quality tests
during the whole study period with a statistically significant
fall between month 1 (67%) and month 12 (62%) (p50.011).
Throughout the study, the difference in percentage of high-
quality tests between intervention and control groups increased
from 4%-points at month 1 up to 16%-points at month 12
(p,0.05). No differences between groups were seen in score C
(table 1). However, while the proportion of tests within the
lowest score (F) increased from 9.3 to 16.2% in the control group,
we observed a decrease in the intervention group, from 15.2 to
5.2%. The results of the logistic regression analysis indicated
that the effects of the intervention remained after adjusting for
baseline differences (age, lung function and sex), such that tests
TABLE 1 Quality scores for spirometric manoeuvres according to American Thoracic Society (ATS)/European Respiratory
Society (ERS) standardisation [9, 10, 17]
Score Description
A 3 acceptable manoeuvres, and best 2 matched with differences in FVC and/or FEV1 ,150 mL
B 3 acceptable manoeuvres, and best 2 matched with differences in FVC and/or FEV1 ,200 mL
C 2 acceptable manoeuvres, and best 2 matched with differences in FVC and/or FEV1 ,250 mL
D 1 acceptable manoeuvre
F 0 acceptable manoeuvres
A and B were considered high-quality spirometry; C was considered to represent high variability among manoeuvres. FVC: forced vital capacity; FEV1: forced expiratory
volume in 1 s.
TABLE 2 Main characteristics of the two study groups
All Intervention Control p-value
Subjects n 4581 3383 1198
Males % 55.7 55.2 56.8 0.335
Age yrs 53.6¡18.9 54.5¡18.0 51.1¡21.0 ,0.001
Height cm 163.2¡10.5 163.5¡10.0 162.2¡11.7 0.030
FEV1 % pred 78.5¡22.8 78.5¡22.9 78.3¡22.4 0.784
FVC % pred 83.5¡19.6 83.8¡19.6 82.5¡19.3 0.037
FEV1/FVC % 71.6¡13.1 71.2¡13.3 72.6¡12.6 0.001
Data are presented as mean¡SD, unless otherwise stated. FEV1: forced
expiratory volume in 1 s; % pred: % predicted; FVC: forced vital capacity. Bold
indicates statistically significant p-values.
TABLE 3 Status of forced spirometry (FS) among
participating general practitioners (GPs) at
baseline
GPs %
Availability of FS equipment 26
Use of FS among those that had equipment 73
Specific training on FS 65
Knowledge of the equipment 7
Performance of the calibration routines 12
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in the intervention group had a 73% higher chance of high-
quality performance than those of the control group.We noticed
that PCi professionals performed a higher number of spiro-
metric manoeuvres than those of the PCc group. Up to 3% of
intervention subjects made eight manoeuvres whereas the
maximum amount of manoeuvres in the control group was six.
Automatic assessment of quality
In the subset of primary care centres using EasyOne, we
compared quality scores automatically generated by the system
with those provided remotely by experienced professionals.
Automatic quality assessment presented a pattern indicating
statistically significant effects of the intervention similar to those
indicated in figure 1, but the absolute figures of spirometric
manoeuvres identified as acceptable tests were consistently
lower than those seen with remote assessment by experienced
professionals, as indicated below. At the beginning of the study,
automatic quality assessment did not show differences in
percentages of acceptable manoeuvres between intervention
and controls, whereas at the end of the follow-up the amount of
high-quality spirometries in the intervention group (55%) was
higher than in the control group 43% (p50.035) with an average
difference of 13.5%-points. The equivalent figures using the same
equipment but with the remote professional assessment were
71.5% (intervention group) and 59.5% (control group) (p,0.0001)
with a similar mean difference of 12%-points between interven-
tion and control. Accordingly, underestimation of acceptable
spirometric manoeuvres generated by automatic quality assess-
ment as compared with assessment carried out by expert
professionals showed an average of -16%-points.
Acceptability of the web application
The results of the survey carried out among the GPs (n5126,
86% response rate) 1 month after the end of the study indi-
cated an acceptable level of overall appreciation of the web
functionalities (97% were satisfied with a score of 7.3¡2, from 0
to 10) together with a rather low percentage (26%) of GPs
indicating problems of implementation of the intervention.
Overall, the GPs reported that the web application provided
added value both enhancing quality of the tests and providing
support for interpretation.
Finally, the usability of the web application was examined by
administering the SUMI [20] questionnaire to the 34 nurses that
carried out the tests with an 87% response rate. Figure 3 presents
the results obtained for the five dimensions assessed in the
questionnaire (efficiency, effect, helpfulness, control and learn-
ability) as well as the score of overall satisfaction. Notice that
except for the control, all the scores were .50, representing an
acceptable degree of usability. As expected, the control (fig. 3)
was uniformly ,50, consistent with the fact that the tested
software, by study design, did not allow choices to the users.
DISCUSSION
The principal aims of the current research were to examine
efficacy, acceptability and usability of a web-based application
covering three main functionalities: 1) accessibility to educa-
tional material for continuous professional development; 2)
remote support for quality assurance of tests performed by
nonexperts; and 3) remote assistance for lung function
interpretation. We acknowledge that previous reports [11–14]
have indicated the potential of telemedicine to enhance quality
of both testing and diagnosis of FS carried out by nonexpert
healthcare professionals, but none of the studies show potential
for generalisation across the healthcare system due to techno-
logical and/or logistical factors precluding their scalability.
Our research clearly indicates a sustained beneficial impact of
the intervention increasing high-quality tests (scores A and B)
by ,20% (fig. 2) and decreasing the percentage of very low-
quality spirometries (score F) during the follow-up period.
Also, the professionals acknowledged the usefulness of the
web application as a tool for remote assistance on interpreta-
tion of the tests and to empower nonexpert professionals
increasing their skills to perform high-quality FS in primary
care. It is of note, however, that the impact of the application
on diagnosis was beyond the scope of the current research.
Does the intervention fulfil unmet needs in primary care?
The baseline survey carried out with the participating GPs





















FIGURE 2. Percentage of high-quality tests, i.e. scores A and B (three
acceptable manoeuvres and best of two with differences in forced vital capacity
(FVC) and/or forced expiratory volume in 1 s (FEV1) ,150 mL, and three
acceptable manoeuvres and best of two with differences in FVC and/or FEV1
,200 mL, respectively), in the intervention and control groups throughout the study








































FIGURE 3. Median scores of the different dimensions of the Software Usability
Measurement Inventory questionnaire [20] to assess usability of the web application
(see text for further explanation). Whiskers represent 95% confidence intervals.
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support on training and interpretation of the tests in order to
achieve the full potential of FS when used in primary care.
Moreover, international clinical guidelines endorse extensive
use of high-quality FS in primary care. Unfortunately, despite
enhanced awareness of the problem over the last few years,
COPD is still associated with marked underdiagnosis, without
a significant decrease during the last decade (from 78% to 73%
between 1997 and 2007) [21]. Still too often, a diagnosis of
COPD is made after an episode of severe exacerbation or
during the first hospital admission.
Our data confirm that accessibility of appropriate support
facilitating quality assurance of the tests performed at the
primary care level or in the patient’s home is needed. It is
classically accepted that ,10% of patients’ data may need to be
disregarded in lung function laboratories because of technical
inadequacies. This percentage can be as high as 40% in epide-
miological surveys without a proper quality assurance strategy
[4]. We must acknowledge, however, that these figures show a
marked decline when efforts to ensure quality control are
adequately implemented [4, 22].
It is well accepted that training constitutes a pivotal element to
achieve high-quality FS when performed by nonexperts. Recent
data on a centralised quality control programme carried out as
part of the PLATINO (Proyecto Latinoamericano de Inves-
tigacio´n en Obstruccio´n Pulmonar) study [23] fully endorse
the statement. In the primary care setting, WALTERS et al.
[24] recently showed that the percentage of high-quality FS
tests with trained nurses was ,76% whereas that percentage
dropped to 44% in untrained professionals. Different authors
[6, 25–27] have elaborated on the need to transfer well-
established quality assurance programmes from lung function
laboratories to the primary care setting to ensure quality of the
tests. There is evidence [28, 29] suggesting that external quality
assurance to primary care needs to be implemented. In an
extensive review of FS performed in primary care, it was found
that general practitioners identified ,90% of their own tests as
acceptable; whereas the opinion of an expert decreased the
acceptance rate to 64%. Moreover, a recent report [30] indicates
that conventional training does not ensure sustainability of
high-quality testing. Interestingly, our research found that the
effects of the intervention were also seen by automatic assess-
ment of quality. But such a modality of assessment generated a
marked underestimation (-16%-points) of acceptable spiro-
metric manoeuvres as compared with assessment by experi-
enced professionals.
To our knowledge, the current study constitutes the first attempt
to successfully implement a web-based standard training pro-
gramme reinforced by telecollaboration tools allowing remote
assistance of primary care professionals by specialists. In this
regard, the intervention was conceived to provide long-term
sustainability of the training programme through continuous
empowerment of primary care professionals. The results ge-
nerated by the current research endorse this vision and they
suggest that the current approach meets the requirements for an
extensive adoption of FS in primary care.
Limitations of the study
The quality assessment was based on visual examination of the
curves which, in some cases, may limit accurate identification
of the end of the test.We acknowledge that implementation of an
automatic algorithm should be considered as a useful decision
support tool for the node coordinator. As indicated above, the
study is not addressing the impact of remote assistance on
diagnosis with FS. Moreover, we did not aim to perform a
detailed analysis of factors modulating extensive deployment
and adoption of the intervention. The latter would have required
a specific design including several types of chronic patients
covering a broad spectrum of disease severity.
Conclusions
The current study shows that telecollaboration between
primary care professionals and lung function specialists has
a positive impact on quality assurance of FS performed by
nonexperts. We would like to emphasise that the intervention
assessed in the current study seems to show high potential for
generalisation across the healthcare system, such that future
studies aiming to examine adoption of the proposed strategy
should be encouraged.
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Background: COPD case ﬁnding is currently recommended at primary and tertiary care levels only.
Aim: To evaluate the feasibility of a community pharmacy program for COPD case ﬁnding in high-
risk customers by means of spirometry.
Methods: Pilot cross-sectional descriptive study in 13 urban community pharmacies in Barcelona,
Spain, fromApril toMay 2007. Customers>40 years oldwith respiratory symptoms and/or a history
of smoking were invited to participate in the study during pharmacists’ routine work shifts. High-
riskcustomerswere identiﬁedbymeansofa5-itemCOPDscreeningquestionnairebasedoncriteria
of the Global Initiative for Chronic Obstructive Lung Disease, and were invited to perform spirom-
etry accordingly. Those with an FEV1/FVC ratio less than 0.70 were referred to the hospital for
a repeat spirometry.
Results: Of the 161 pharmacy customers studied, 100 (62%) scored 3 or more items in the COPD
screening questionnaire, and after spirometry, 21 (24%) had an FEV1/FVC ratio< 0.7. When these
subjects with airﬂow limitation were offered referral to a hospital respiratory function laboratory
for further assessments, 11 (52%) attended the appointment. Over 70% of spirometries were rated
as being of acceptable quality. No signiﬁcant differences were observed in lung function parame-
ters between the pharmacy and hospital measurements.
* Corresponding author. Servei de Pneumologia, Hospital del Mar, Institut Municipal d’Investigacio´ Me`dica (IMIM), Passeig Marı´tim 25-29,
08003 Barcelona, Spain. Tel.: þ34 93 2483138; fax: þ34 93 2483425.
E-mail address: d.castillo@diurba.com (D. Castillo).
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Conclusions: COPD case ﬁnding by spirometry in high-risk customers of urban community pharma-
cies is feasible. Similarly to primary care practitioners, pharmacists have access to high-risk,
middle-aged subjects who have never been tested for COPD. Pharmacists can help with early
detection of COPD if they are correctly trained.
ª 2009 Elsevier Ltd. All rights reserved.
Introduction
Early diagnosis of COPD is important because smokers with
demonstrated airway obstruction are more likely to quit
smoking.1 Recently, the U.S. Preventive Services Task Force
(USPSTF) recommended against screening the general
population for chronic obstructive pulmonary disease
(COPD) using spirometry (grade D recommendation).2
However, the same document recognised that individuals
presenting respiratory symptoms (chronic cough, increased
sputum production, wheezing, or dyspnea) should be
tested. This position is consistent with the recommenda-
tions of other relevant groups: the American Thoracic
Society (ATS) and the European Respiratory Society (ERS)
advise performing spirometry on all persons with smoking
exposure, a family history of chronic respiratory illness, or
respiratory symptoms,3 and the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) recommends that clini-
cians consider a diagnosis of COPD ‘in any patient who has
dyspnea, chronic cough or sputum production, and/or
a history of exposure to risk factors for the disease’ and
that the ‘diagnosis should be conﬁrmed by spirometry’.4
At present, detection of COPD is limited to case ﬁnding
at the primary or tertiary care levels, a strategy that has
proven largely inadequate. One large population-based
survey showed that a high percentage (63%) of subjects
with airﬂow limitation had never received a diagnosis of
obstructive lung disease.5 In Spain, underdiagnosis has been
estimated to be around 80%.6
Pharmaceutical care, which has been useful in the
management of ambulatory patients with chronic diseases
such as asthma,7 might offer a new approach to COPD case
ﬁnding. Community pharmacists trained to perform
spirometry have been successful in improving access to lung
function measurement in rural communities,8 and we
hypothesized that they might also be able to help in an
urban general population. For such an approach to work,
the pharmacist would need to be able to select high-risk
individuals in whom spirometry should be performed. The
aim of this pilot study was to assess the feasibility of
a program of case ﬁnding of COPD by spirometry in
community pharmacies.
Methods
Pharmacist selection and training
To recruit pharmacist participants, we contacted commu-
nity pharmacies in a smoking prevention group formed
through the professional association for this sector (Ofﬁcial
College of Pharmacists, COFB) in Barcelona, Spain. The
study had been approved by the ethics committee of
Hospital Clinic i Provincial, Barcelona. Thirteen of the 19
members of the smoking prevention group accepted,
agreeing that a staff pharmacist would attend a four-day
spirometry training course in February and March 2007.
Training was based on the guidelines of the National Insti-
tute for Occupational Safety and Health (NIOSH),9 the ERS/
ATS,10 and the Spanish Society of Pulmonology and Thoracic
Surgery (SEPAR).11 The volunteer pharmacists recruited
subjects from among customers arriving during their regular
work shifts of about 8 h per day and they conducted
interviews and tests between attending customers. The
daily routine of the pharmacy was not modiﬁed so that our
results would not overestimate the number of new cases of
COPD that can be found by this route in real conditions.
Spirometer and assessment procedures
The portable spirometer (Easy-One Spirometer, ndd Medical
Technologies, Zu¨rich, Switzerland) was chosen because it is
easy to handle and has been used in other population
screening studies.12 Calibration was checked at the begin-
ning of the study and did not have to be re-checked daily.
The device has built-in software that ranks spirometry
quality (grades AeF) in accordance with standard European
classiﬁcations.10 An A or B rating indicated acceptable
quality, because both levels supposed three good
manoeuvres with at least two readings of forced vital
capacity (FVC) and forced expiratory volume in 1 s (FEV1)
differing by <150e200 ml. In addition, an expert in lung
function (F.B.) reviewed and rated all spirometry curves
according to the same criteria.
Lung function measurements included FEV1, FVC and the
FEV1/FVC ratio. FEV1 and FVC were expressed in liters and
as the percentage of reference values for the Spanish
population.13 According to the Spanish COPD guidelines,14
and as recently proposed elsewhere for mass screening
programs,15 we used pre-bronchodilator lung function to
classify airﬂow limitation, deﬁned by an FEV1/FVC
ratio< 0.70.
Subject selection and evaluation
During April and May 2007, customers who entered the
participating community pharmacies and who seemed to be
in the targeted age range (>40 years) were approached
with opening questions about respiratory symptoms or
smoking. If a candidate expressed interest in the topic, the
pharmacist explained the objectives of the research and
the voluntary nature of participation. Participants signed
a consent form if interested, and the pharmacist then asked
about previous diagnoses of lung disease or use of inhaled
medication and sociodemographic data as stipulated by





a written questionnaire. Individuals aged< 40 years or who
had a history of lung disease or use of inhalers were
excluded at this time. To assess the risk of COPD, we used
the GOLD screening questionnaire, as recommended in the
2006 guidelines.4 This questionnaire consisted of questions
on ﬁve items referring to more breathlessness than people
of the same age, chronic cough, chronic sputum, age> 40
years, and smoking. Subjects with 3 afﬁrmative answers
were offered spirometry. Those in whom the FEV1/FVC
ratio was <0.70 were referred to a lung function unit in
a university hospital (Hospital de la Santa Creu i Sant Pau or
Hospital Clinic I Provincial, both in Barcelona). Within
24e48 h spirometry was repeated by an expert nurse using
the same brand of spirometer. Refusal to continue partici-
pating in the study was recorded with the speciﬁed reason.
Smokers were also encouraged to quit smoking through
a cessation program, as giving this advice was part of the
normal routine for these volunteer community pharmacists.
Statistical methods
Descriptive data of participants and subgroups are pre-
sented as mean and standard deviation unless otherwise
stated. We compared participants with a low and high COPD
risk, and spirometry data in the normal and abnormal
groups, using t-tests for normally distributed parametric
data and the KolmogoroveSmirnov test for non-parametric
data (quality spirometry, gender, tobacco exposure and
GOLD screening score). Using the Wilcoxon rank sum test
we compared each subject’s expiratory ﬂow rates
measured at the pharmacy and the hospital. A BlandeAlt-
man graph was also created to show individual differences
between pharmacy and hospital FEV1 values. Statistical
signiﬁcance was set at P 0.05 for comparisons between
groups. All analyses were performed using the Statistical
Package for Social Sciences (SPSS) for Windows, version
15.0 (SPPS Inc., Chicago, Illinois, USA).
Results
A total of 254 customers approached by the pharmacists
expressed interest in the study; 188 (74%) agreed to
participate by signing the consent form after the nature of
the study was explained. Reasons given by the 66 subjects
who declined to participate included no time to wait
(nZ 28, 42%), no interest (nZ 12, 18%), already diagnosed
with a respiratory condition (nZ 14, 21%) and others
(nZ 12, 18%). Twenty-seven of these 188 initial partici-
pants were excluded by the pharmacists when criteria were
reviewed; reasons for exclusion at this time were age< 40
years or previous lung disease (Fig. 1).
The 161 remaining volunteers agreed to ﬁll in the GOLD
screening questionnaire for COPD. The average age of these
participants was 55 11 years, 94 (58%) were women, and
124 (77%) were smokers or ex-smokers. The mean GOLD
screening score was 3.0 1.2. Sixty-one of the 161
respondents (38%) had a score< 3 and 100 (62%) a score of
3, indicating they were at high risk for COPD (Table 1).
The age and proportion of women in the two groups were
similar. More high-risk customers were smokers or
ex-smokers, and they also had a higher mean GOLD
screening score than those at low risk. Those in the high-
risk group were offered spirometry; only three refused and
one was excluded because she was ill with a respiratory
infection at that time. Customers who attended spirometry
had at least one symptom. Chronic cough was the most
common (66%) but each symptom was present in about half
the subjects (chronic sputum 54%, breathlessness 63%).
Low-risk subjects were more frequently asymptomatic
(chronic cough 6%, chronic sputum 5%, breathlessness 3%).
Thus, 96 high-risk subjects performed spirometry in the
pharmacy. Sixty-ﬁve (68%) had an FEV1/FVC% ratio 0.70
and 21 (22%) had an FEV1/FVC% ratio< 0.70, indicating
airﬂow limitation. The distribution of airﬂow limitation by
age is shown in Fig. 2. Ten were unable to perform the
manoeuvres correctly. Personal characteristics and
spirometry results for those who performed a correct
spirometry are shown in Table 2. According to our pre-
bronchodilator data, airﬂow limitation was mild in 13 (62%)
of the subjects in whom it was detected, moderate in 7
(33%) and severe in 1 (5%).
Out of the 86 patients who underwent spirometry,
airﬂow limitation (FEV1/FVC ratio< 0.70) was detected in
21 (24%), and they were invited for referral to a hospital
pulmonary function laboratory for further assessment. Only
11 (52%) subjects both accepted referral and actually went
to the laboratory. In all cases, the airway obstruction was
conﬁrmed. Moreover, the lung function values recorded in
the community pharmacy and in the hospital pulmonary
function laboratory were similar in both settings (FEV1,
PZ 0.5; FVC, PZ 0.89; and FEV1/FVC ratio, PZ 0.14)
(Fig. 3). Of note, among those referred to the hospital, two
presented a pre-bronchodilator FEV1< 60%.
Finally, spirometric curves in the pharmacy were of
acceptable quality overall, with 70% rated as A or B quality
by the spirometer software and 73% were considered of
acceptable quality by the lung function expert. The quality
rating tended to be even better in subjects with airﬂow
limitation, 76% of whom were considered to have A or B
quality curves, but the difference was not signiﬁcant
(PZ 0.71).
Discussion
Individuals at high risk for COPD can be detected by
spirometry screening undertaken by adequately trained
pharmacists in urban community pharmacies. Our data
show that pharmacists were able to identify customers with
respiratory symptoms and/or smokers in a population in
which the majority were middle-aged subjects who had
never been tested for COPD. Furthermore, the pharmacists
were able to supervise high quality spirometry manoeuvres
in 70% of subjects, ﬁnding one case of airﬂow limitation for
every ﬁve individuals tested, a rate that was similar to that
reported for the UK primary care setting.16
Spirometry in the primary care setting has been shown
to be useful in screening for COPD and it continues to be
promoted as the means for diminishing the population
underdiagnosis of this disease.17 Additionally, the
usefulness of reporting individual lung age to smokers has
been elegantly conﬁrmed recently.19 However, lack of
technical or human resources in primary care is a limiting
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factor,18 compounded by primary care physicians’ low
rate of request for spirometry.20 Therefore, under-
diagnosis in the primary care setting continues to be
inordinately common.21 In this pilot study, our ﬁnding
that the community pharmacy can provide a complemen-
tary setting for COPD case ﬁnding in the general pop-
ulation offers hope of improving the health care system’s
screening potential.
FEV1/FVC < 0.70Incorrect manoeuvre FEV1/FVC ≥ 0.70
61 subjects
GOLD questionnaire
Pharmacy customers, mainly former or current 
smokers or those with respiratory symptoms 
254 subjects invited to participate
161 included66 refuse:
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10 subjects 21 subjects 65 subjects
Hospital referral
11 Accept 10 Refuse
Figure 1 Flow chart showing subject processing from pharmacy to hospital referral.
Table 1 Characteristics of the participating pharmacy customers.
All customers (nZ 161) Low risk (nZ 61) High risk (nZ 100)
Age, mean SD 55 11 56 11 55 11
Women, n (%) 94 (58) 38 (62) 56 (56)
Smoking history, n (%) 124 (77) 36 (59) 88 (88)a
GOLD score, mean SD 3.0 1.2 1.7 0.4 3.8 0.8a
a Signiﬁcant differences were found between low-risk and high-risk groups for smoking history (smokers or ex-smokers) (PZ 0.01) and
GOLD score (PZ 0.01). GOLDZGlobal Initiative for Chronic Obstructive Lung Disease.





Widespread use of spirometry in screening for COPD has
been questioned.2 The current recommendations are to
study subjects at high risk.2e4 All subjects offered spirom-
etry in our study were in fact symptomatic as detected by
the questionnaire, suggesting that inappropriate resource
consumption can be kept under control by applying a GOLD-
criteria-based screening questionnaire. Our use of the
GOLD screening questionnaire to assess the risk of COPD
followed recommendations in the 2006 guidelines,4
although recently validated questionnaires with the same
goal are available elsewhere.22
Our study also shows that pharmacists can obtain valid
spirometries if they are well-trained and highly motivated.
Seventy percent of the spirometry curves were judged to be
of A- or B-level quality after review by an expert in lung
function testing; that success rate was higher than the
reported 63% in a previous pharmacy study.8 Only 10% of
the subjects who were invited to perform spirometry in the
community were unable to produce correct manoeuvres
under the pharmacists’ supervision, a situation quite similar
to that reported for the primary care level.23 The quality of
spirometry was also reﬂected in the lack of differences in
results in pharmacy and hospital measurements for the
same subjects.
An interesting ﬁnding was the predominance of women
among the pharmacy customers. Given that the prevalence
of COPD in Spain has been found to be 14.3% in men and
3.9% in women in a population-based study,6 we expected
males to predominate among the tested subjects.
However, women accounted for 58% of the subjects and
57% of the positive spirometries. The pharmacy seems to
be a particularly good setting, therefore, to ﬁnd cases in
women, among whom the prevalence of COPD seems to be
rising.24
A limitation of this study was the absence of a broncho-
dilator test. Although most guidelines recommend the use
of post-bronchodilator spirometry to diagnose and stage
COPD, other authors call for simplicity, especially for large-
scale screening.15,25,26 We ruled out the use of post-bron-
chodilator tests in pharmacies because of evident concerns
about practicality, safety, and efﬁciency. Should this
approach be implemented, we continue to consider that
bronchodilator tests should be performed in the hospital
laboratory after referral. Another limitation and the main
logistical problem of this study is related to referral of
subjects with possible COPD from the community pharmacy
to the hospital. In our study, nearly half of those with
spirometry results indicating airﬂow limitation declined
a hospital appointment. No time or lack of interest were
the reasons most often stated. We suspect that declining
referral may reﬂect either a lack of interest in quitting
smoking or milder disease. The general population has little
knowledge about COPD,27 in comparison with other condi-
tions such as cardiovascular disease, and they, therefore,
do not consider respiratory disease to be a serious personal
threat.
To conclude, in this pilot study, we have shown that
COPD case ﬁnding by spirometry in urban community
pharmacies is feasible. Pharmacists have access to high-
risk, middle-aged subjects who have never been tested for
COPD, and if the pharmacists are correctly trained, they
can detect airﬂow limitation by spirometry with results that
are similar to those previously reported at primary care
level. Pharmacists are health service professionals who are



























Figure 2 Distribution of percent predicted FEV1 by age for all
participants (subjects with airﬂow limitation are represented
by ﬁlled circles).
Table 2 Characteristics and respiratory function data for subjects who performed spirometry correctly and were classiﬁed by







Women, n (%) 49 (57) 37 (57) 12 (57)
Age (y) 55 11 54 10 57 12
Smoking history, n (%) 74 (86) 56 (86) 18 (86)
GOLD score 3.8 0.8 3.8 0.8 3.7 0.8
BMI 27.1 5.1 27.8 4.7 25 5.7a
FEV1 (l) 2.5 0.7 2.7 0.6 2.1 0.7a
FEV1 (% ref. val.) 86 0.2 91 0.1 72 0.1a
FVC (l) 3.4 0.9 3.4 0.9 3.24 1.0
FVC (% ref. val.) 89 (0.2) 90 (0.2) 85 (0.1)
FEV1/FVC ratio 0.76 (0.1) 0.79 (0.1) 0.64 (0.1)
a
Data are expressed as mean SD unless otherwise noted.
a Signiﬁcant differences in BMI (PZ 0.03), FEV1 (PZ 0.01), FEV1% (PZ 0.01) and FEV1/FVC ratio (PZ 0.01) were found between the
normal and abnormal spirometry groups.
FEV1Z forced expiratory volume in 1 s; FVCZ forced vital capacity; and GOLDZGlobal Initiative for Chronic Obstructive Lung Disease.
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participation may represent a useful complementary
strategy for early case ﬁnding.
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Objective: To assess the effectiveness of a COPD case finding program in community 
pharmacies. 
Methods: Prospective, cross-sectional, descriptive, uncontrolled, remotely supported 
study (NCT01576068) in 100 community pharmacies (CP) in Barcelona, Spain. 
Pharmacists were trained in a four-day workshop on spirometry and COPD, and each 
was provided with a spirometer during 12 weeks. The program included questionnaires 
and forced spirometry measurements, whose quality was controlled and monitored by 
web-assistance.   
Results: Overall  2,295 (73.5%) of 3,121 CP customers invited,  accepted to participate 
in the program, and 1.456   !
	
"
#high risk$"%&using the 
GOLD questionnaire. Only 33 could not conduct spirometry, and a pre-bronchodilator 
airflow limitation (FEV1/FVC ratio <0.7) was confirmed in 282 (19.8%);  244 of them 
were referred to their primary care (PC) physician for further diagnostic and therapeutic 
work-up, but only 39 of them (16%) fed-back this information to the pharmacist. 
Finally, it is of note that clinically acceptable quality spirometries (grade A or B) were 
obtained in 69.4% of the cases. 
Conclusions: This study shows that adequately trained and supported community 
pharmacists can effectively identify individuals at high risk of having COPD and can 
thus contribute to ameliorate underdiagnosis in this disease.  
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Section 1: What is already known on this subject 
COPD underdiagnosis is one of the major problems in management of the disease. 
Current case-finding strategies have shown to be insufficient.  
Section 2: What this study adds 
Adequately trained and supported community pharmacists can effectively identify 
individuals at high risk of suffering COPD. Then, CP could be added to COPD case-





It is now estimated there are at least 328 million people with chronic obstructive 
pulmonary disease (COPD) in the World, yet 80% or more of them are not diagnosed 
and, hence, not treated.1-2 Several position papers have recently emphasized the 
importance of strategies to reducing under-diagnosis in COPD.3-4 In a previous small 
pilot study, we showed that COPD case finding in community-pharmacies (CP) is 
feasible.5 Now, in the current study: (1) we extend this pilot observation to a much large 
number of CP (n=100); (2) we use Information and Communication Technologies (ICT) 
to provide remote spirometric quality control to CP, as recently shown in primary 
care(PC);6 and, (3) we explore the real-life effectiveness of this COPD case finding 
program by focusing in particular on the inter-relationship between the formal (PC) and 
informal (CP) components of the health-care system.  
 
METHODS 
Design of the study, Participants and Ethics 
This was a prospective, cross-sectional, descriptive, multicenter (CP), uncontrolled, 
remotely supported study (NCT01576068). The Official College of Pharmacists of 
Barcelona (Col·legi Oficial de Farmacèutics de Barcelona-COFB) offered to all its 
members the possibility to participate, and 100 CP located in the province of Barcelona 
(both rural and urban settings) volunteered, most of whom had previously participated 
in other CP health-care programs. CP were divided in 5 groups (20 pharmacists each) 
that participated in the study 
"
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,#	-.$/from September 2010 
to February 2012 (approximately 12 weeks each round). The study protocol was 







participants signed a consent form. Also, all smokers were encouraged to quit smoking 
by the attending pharmacist.  
In brief (Figure 1), during regular working hours, CP customers within the targeted age 
range (>40 years) were asked by the attending pharmacists about respiratory symptoms 
and smoking. If the customer expressed an interest in the topic, the pharmacist 
explained the volunteer nature, objectives, goals and risks of the study. If interested, 
customers signed a consent form and answered a standardized questionnaire that 
included socio-demographic data as well as questions about previous respiratory 
diseases and use of respiratory medications. Individuals younger than 40 years or with a 
previous history of lung disease or use of respiratory medication were excluded from 
the study at this time (Figure 1). Remaining participants were asked to answer a 5-item 
questionnaire (older than 40 years of age?, current or previous smoking exposure?, more 
breathlessness than peers of the same age? and presence of chronic cough or 
expectoration?) to identify subjects at high-risk of suffering COPD (those with 3 or 
more #-$ answers), as proposed by the Global Initiative for Chronic Obstructive 
Disease (GOLD).7 High risk subjects were then offered a standardized forced 
spirometry (see below), and those with evidence of airflow limitation (as defined by an 
FEV1/FVC ratio lower than 0.70), were recommended to contact their PC physician for 
further clinical evaluation and eventual treatment (Figure 1). Finally, the PC physician 
was asked to return to the CP a questionnaire with the specific diagnostic and/or 
therapeutic actions taken in that particular individual within the next 3 months. In all 
cases, the specific reason(s) for refusal to participate in the study at any stage (Figure 1) 






Education and training of pharmacists 
Every pharmacist participating in the study attended a four-day (16 hours) hands-on 
training course on forced spirometry (FS) according to international guidelines and 
officially accredited by the Catalonian Government using the spirometer later employed 
in the study (Easy-One®, ndd Medical Technologies and Sonmedica, Zurich, 
Swizerland).8-10 Pharmacists were also instructed in the management of the web-
database used during the study to collect all data (Linkcare®).6 
 
Spirometry 
Like in our pilot study,5 spirometry was conducted by using an Easy-One® spirometer, 
because it has been shown to be adequate for population studies, it does not require 
regular calibration, and it fulfils all ERS/ATS technical recommendations.11-13  As 
recommended by guidelines, each CP allocated an adequate space for spirometry 
testing. The spirometer was connected to a personal PC with internet access so 
spirometric results were uploaded automatically into a specific web database 
(Linkcare®).6  
As have been recommended for COPD case-finding strategies, and in order to make a 
simple and feasible initial measure in CP, only pre-bronchodilatador spirometry was 
done.14 Reference values used correspond to the Spanish population.15 Spirometry 
quality was classified into grade A to F following international recommendations 
(Table 1).8-9,16 An expert in spiromety (FB) reviewed and rated manually all 
measurements loaded into the system and reported back weekly to each CP on the 
quality of their tests, including their repeatability, characteristics and onset (back 







specific queries and feedback to the expert. The Linkcare® ICT platform provided 
traceability of all actions and dialogs that occurred during the study.6 
 
Statistical analysis 
Data were quality controlled centrally and a homogeneous template to translate all 
coding was applied. Variables were double-checked by each pharmacist and the 
principal investigator, and values that were considered as potential errors or outliers 
were individually discussed and confirmed, or removed. Comprehensive tabulations 
with ranges, mean and standard deviation of all quantitative variables, and percentages 
of all qualitative variables, were available for each CP. Results are presented as mean 
(standard deviation) or n (and percentage) as needed. The Student T-test and Chi2 test 
were used to compare differences between groups as appropriate. A p <0.05 was 
considered statistically significant.  
 
RESULTS 
The flow of participation in the study is presented in Figure 1. Of 3,121 CP customers 
invited to participate in the program, 2,295 (73.5%) accepted. There was no non-
response bias, as the age and gender distribution of participants in all five rounds were 
not significantly different from those not participating (Table 2).  Of the 2,295 
participants, 1,456  ! 
	
"
#high risk$"%&using the GOLD 
screener questionnaire. Demographic and clinical characteristics of participants at low 
or high risk groups for COPD are presented in Table 3, where it can be seen that age 
was similar in both groups (55.4±10.4 years versus 54.2±10.2 years in the low vs. high 




(p<0.05), and with higher smoking exposure and, experiencing more respiratory 
symptoms, all these being items within the screener questionnaire (Table 3).  
 
The majority (69.4 %) of spirometries performed were grade A and B, and they were 
considered of acceptable clinical quality by the expert (FB). This percentage remained 
stable in the five sequential study rounds (Figure 2, panel A). As a sensitivity analysis 
following previous reports, should we had considered grade C also as clinically 
acceptable, this figure would have risen to 75.1 %.17 Only 8.9% were ranked as quality 
grade F, the worst possible. 
 
Table 4 shows the clinical characteristics and spirometric results of participating 
subjects at high risk for COPD. Of 1,423 individuals completing quality-controlled pre-
BD spirometry, 282 (19.8%) had airflow limitation with an FEV1/FVC% ratio <0.70 
compatible with COPD. This was remarkably reproducible in all temporal study rounds 
(Chi2 p for trend n.s.) (Figure 2, panel B). Patients with airflow limitation were 
significantly older, mostly males and (by definition) had worse lung function than those 
with normal spirometry but interestingly, cumulative smoking exposure and body-mass 
index (BMI) were similar in both groups (Table 4). Figure 3 presents the distribution of 
FEV1 (% predicted) by age in participants with and without airflow limitation.  
 
All subjects with pre-BD airflow limitation but those 38 (13.5%) with poor quality 
spirometry were referred to their PC physician for further evaluations (244). Only 39 
(15%) of them provided feed-back to the CP and returned the filled up questionnaire 
requested. In eleven of them (28%) COPD was confirmed by the PC physician, and in 6 









This study: (1) extends our previous pilot experience (7) to a larger population of 
community pharmacies (n=100) and confirms that a COPD case finding program in 
high-risk customers is feasible using a simple questionnaire and forced spirometry; (2) 
confirms that the use of a TIC platform to control the quality of spirometries is both 
feasible and effective, not only in PC as previously reported by our group, but also in 
CP;6 and, (3) shows that this strategy can effectively identify undiagnosed COPD 
patients. 
 
Underdiagnosis, hence undertreatment, is one of the main unmet medical needs in 
COPD. Decreased quality of life and daily life activities have been reported in 
undiagnosed COPD subjects.18-19 Unfortunately, epidemiological studies in Spain 
showed that from 1997 to 2007 COPD underdiagnosis was reduced by only 5 
percentage points, from 78% to 73%.20 Therefore, reducing COPD underdiagnosis is a 
public-health priority. The spirometry case finding program assessed here was able to 
identify one in five (20%) of high risk individuals with airflow limitation. Because we 
limited our case-finding to find new diagnoses, as we excluded 245 participants who 
reported prior lung disease or current use of inhalers, the GOLD screener could have 
given a much higher yield, higher than one in three (i.e.: (282+245)/1423=37.0%).  This 
figure is remarkably similar to that published in primary care,21-22 indicating that this 
type of case finding strategies are likely to work similarly in PC and CP. Further, the 
proportion of individuals with airflow limitation in our study was independent of the 
study round (Figure 2, panel B), supporting the internal validity of this observation. 




factors, symptoms, non-fully reversible airflow limitation and the exclusion of other 
obstructive airway diseases such as asthma and bronchiectasis, among others.23 Given 
that only a minority of individuals returned the information requested to their PC 
physician (Figure 1), we cannot provide a final figure for a confirmed diagnosis of 
COPD. Yet, this limitation illustrates the need to improve the coordination between 
formal (PC) and informal (CP) stake-holders in our health-care system, but does not 
detract from the validity of the case finding strategy in CP investigated here.  
 
High quality forced spirometry is essential for the diagnosis and management of COPD. 
2,23-26 We found that most spirometries were of clinically acceptable quality grade. Our 
study clearly indicates that well-trained and supervised (using web-based tools) 
pharmacists can obtain high quality spirometries in CP, similarly to what we showed 
recently in a primary care setting using similar tools.6 In fact, these observations add to 
	(
)	"#Healthy Living Pharmacy$ (HLP) that explores the potential 
of CP to promote healthy living.27 CP can play an important role in a number of health-
promoting programs, including smoking cessation, cardiovascular diseases or screening 
for HIV.28-29 Within respiratory diseases, previous studies have shown that CP can help 
in the management of asthma,30  but to our knowledge, their role in COPD case finding 
had not been addressed before (other than in our previous pilot study).5  
 
Our study has some limitations. Firstly, because of logistic issues, we did not measure 
post-bronchodilator spirometry despite that this is recommended for COPD diagnosis. 
2,23 Yet, pre-bronchodilator spirometry has been widely used in epidemiological studies 
and, in any case, the goal of the COPD case-finding program was not establish the 







work up undiagnosed individuals whom are most likely to suffer this disease.14-31 
Second, our strategy involved the use of well-trained pharmacists, TIC support, two 
questionnaires and quality-controlled forced spirometry. It can be argued it is too 
cumbersome for many CP, so simpler screening strategies, perhaps using questionnaires 
and peak-expiratory flow measurements, deserve investigation.32-33 
 
In summary, this study shows that adequately trained and supported community 
pharmacists can effectively identify individuals at high risk of suffering COPD.  
 
Study founded by: A research grant from the Sociedad Española de Neumología y 
Cirugía Torácica (Becas SEPAR 2008), and an unrestricted grant from Boheringer-
Ingelheim and Pfizer. This study is integrated in the strategy of research in COPD of the 
Spanish Respiratory Society (PII-EPOC SEPAR). 
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Figure 1. STROBE flowchart of participation in the study 
 
Figure 2. Panel A. Proportion of A and B grade spirometries by study rounds. 
Footnote: There were no statistically significant differences between them. Panel B. 
Proportion of high-risk subjects for COPD with airflow limitation (FEV1/FVC < 0.70) 
by study rounds. There were no statistically significant differences between them  
 
Figure 3. Relationship between age and FEV1 (% predicted) in participants with (blue 





Table 1.  Quality scores of spirometry maneuvers according to ATS/ERS 
standardization.(9,16)  A and B scores are considered high quality measurements.  
 
 
Quality score Description 
A 3 acceptable  maneuvers, and best 2 matched with differences in FVC and / or FEV1 
<0.15 L 
B 3 acceptable  maneuvers, and best 2 matched with differences in FVC and / or FEV1 
<0.20 L                     
C 2 acceptable  maneuvers, and best 2 matched with differences in FVC and / or FEV1 
<0.25 ml                                     
D 1 acceptable  maneuver 







Table 2. Demographic characteristics of all invited individuals(see Figure 1) and also 










Age (years), mean±SD  55.0±11 55.3±11 
Women, % 46.4 45.8 
Study Round, % 
   One 
   Two 
   Three 
   Four 


















Table 3. Demographic and clinical characteristics of participants at low and high risk of 
COPD.  Asterisk indicate p<0.05 between the two groups. 
 




Age, mean± SD  55.4±10.4 54.2±10.2 
Women, n (%) 53.7% 45.1%* 
Smoking history, (%) 
          Never 
          Current 









GOLD Risk Score, mean±SD 1.7±0.7 3.6±0.7* 
With Chronic Cough, (%) 1.3 49.2* 
With. Chronic sputum production, (%) 3.1 48.5* 
More breathlessness than people of the same age, (%) 3.1 64.6* 
Age over 40 years old, (%) 100 100 










Table 4. Clinical characteristics and respiratory function for subjects who performed 
spirometry correctly and were classified by FEV1/FVC ratio as normal or with airflow 
limitation (FEV1/FVC <0.70). 
 
 




Age, mean±SD  52.8±9.6 59.7±10.7* 
Women, n (%) 47.5 35.5* 
Smoking history, (%) 
            Never 
          Current 









GOLD screener score, mean±SD 3.5±0.7 3.7±0.7* 
BMI in kg/m2, mean± SD 26.9±6.0 26.5±4.4 
FEV1 in L. , mean±SD 2.9±0.69 2.21±0.75* 
% predicted FEV1, mean±SD 1.02±0.2 0.82±0.2* 
FVC in L. , mean±SD 3.7±0.87 3.5±1.06* 
% predicted FVC, mean±SD 1.01±0.2 0.99±0.2* 
FEV1/FVC, mean±SD 0.78±0.05 0.63±0.07* 
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r e s u m e n
Introducción: El infradiagnóstico es uno de los problemas de mayor impacto en las enfermedades respi-
ratorias y requiere intervenciones especíﬁcas. Una de ellas es tener acceso a una espirometría de calidad.
Este es uno de los objetivos del Plan Director de Enfermedades Respiratorias del Departament de Salut
de la Generalitat de Catalunya.
Objetivo: Conocer la utilización de la espirometría hospitalaria en Catalun˜a, y conocer los posibles déﬁcits
y las opciones de mejora.
Método: Estudio transversal mediante una encuesta a los 65 hospitales públicos de Catalun˜a durante el
an˜o 2009. Se realizó un análisis descriptivo para cada región sanitaria.
Resultados: Se observó una falta de homogeneidad en la utilización de la espirometría a nivel territorial
(de 0,98 a 1,50 espirometrías por 100 habitantes). Se identiﬁcaron 2 factores que están asociados a una
mayor tasa de espirometrías: la existencia de un servicio de neumología en el centro y disponer de
unaubicaciónestablepara realizar espirometrías. Comoáreasdemejora se identiﬁcaronel control de cali-
dad de la prueba, la inclusión en los sistemas hospitalarios de información y los programas de formación
continuada.
Conclusiones: Los resultados de este estudio han permitido identiﬁcar las áreas de mejora para un pro-
grama a desarrollar.
© 2012 SEPAR. Publicado por Elsevier España, S.L. Todos los derechos reservados.







a b s t r a c t
Background: Underdiagnosis is one of the problems with the greatest impact on respiratory disease
management and requires speciﬁc interventions. Access to quality spirometry is especially important and
is an objective of the Master Plan for Respiratory Diseases of the Department of Health of the Generalitat
de Catalunya.
Objective: To determine the current use of spirometry at public hospitals in Catalonia, possible deﬁcien-
cies and options for improvement.
Methods: A cross-sectional survey of 65 public hospitals in Catalonia in 2009. Descriptive analyses were
developed for each public health-care region.
∗ Autor para correspondencia.
Correo electrónico: nuria.roger.casals@gmail.com (N. Roger).
♦ Ver anexo 1.
0300-2896/$ – see front matter © 2012 SEPAR. Publicado por Elsevier España, S.L. Todos los derechos reservados.
http://dx.doi.org/10.1016/j.arbres.2012.12.006
Cómo citar este artículo: Roger N, et al. Encuesta de utilización de la función pulmonar en los hospitales públicos de Catalun˜a en 2009.
Arch Bronconeumol. 2013. http://dx.doi.org/10.1016/j.arbres.2012.12.006
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Results: A lack of uniformity was observed in the use of spirometry at the regional level (between 0,98
and 1.50 spirometries per 100 inhabitants). We identiﬁed two factors associated with a higher rate of
spirometry: i) the existence of a Respiratory Medicine Department at the hospital, and ii) the existence
of a set location to carry out spirometries. Several areas for improvement also were identiﬁed: quality
control of the test itself, the inclusion of spirometry in electronic health-care records and continuing
education programs.
Conclusions: The results of this study have identiﬁed areas for improvement in spirometry programs.
© 2012 SEPAR. Published by Elsevier España, S.L. All rights reserved.
Introducción
Las enfermedades respiratorias son la tercera causa de muerte
en los países desarrollados1. El impacto sobre el sistema sanitario es
muyelevado. Ennuestromedio las enfermedades respiratorias cau-
san el 10% de los ingresos hospitalarios, y el 20% de dichos ingresos
está relacionado con la enfermedad pulmonar obstructiva crónica
(EPOC)2. La prevalencia de la EPOC en personas de más de 40an˜os
se sitúa alrededor del 10%3,4. La agudización de la EPOC es un pro-
blema de salud relevante, por el riesgo elevado para el paciente en
lo que concierne a la supervivencia, y las exacerbaciones frecuentes
aumentan la mortalidad5. La mortalidad durante el ingreso es del
6,7% y la mortalidad al an˜o tras la agudización es del 33%6, aunque
en nuestro medio Almagro et al.7 reportan una mortalidad del 22%,
con un elevado porcentaje de reingresos: el 38% de los pacientes
reingresan al an˜o, y la media del tiempo desde el alta al reingreso
es de 5 meses8.
El infradiagnóstico es uno de los problemas más graves en
el manejo de las enfermedades respiratorias, especialmente de
la EPOC9, que se mantiene persistente a lo largo de los an˜os.
Únicamente un tercio de los pacientes con EPOC reconocen que
padecen esta enfermedad10, y el 21% de los pacientes que ingre-
san por exacerbación de la EPOC aﬁrman que ningún médico
les atiende regularmente por el problema respiratorio11. Además
del infradiagnóstico, es preciso considerar el porcentaje de «mal
diagnóstico»12,13. Pellicer Císcar et al.14 observan que, incluso en el
medio hospitalario, la falta de espirometría es el factor más impor-
tante para explicar el mal diagnóstico de la EPOC. En comparación
con los pacientes con insuﬁciencia cardiaca crónica, los pacientes
con EPOC es menos probable que tengan una prueba conﬁrmatoria
realizada, incluso si ambas condiciones coexisten15,16.
La reducción del infradiagnóstico y el diagnóstico apropiado
requieren intervenciones especíﬁcas, pero sobre todo garantizar el
acceso a una espirometría de calidad17,18.
Uno de los retos más importantes de todos los sistemas sani-
tarios consiste en identiﬁcar las estrategias más adecuadas para
establecer prioridades y trasladar las decisiones a la primera
línea asistencial19,20. El Departament de Salut de la Generalitat
de Catalunya se sirve de los Planes Directores21 para acercar los
planteamientos estratégicos a los operativos con el ﬁn de mejo-
rar la atención al paciente. Uno de los objetivos del Plan Director
de Enfermedades Respiratorias (PDMAR) del Departament de Salut
es el de garantizar al clínico el acceso a una espirometría de cali-
dad independientemente del ámbito asistencial en el que trabaje.
En este contexto, el presente estudio pretende conocer la utiliza-
ción de la espirometría en el ámbito hospitalario de prestación
pública de Catalun˜a, y hacer patentes los posibles déﬁcits, opcio-
nes de mejora y posibles desequilibrios territoriales en el estudio
de función pulmonar, y especialmente en la espirometría.
Material y método
El estudio se ha realizado en el marco de la red de hospitales
públicos de Catalun˜a. El sistema sanitario público de Catalun˜a es
un sistema nacional de salud por el que se garantiza la cobertura a
toda la población, se ﬁnancia a través de impuestos y el paciente no
debe realizar pago alguno en el momento de la atención. La ﬁnan-
ciación de los servicios se realiza a través del Servicio Catalán de
la Salud (CatSalut), que compra servicios a diversos proveedores.
La encuesta se ha distribuido en la red de hospitales (XHUP) con
los que el CatSalut tiene contratada la prestación de servicios. Estos
proveedores, independientemente de la titularidad pública o pri-
vada, constituyen la red de hospitales de utilización pública que
representa el porcentaje mayoritario del total de la red sanitaria de
Catalun˜a.
Encuesta
Se realizó un estudio transversal mediante una encuesta que se
distribuyó a los 65 hospitales de la red pública catalana durante el
primer trimestre de2009 (anexo1). La distribuciónde las encuestas
se realizó a través de las gerencias de los hospitales, que designa-
ron un referente de neumología para conseguir las respuestas y la
información complementaria si fuera necesario. Los resultados se
recogieron entre los meses de abril y junio de 2009. Se hicieron
un máximo de 3 intentos para conseguir los datos, efectuando un
recordatorio telefónico a partir del segundo intento.
Datos
La encuesta recogía información sobre actividad del hospi-
tal, pruebas funcionales respiratorias que se realizaban en cada
hospital, tanto básicas (espirometría forzada) como complejas
(volúmenes pulmonares, capacidad de transferencia de CO, gaso-
metría arterial), número de espirometrías realizadas en el an˜o
anterior, informaciónsobre losespirómetros, solicitantedelasespi-
rometrías y el lugar de realización de estas, control de calidad que
se realizaba, su incorporación a las bases de datos de los hospitales,
información sobre los profesionales que realizaban e interpretaban
las espirometrías, formación que recibían, etc. (anexo 1).
Respecto al lugar donde se realizan las espirometrías, a efec-
tos del presente estudio, se deﬁnió el «laboratorio de función
pulmonar» como un espacio identiﬁcado como tal en el que de
una manera estable trabaja como mínimo un profesional de enfer-
mería para realizar espirometrías, la medición de la capacidad de
transferencia de CO (DLCO) y/o los volúmenes pulmonares.
Indicadores
Los indicadores calculados fueron: el número de espirome-
trías por cada 100 camas de hospital, por cada 100 altas, por
cada 100 consultas externas, por cada 100 urgencias y por cada
100 habitantes. Todos ellos se calcularon por un an˜o. Se obtuvieron
los resultados globales y por región sanitaria.
Análisis estadístico
De forma inicial se realizó un análisis descriptivo de los ítems
del cuestionario por el total de Catalun˜a, por cada una de las regio-
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Barcelona. Se calcularon el número de casos y las frecuencias de
las variables categóricas y los estadísticos de tendencia central y
dispersión de las variables continuas. Para describir la magnitud de
la diferencia entre regiones se ha empleado la razón de variación
(RV). Este estadístico es el cociente entre el valor más alto y el más
bajo de las tasas para el conjunto de regiones estudiadas. Su valor
indica cuánto más varía la región con la tasa más alta respecto a la
región con la tasa más baja.
El número de espirometrías realizadas en cada centro se dis-
tribuye siguiendo una ley de Poisson. Para explorar la asociación
entre el número de espirometrías realizadas en cada centro y los
distintos factores encuestados se construyóunmodelode regresión
de Poisson multinivel, incluyendo el número de altas en el centro
como variable offset. Los factores estudiados fueron la existencia de
un servicio de neumología en el centro, que los pacientes ingresa-
dos fueran atendidos por un neumólogo, el número de pruebas de
función pulmonar, disponer de una ubicación estable para realizar
espirometrías, efectuar control de calidad de las pruebas, disponer
de un sistema de información, que los profesionales reciban for-
mación reglada y haber realizado formación en el último an˜o. Se
consideró signiﬁcativa una asociación con un valor de p inferior a
0,05. Para el tratamiento de los datos se ha utilizado el programa
SPSS v18, y para el análisis estadístico el programa STATA v11.
Resultados
Respuestas
Los 65 hospitales de la red pública catalana respondieron a la
encuesta, y se identiﬁcó que 8 de ellos, por ser de características
monográﬁcas, no realizaban espirometrías. Los resultados que se
presentan a continuación se expresan sobre los 57 hospitales que
realizaban espirometrías. La encuesta se pilotó en 3 centros hospi-
talarios de Barcelona y Vic (autores del disen˜o) a ﬁn de valorar la
factibilidad de los ítems a responder. Las respuestas a la encuesta
fueron encargadas a los responsables médicos de cada uno de los
laboratorios de función pulmonar, que a su vez designaron al pro-
fesional que contestó la encuesta; no tenemos datos de la categoría
profesional y/o responsabilidad.
Presencia del neumólogo
En el 34,5% (n=19) de los hospitales existía servicio de Neu-
mología, en el 34,5% (n=19) existía sección de Neumología, en el
25,5% (n=14) existía la ﬁgura del neumólogo consultor y en el 5,5%
(n=3) de los hospitales no existía ninguno de los 3 recursos ante-
riores. Los pacientes respiratorios ingresados eran atendidos en el
24,1% (n=13) de los casos mayoritariamente por neumólogos, en
el 35,2% (n=19) por internistas y en el 40,7% (n=22) restante de
manera compartida entre neumólogos e internistas.
Tipos de pruebas
En la tabla 1 semuestra el tipo de exploraciones funcionales res-
piratorias que se realizaban en los 57hospitales estudiados. Todos
los centros realizaban espirometrías. En el 85,9% (n=49) de los cen-
tros se realizaban almenos 3 de estas pruebas. En todas las regiones
sanitarias se realizaban pruebas en pacientes pediátricos, aunque
únicamente las realizaban el 67% de los hospitales, es decir, 39
de ellos. Los hospitales realizaban espirometría en diversas ubi-
caciones del hospital o fuera del hospital que no son mutuamente
excluyentes: en el 47% (n=27) de los hospitales tienen una ubica-
ción física estable; en estos, el 37% (n=21) tienen un laboratorio de
función pulmonar según la deﬁnición efectuada previamente. Así
mismo, la espirometría también se realiza en otros entornos hospi-
talarios: en el 37% (n=21) en consultas externas, en el 26% (n=15)
en el hospital de día, en el 10% (n=17) en la sala de hospitalización
convencional, en el 7% (n=4) en la casadel paciente, en el 14% (n=8)
en la sala de hospitalización de neumología y en el 10% (n=17) en
la sala de hospitalización de medicina general.
Control de calidad
En todos los hospitales se calibraba el espirómetro haciéndolo
preferentemente el personal de enfermería o personal técnico: 81%
(n=43) enfermería, 30% (n=16) técnico, 17% (n=9)médico, aunque
en algunos casos la calibración se realizaba indistintamente por los
diferentes profesionales. La interpretación de las pruebas dependía
de la organización de cada centro. En el 11% (n=6) de los casos cada
médico interpretaba las pruebas solicitadas por élmismo. En el 87%
(46%) de los hospitales los neumólogos interpretan pruebas y en el
19% (n=10) también los internistas. En el 9% (n=5) de los centros
la interpretación la realizan los médicos de familia, y en solo un
hospital el personal de enfermería.
El 71% (n=40) de los hospitales respondieron que efectuaban
control de calidad de las pruebas. Dado que la pregunta permitía
una respuesta abierta, los centros respondieron de forma variada,
y las respuestas más frecuentes fueron la utilización de voluntarios
o profesionales sanos, la supervisión directa de las pruebas, o la
información procedente del propio equipo de espirometría y/o el
análisis visual de las curvas ﬂujo-volumen.
En el 35% (n=20) la información aportada por la espirometría
estaba en el sistema de información del hospital, incorporándose
de forma manual en 9 de ellos y automáticamente en 11. En el
24,5% (n=13) de los hospitales el contenido exacto del informe de
la espirometría pasaba a la base de datos del hospital o a la historia
clínica. En el 20,8% (n=11) de los casos se incorporaban los datos
de la espirometría en formato no desagregado, que no permite el
tratamiento individualizado de los datos (formato pdf), en el 7,5%
(n=4) de los hospitales solo los datos en un formato desagregado,
y la espirometría en su totalidad en un formato desagregado en el
3,8% (n=2) de los hospitales.
Formación de los profesionales
Se observó que únicamente un hospital seleccionaba profesio-
nales con formación previa, mientras que en la mayoría de ellos
(86,8%, n =46) se seleccionaban los profesionales y posteriormente
recibían formación. En el 43,9% (n=25) de los hospitales los profe-
sionales que realizaban espirometrías recibían formación interna
no reglada, en el 26,3% (n=15) recibían formación interna reglada.
A la pregunta de qué tipo de formación continuada realizaban,
el 25% (n=14) únicamente realizaban formación en el momento
de la selección de los profesionales, el 14% (n=8) realizaban for-
mación periódica anual, mientras que el 59,6% (n=34) realizaban
formación de manera espontánea. A la pregunta de cuánto tiempo
hacía desde que un profesional implicado en la realización de
espirometrías había realizado un curso, en el 14,8% (n=8) de hos-
pitales la respuesta fue menos de 3meses, en el 5,6% (n=3) entre
3 y 6 meses, en el 20,4% (n=11) fue menos de un an˜o, en el
24,1% (n=13) entre uno y 2an˜os, y en el 35,2% (n=19), más de
2an˜os.
Solicitud de exploraciones
La encuestamostró que los profesionales que solicitaban la espi-
rometría eran en el 57% (n=30) el neumólogo de hospital, en el 18%
(n=9)médicos especialistas enmedicina interna, otrosmédicos del
hospital en el 11% (n=6) de los casos, neumólogos de fuera del hos-
pital en el 3% (n=2) de los casos, médicos de atención primaria en
el 4% (n=2), y médicos de otros hospitales en el 2% (n=1).
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Tabla 1
Número y porcentaje de hospitales con pruebas de función respiratoria en cada región sanitaria. Catalun˜a, 2009
Región sanitaria Vol +Difusión Broncoprov. P6M Gases Esfuerzo
n % n % n % n % n %
Alt Pirineu i Aran 0 0% 1 25% 0 0% 4 100% 0 0%
Barcelona 18 62% 19 66% 23 79% 29 100% 10 34%
Catalunya Central 3 75% 3 75% 4 100% 4 100% 2 50%
Girona 1 13% 5 63% 7 88% 7 88% 4 50%
Lleida 2 100% 2 100% 1 50% 2 100% 2 100%
Camp de Tarragona 2 33% 3 50% 2 33% 6 100% 3 50%
Terres de l’Ebre 1 25% 1 25% 1 25% 4 100% 2 50%
Total 27 47% 34 60% 38 67% 56 98% 23 40%
Broncoprov.: pruebas de broncoprovocación; P6M: prueba de los 6 min de marcha; Vol +Difusión: volumen + difusión.
Distribución del número de exploraciones
La tasa de espirometrías por 100 altas hospitalarias/an˜o fue de
14,97, con una RV de 1,82, indicando un 82% más de utilización
entre la región con la tasa mayor respecto a la región con la tasa
menor. La tasa de espirometrías por 100 habitantes/an˜o fue de 1,32,
con una RV de 1,53; en la ﬁgura 1 se puede observar la gran variabi-
lidad en la región sanitaria deBarcelona. Dicha región se analizó por
sectores sanitarios, debido a que aglomera el 67,8% de la población
total de Catalun˜a (ﬁgs. 1 y 2 y tabla 2).
En la tabla 3 se presenta el análisis para explorar la asociación
entre el número de espirometrías realizadas en cada centro y los
distintos factores encuestados mediante un modelo de regresión
de Poisson multinivel. De los distintos factores estudiados presen-
taron una asociación estadísticamente signiﬁcativa la existencia de
un servicio de neumología en el centro y disponer de una ubicación
estable para realizar espirometrías, La presencia de estos factores
en un centro incrementa el 59 y el 56%, respectivamente, las tasas
de espirometrías. Así mismo conseguían explicar (el 8%) parte de la
variancia existente entre centros, aunque esta seguía siendo consi-
derable. En este sentido, el estadístico de la mediana de la razón de
tasas de espirometrías (median incidence rate ratio, MIRR) se inter-
preta de forma que el incrementomedio de la tasa de espirometrías
entre 2 centros cualesquiera es del 98% en elmodelo vacío y del 88%
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Tabla 2
Tasa de espirometrías por regiones sanitarias de Catalun˜a. Catalun˜a, 2009
Región sanitaria Tasa espirometrías/100 habitantes/an˜o Tasa espirometrías/100 altas/an˜o Tasa espirometrías/100 consultas externas declaradasa/an˜o
Alt Pirineu i Aran 1,50 12,99 2,90
Barcelona 1,37 16,33 5,20
Catalunya Central 1,18 13,31 3,11
Girona 1,50 14,82 4,08
Lleida 1,01 13,78 5,65
Camp de Tarragona 0,98 8,97 1,87
Terres de l’Ebre 1,14 11,15 2,24
Total 1,32 14,97 4,31
Fuentes: Encuesta de Espirometrías PDMAR, 2009, y Registro Central de Asegurados del CatSalut, 2009.
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Figura 2. Tasas de espirometrías por centro (Catalun˜a, 2009). Se representan las
tasas de espirometrías por centro para toda Catalun˜a y por región sanitaria en escala
logarítmica y centradas en la media para mejorar su comparabilidad. Cada punto
representa un centro hospitalario.
Bcn: región sanitaria Barcelona; Cat: total Catalun˜a; Centre: región sanitaria Centro;
Ebre: región sanitaria Terresde l’Ebre;Girona: región sanitariaGirona; Lleida: región
sanitaria Lleida; Piri: región sanitaria Alt Pirineu; Tarra: región sanitaria Tarragona.
en el modelo ﬁnal. Esto sugiere una elevada variabilidad entre las
tasas por centro, como reﬂejan la ﬁgura 1 y la tabla 2. En esta ﬁgura
los puntos representan las tasas de espirometría de cada centro
logaritmizadas y centradas en el 0 para una mejor comparabilidad.
Tabla 3
Modelo Poisson multinivel entre el número de espirometrías y distintos factores
encuestados
Estimador (error estándar)
Modelo vacío Modelo ﬁnal
Servicio de neumología – 1,59 (0,33)
Ubicación física estable – 1,56 (0,30)
Variancia hospital 0,72 (0,07) 0,66 (0,07)
Log likelihood –409.986 –405.985
MIRR 1,98 1,88
El modelo de regresión de Poisson se emplea en estudios con variables de recuento
en una unidad de tiempo o espacio, en este caso el número de espirometrías reali-
zadas en un an˜o. Los coeﬁcientes del modelo se interpretan en términos de razones
de tasa de incidencia. Tomando como ejemplo la variable «servicio de neumología»,
la presencia de este en un centro incrementa en un 59% la tasa de incidencia de
espirometrías.
Se presenta primero el modelo vacío para mostrar la reducción, tanto en términos
de verosimilitud (log-likelihood) como de varianza entre centros, que representa la
inclusión de las variables «Servicio de neumología» y «Ubicación física estable».
El estadístico MIRR (del inglés median incidence rate ratio) representa la mediana
de la distribución de la diferencia de tasas de espirometrías entre 2 centros cuales-
quiera.
Discusión
Los resultados de la encuesta de espirometrías de hospita-
les muestran una falta de homogeneidad entre los hospitales
y regiones sanitarias de Catalun˜a respecto a la utilización de
la espirometría, lo que puede ser un factor que contribuya al
infradiagnóstico9,22 de las enfermedades respiratorias23.
Esta heterogeneidad en algunos estudios ha sido atribuida a fac-
tores como la accesibilidad a la prueba15, o la falta de solicitud de la
prueba por parte del médico. En nuestro estudio la variabilidad no
puede ser atribuidaa la accesibilidad, yaque todas las regiones sani-
tarias y todos los hospitales disponen de la infraestructura nece-
saria para la realización de espirometrías. La variabilidad puede
explicarse por la existencia o no de un servicio deNeumología y por
una ubicación física estable para la realización de la espirometría.
Estos factoresestánasociadosaunmayornúmerodeespirometrías.
El servicio de Neumología implica un reconocimiento explícito de
la distribución de tareas en el centro. Por lo tanto, a la luz de los
datos de la encuesta, podemos sostener que lo importante no es la
estructura en sí misma (es decir, la existencia del Servicio) sino el
reconocimiento explícito de la importancia de las pruebas funcio-
nales respiratorias. Algunos estudios atribuyen a las características
de la propia enfermedad la infrautilización de la espirome-
tría respecto a otras pruebas como la ecocardiografía15,16,24. No
hemos encontrado un indicador que nos permita conocer el rango
adecuado de espirometrías por volumen de altas o por camas hos-
pitalarias o por 100 habitantes, pero sí consideramos que obtener
estos resultados en el momento inicial del disen˜o de un plan direc-
tor nos puede proporcionar nuestro propio indicador para evaluar
futuros resultados, teniendoen cuentanoobstanteque siemprenos
encontraremos ante un indicador de proceso y no de resultado.
Es probable que diversos factores puedan explicar la diferente
utilización de la espirometría en los hospitales, desde factores cen-
trados en los propios profesionales, a factores organizativos. La
adhesión a la utilización de las guías de práctica clínica entre los
profesionales25 o la formación básica de los que atienden a los
pacientes respiratorios de los hospitales puede hacer variar la uti-
lización de la espirometría. Así, tal y como se muestra en nuestro
estudio, en los hospitales en los que existía un servicio de Neu-
mología y que disponían de una ubicación física estable para la
realización de espirometrías, se realizaba un número mayor de
espirometrías. Este resultado conﬁrma el importante trabajo a rea-
lizar en todos los ámbitos y dispositivos sanitarios por parte de
los neumólogos para potenciar el uso de la espirometría por otros
especialistas y por los médicos de atención primaria.
La espirometría es una prueba con una elevada dependencia
del profesional sanitario que la realiza. Se constata la importan-
cia de la formación de este profesional en el momento de realizar la
espirometría26–28 y, por tanto, una necesidad organizativa de pro-
fesionales formados en el momento de acceder a dichos lugares
de trabajo. Se evidencia además la necesidad de programas de for-
mación continuada estandarizados y homogéneos aceptados por
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todas las organizaciones para lograr un elevado nivel de calidad
en la espirometría. Destaca en nuestra encuesta la escasa riguro-
sidad en el apartado de formación continuada en espirometría, ya
que en elmomento de la selección de los profesionales para la reali-
zación de espirometrías, en la mayoría de los hospitales no se tiene
en cuenta la formación previa y la formación que se realiza es una
formación no reglada ni realizada de manera regular.
Al analizar el control de calidad efectuado sobre las espirome-
trías, destaca la diversidad de respuestas ante una pregunta abierta
como era la realización de control de calidad. Estrategias de tele-
medicina probablemente podrían contribuir a mejorar este control
de calidad y a conseguir un incremento de las espirometrías de
calidad29. Así mismo se ha detectado otra área de mejora, como
es el acceso a los datos de la espirometría desde los sistemas de
información hospitalarios. A nuestro entender es crucial que, en el
progresivo desarrollo de la historia clínica informatizada, la espi-
rometría no debe quedar postergada.
La evaluación del resto de exploraciones funcionales respirato-
rias nosmuestra que todas las regiones sanitarias tienen acceso a la
realizacióndepruebas funcionales respiratorias complejas, excepto
la Vall d’Aran, una región sanitaria de alta montan˜a pero que tiene
sus ﬂujos de conexión bien establecidos con la región sanitaria más
cercana. Destaca no obstante que la prueba de los 6min de marcha
no está ampliamente difundida en todos los hospitales, como sería
de esperar por su sencillez de utilización30 y por su importancia en
la valoración integral de los pacientes con EPOC31.
Limitaciones del estudio
La metodología utilizada en el presente estudio ha sido una
encuesta. Aunque no existían alternativas metodológicas para la
realización del estudio, se deben tener en cuenta las limitaciones
de esta fuente de información. El presente estudio no ha evaluado
la red de atención primaria, pero recientemente hemos iniciado
una encuesta a todos los centros de salud de la red pública de
Catalun˜a. Dado que no existían otras encuestas territoriales ni
nacionales ni internaciones, no podemos comparar nuestros datos
con la bibliografía existente. No existe en la literatura ningún indi-
cador sobre el número de espirometrías por habitante; por lo tanto,
uno de los objetivos que se planteaban inicialmente sobre la valo-
ración de la variabilidad de los resultados y su comparación con la
literatura no ha podido ser estimado. Es por este motivo que no se
valora la relevancia estadística y clínica de las tasas de espirometría
por habitante y an˜o.
Otras limitaciones de nuestro estudio pueden ser el sesgo de
información derivado de quien ha respondido la encuesta y que las
tasas estimadas no han podido ser estandarizadas en relación a la
edad y el sexo de los pacientes. Parte de la variabilidad encontrada
podría ser explicada por una distinta estructura de poblacional
de cada área sanitaria, como también por un nivel de gravedad o
comorbilidad distinto.
Conclusiones
El análisis de la utilizaciónde las espirometrías en el ámbito hos-
pitalario nos ha permitido: a) detectar como factores relacionados
con la mayor realización de espirometrías la existencia de un servi-
cio de neumología y de una ubicación estable para la realización
de las mismas; b) elaborar un programa formativo homogé-
neo, descentralizado y «autorreplicable» para todas las regiones
sanitarias de Catalun˜a que permita mantener la realización de
espirometrías de calidad dentro de unas organizaciones en cons-
tante cambio32; c) objetivar la necesidad de la incorporación de
la espirometría a las bases de datos de los hospitales (historia clí-
nica electrónica) estandarizando la transferencia de datos, lo que
facilitará la interoperabilidad, y d) establecer modelos de control
de calidad de la espirometría utilizando las TIC29. Así mismo, nos
ha permitido elaborar un indicador de la utilización de la espiro-
metría forzada en una población (0,98 a 1,53 espirometrías por
100 habitantes), que según nuestro conocimiento no existe en la
bibliografía revisada33. Todos estos cambios deben impactar tanto
en los propios profesionales como en las estructuras organizativas
de loshospitales, y en todos los casosgarantizar el accesoaunaespi-
rometríade calidadpara todos los clínicos, independientementedel
nivel sanitario en el que trabajen.
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celona); E. Saltó (Direcció General de Salut Pública, Barcelona);
R. Tresserras (Direcció General de Regulació, Planiﬁcació i Recursos
Sanitaris; Departament de Salut, Barcelona), E. Torrente (Agència
d’informació, Avaluació y Qualitat en Salut [AIAQS]).
Bibliografía
1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional
burdenofdiseaseandrisk factors, 2001: systematic analysisofpopulationhealth
data. Lancet. 2006;367:1747–57.
2. Activitat assistencial de la xarxa sanitaria de Catalunya. Any 2009. Registre del
Conjunt Bàsic Mínim de Dades (CMBD) CatSalut. Departament de Salut. Gene-
ralitat de Catalunya.
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Glo-
bal burden of COPD: systematic review and meta-analysis. Eur Respir J.
2006;28:523–32.
4. Miravitlles M, Soriano JB, García-Río F, Mun˜oz L, Duran-Tauleria E, Sanchez G,
et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of
life and daily life activities. Thorax. 2009;64:863–8.
5. Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, Salcedo E, Navarro M,
Ochando R. Severe acute exacerbations and mortality in patients with chronic
obstructive pulmonary disease. Thorax. 2005;60:925–31.
6. Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, Vestbo J, Feenstra TL.
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling
approach. Eur Respir J. 2011;37:508–15.
7. Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL,




Cómo citar este artículo: Roger N, et al. Encuesta de utilización de la función pulmonar en los hospitales públicos de Catalun˜a en 2009.
Arch Bronconeumol. 2013. http://dx.doi.org/10.1016/j.arbres.2012.12.006
ARTICLE IN PRESSG ModelARBRES-730; No.of Pages7
N. Roger et al / Arch Bronconeumol. 2013;xxx(xx):xxx–xxx 7
8. Bahadori K, FitzGerald JM, Levy RD, Fera T, Swiston J. Risk factors and outcomes
associated with chronic obstructive pulmonary disease exacerbations requiring
hospitalization. Can Respir J. 2009;16:e43–9.
9. Soriano JB, Ancochea J, Miravitlles M, García-Río F, Duran-Tauleria E, Mun˜oz L,
et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional
survey 1997-2007. Eur Respir J. 2010;36:758–65.
10. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalence
and underdiagnosis of chronic obstructive pulmonary disease among patients
at risk in primary care. CMAJ. 2010;182:673–8.
11. Garcia-Aymerich J, Escarrabill J, Marrades RM, Monsó E, Barreiro E, Antó JM,
EFRAM Investigators. Differences in COPD care among doctors who control the
disease: general practitioner vs. pneumologist. Respir Med. 2006;100:332–9.
12. Menezes AM, Perez-Padilla R, Jardim JR, Muin˜o A, Lopez MV, Valdivia G, et al.,
PLATINO Team. Chronic obstructive pulmonary disease in ﬁve Latin American
cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–81.
13. Menezes A. Multi-center survey of COPD in ﬁve major Latin American
cities. The Platino Survey. 2002 [consultado 2 Feb 2011]. Disponible en:
www.platino-alat.org
14. Pellicer Císcar C, Soler Catalun˜a JJ, Andreu Rodríguez AL, Bueso Fabra J, en repre-
sentación del Grupo EPOC de Sociedad Valenciana de Neumología. Calidad del
diagnóstico de enfermedad pulmonar obstructiva crónica en el ámbito hospita-
lario. Arch Bronconeumol. 2010;46:64–9.
15. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of
conﬁrmatory tests inpatientshospitalizedwith thediagnosisof chronicobstruc-
tivepulmonarydiseaseor congestiveheart failure. RespirCare. 2006;51:1120–4.
16. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obs-
tructive pulmonary disease. Lancet. 2009;374:721–32.
17. Torrubia Fernandez MJ, Comin Orce A, Moreno Venris M, Carrizo Sierra J, Marin
Trigo JM. Uso de la espirometría versus ecocardiografía en pacientes hospita-
lizados por EPOC o insuﬁciencia cardíaca. An Med Interna (Madrid). 2008;25:
222–5.
18. Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, Halbert RJ, et al. Using
targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary
disease. Respiration. 2011;81:476–82.
19. Lavis JN, Permanand G, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for
evidence-informed health Policymaking (STP) 13: Preparing and using policy
briefs to support evidence-informed policymaking. Health Res Policy Syst.
2009;7 Suppl 1:S13.
20. Lavis JN, Boyko JA, OxmanAD, Lewin S, FretheimA. SUPPORT Tools for evidence-
informedhealthPolicymaking (STP)14:Organisingandusingpolicydialogues to
support evidence-informed policymaking. Health Res Policy Syst. 2009;7 Suppl
1:S14.
21. Tresserras R. Planiﬁcación según prioridades de salud. Criterios de planiﬁca-
ción relacionados con los Planes Directores. Med Clin (Barc). 2008;131 Supl 4:
42–6.
22. Soriano JB, Miravitlles M, Borderías L, Duran-Tauleria E, García Río F, Martínez J,
et al. Diferencias geográﬁcas en la prevalencia de EPOC en Espan˜a: relación con
hábito tabáquico, tasas de mortalidad y otros determinantes. Arch Bronconeu-
mol. 2010;46:522–30.
23. Ulrik CS, Løkke A, Dahl R, Dollerup J, Hansen G, Cording PH, et al., TOP study
group. Early detection of COPD in general practice. Int J Chron Obstruct Pulmon
Dis. 2011;6:123–7.
24. Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, et al. Spirometry
utilization for COPD. Chest. 2007;132:403–9.
25. Lee TA, Bartle B,Weiss KB. Spirometry use in clinical practice followingdiagnosis
of COPD. Chest. 2006;129:1509–15.
26. Center for Disease Control and Prevention. Workplace safety and health topics.
Spirometry Spirometry training. 2004 [consultado 1 Mar 2011]. Disponible en:
www.cdc.gov/niosh/topics/spirometry/training
27. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al.,
ATS/ERS Task Force. General considerations for lung function testing. Eur Respir
J. 2005;26:153–61.
28. Pérez-Padilla R, Vázquez-García JC, Márquez MN, Menezes AM, PLATINO Group.
Spirometry quality-control strategies in a multinational study of the prevalence
of chronic obstructive pulmonary disease. Respir Care. 2008;53:1019–26.
29. Burgos F, Disdier C, Lopez de Santamaria E, Galdiz B, Roger N, RiveraML, et al., on
behalf of e-Spir@p Group. Telemedicine enhances quality of forced spirometry
in primary care. Eur Respir J. 2012;39:1313–8.
30. Burgos F, Casan P. Manual SEPAR de procedimientos n.◦ 4. Procedimientos de
evaluación de la función pulmonar II. Barcelona: Permanyer; 2004.
31. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The
body-mass index, airﬂow obstruction, dyspnea, and exercise capacity index in
chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–12.
32. Escarrabill J, Roger N, Burgos F, Giner J, Molins A, Tresserras R, en nombre del
Grupo de Función Pulmonar y del equipo directivo del PDMAR. Disen˜o de un
programa de formación básico para conseguir espirometrías de calidad. Educ
Med. 2012;15:103–7.
33. Mohanka M, McCarthy K, Xu M, Stoller JK. A survey of practices of pul-









Mª Antonia Llauger, Alba Rosas,	, Elena Torrente, Ricard Tresserras, Joan Escar-
rabill y el grupo de trabajo de función pulmonar del Plan Director de las Enfermedades del 
Aparato Respiratorio (PDMAR).





	: Forced spirometry (FS) is key in the diagnosis of respiratory diseases, but several 
studies suggest unavailability of equipment, deficits in training and insufficient quality control 
as causes of suboptimal results of FS in primary care. The aim of the study was to examine the 
accessibility and use of FS in public primary care facilities in Catalonia.
0: Cross-sectional study using a survey of 366 Primary Care Areas (ABS) during the third 
quarter of 2010, with information on spirometers, training, interpretation and quality control, 
and the priority that the quality of spirometry had for the team. 
	: FS/100 inhabitants/year, FS/month/ABS; FS/month/10,000 inhabitants.
: Response rate to the survey was 75%. 97.5% of the ABS had spirometer and made an 
average of 2.01 spirometries/100 inhabitants (34.68 spirometry/ABS/month). 83% of the pri-
mary care centers have trained professionals. Formal training is performed in more than 50% 
of the centers, but information was not obtained on quality control and 70% of the centers 
performed some sort of calibration. 
The interpretation of the tests is made by the family physician in 87.3% of cases. In 68% of 
cases no quality control is carried out. 66% of the data is entered into the health medical re-
cord manually. 50% of the survey responders recognized the need for prioritization strategies 
for improving the quality of FS.
		: Despite the accessibility of FS, efforts should be prioritized in the integration of 
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Abstract
Forced spirometry (EF) is key in the diagnosis of respiratory disease, but several studies 
suggest unavailability of spirometers, deficits in training and insufficient quality control.
The study wants to examine the accessibility and use of EF in public primary care facilities 
in Catalonia.
Cross-sectional study using a survey to 366 health areas (ABS) during the third quarter of 2010, 
with information on spirometers, training, interpretation and quality control, and the priority that the 
quality of spirometry had for the team.
Indicators: EF/100 inhabitants/year, EF/month/ABS; EF/month/10000 inhabitants.
Response rate: 75%. 97.5% of the ABS had spirometer and made an average of 2.01
spirometries/100 inhabitants (34.68 spirometry/ABS/month). 83% have trained
professionals. > 50% centers perform formal training but no information is available on the 
quality. 70% performed some sort of calibration. Interpretation: the family
physician in 87.3% of cases. In 68% of cases not performed any quality control of exploration. 
2/3 typed data manually into the computerized medical record. > 50%
recognized a high priority strategies for improving the quality. Despite the accessibility of EF 
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Resumen
La espirometría forzada (EF) es clave en el diagnóstico de las enfermedades 
respiratorias, pero diversos estudios sugieren falta de disponibilidad de espirómetros, 
déficits en la formación e insuficiente control de calidad.
El presente estudio pretende conocer la accesibilidad y la utilización de la EF en los
dispositivos públicos de atención primaria en Cataluña.
Estudio transversal mediante una encuesta a 366 áreas básicas de salud (ABS) durante
el tercer trimestre de 2010, con información relativa a los espirómetros; la formación;
la interpretación y el control de calidad; y el grado de prioridad que la calidad de la
espirometría tenía para el equipo.
Indicadores: media de EF/100 habitantes/año; índice de EF/mes/ABS; índice de
EF/mes/10000 habitantes.
Porcentaje de respuesta: 75%. El 97,5% de las ABS disponen de espirómetro y realizan
una media de 2,01 espirometrías/100 habitantes (34,68 espirometrías/ABS/mes). El
83% disponen de profesionales formados. >50% de los centros realizan formación
reglada, pero no se dispone de información sobre la calidad de la misma. En el 70% se
realiza algún tipo de calibración. Interpretación: el médico de familia en el 87,3%de los
casos. En el 68% de los casos no se realiza ningún tipo de control de calidad de la
exploración. 2/3 introducen manualmente los datos en la historia clínica informatiza.
>50% se atribuye una prioridad alta a las estrategias de mejora de la calidad EF.
A pesar de la accesibilidad a la EF deben realizarse esfuerzos para estandarizar la
formación, incrementar el número de exploraciones y promover el control de calidad
sistemático.
Palabras clave: espirometría forzada, control de calidad, formación, interpretación.
Abstract
Forced spirometry (EF) is key in the diagnosis of respiratory disease, but several studies
suggest unavailability of spirometers, deficits in training and insufficient quality
control.
The study wants to examine the accessibility and use of EF in public primary care
facilities in Catalonia.
Cross-sectional study using a survey to 366 health areas (ABS) during the third quarter
of 2010, with information on spirometers, training, interpretation and quality control,
and the priority that the quality of spirometry had for the team.
Indicators: EF/100 inhabitants/year, EF/month/ABS; EF/month/10000 inhabitants.
Response rate: 75%. 97.5% of the ABS had spirometer and made an average of 2.01
spirometries/100 inhabitants (34.68 spirometry/ABS/month). 83% have trained
professionals. > 50% centers perform formal training but no information is available on
the quality. 70% performed some sort of calibration. Interpretation: the family 
physician in 87.3% of cases. In 68% of cases not performed any quality control of 
exploration. 2/3 typed data manually into the computerized medical record. > 
50% recognized a high priority strategies for improving the quality.
Despite the accessibility of EF efforts should be made to standardize training, 
increasing the number of scans and promote systematic quality control.
Key words: spirometry, quality control, training, interpretation.
Introducción
Las enfermedades respiratorias son la tercera causa de muerte en Cataluña1, tras el 
cáncer y las enfermedades cardiovasculares, tal como ocurre en la mayoría de los 
países desarrollados2. Cerca del 30% de la población de 15 años o más se declara 
fumadora 3 y el tabaquismo sigue siendo un problema de salud importante y el 
mayor factor de riesgo de aparición y exacerbación de enfermedades respiratorias. 
En el caso de la enfermedad pulmonar obstructiva crónica (EPOC), a
diferencia de las enfermedades cardiovasculares, no se ha constatado un descenso de 
la mortalidad. La prevalencia de la EPOC en la población de 40 a 80 años
en nuestro medio se sitúa en un 10,2%4 5.
El infradiagnóstico es otro problema relevante en relación a las enfermedades 
respiratorias. Únicamente un tercio de los pacientes con EPOC reconocen que la 
padecen y el 21% de los que ingresan por una agudización afirman que ningún médico 
les atiende regularmente por el problema respiratorio7. Además, en un elevado 
porcentaje de pacientes el diagnóstico de EPOC no se confirma mediante 
espirometría. Estudios recientes revelan que en el ámbito de la Atención Primaria (AP) 
se confirma el diagnóstico de EPOC con espirometría sólo en la mitad de los 
pacientes8. Walters et al9 señalan que en Australia el 31% de los pacientes 
diagnosticados de EPOC carecen de espirometría forzada (EF) y que el 56% de los 
pacientes diagnosticados de EPOC tienen una espirometría normal.
La reducción del infradiagnóstico y el diagnóstico apropiado requiere intervenciones 
específicas, pero sobre todo garantizar el acceso a una espirometría de calidad10 11. En 
trabajos preliminares en nuestro medio ya se ha destacado la importancia de la 
formación y disponibilidad de espirómetros en el ámbito de AP12. Esta disponibilidad 
de EF mejora el diagnóstico y tratamiento de la EPOC13. La introducción de 
espirómetros pequeños permite realizar la espirometría en cualquier lugar14. No queda 
claro cuál es la mejor manera de organizar la logística para realizar EF en AP, pero no 
debería separarse la estrategia de mejoría en la realización de la prueba con de la de 
mejoría de su interpretación15.
Uno reto importantes de todos los sistemas sanitarios consiste en identificar las 
estrategias más adecuadas para establecer prioridades y trasladar las decisiones a la 
asistencia 16. El Departament de Salut de la Generalitat de Catalunya se sirve de los 
Planes Directores17, como el Plan Director de Enfermedades Respiratorias (PDMAR), 
para acercar los planteamientos estratégicos a los operativos para mejorar la atención 
al paciente. Uno objetivo del PDMAR es garantizar al clínico el acceso a una 
espirometría de calidad independientemente del ámbito asistencial.




dispositivos de AP del ámbito de la prestación pública de Catalunya, identificando los 
posibles déficits y opciones de mejora y los posibles desequilibrios territoriales.
Material y métodos
Estudio transversal mediante una encuesta, elaborada ad-hoc, que se distribuyó a las 
366 áreas básicas de salud (ABS) de Cataluña durante el tercer trimestre de 2010. La 
distribución de las encuestas se realizó a través de las gerencias territoriales de AP, 
que enviaban la encuesta a los directores de los EAP y éstos mandaban las respuestas 
al PDMAR o a las gerencias; el PDMAR hacía el seguimiento de las respuestas. Tras el 
envío inicial se realizó un recordatorio a los 2 meses a aquellas ABS que no habían 
contestado.
El cuestionario recogía información sobre los equipos de espirometría, los 
profesionales y su formación en EF, la interpretación y el control de calidad; y el grado 
de prioridad que la calidad de la espirometría tenía para cada EAP.
Los resultados se recogieron entre julio y agosto de 2010. Se obtuvieron los resultados 
globales para cada ABS y para cada región sanitaria y, para esta última, se calculó la 
tasa de EF por 100 habitantes. Para estudiar el grado de variabilidad en la actividad 
relacionada con la espirometría de cada EAP, se midió la proporción mensual de 
espirometrías realizadas en cada equipo. Para cuantificar esta proporción de acuerdo
al volumen de población de referencia para cada uno de ellos se calculó la tasa de 
actividad mensual en relación a los habitantes asignados.
Se estudió la distribución univariante de cada una de las variables y se realizaron 
análisis territoriales de aquellas más relevantes.
El análisis estadístico se realizó con el paquete estadístico SPSS versión 18.0 (SPSS, Inc, 
Chicago, IL), y se procedió a la elaboración del análisis descriptivo de los ítems del 
cuestionario para Cataluña, para cada región sanitaria y para los sectores sanitarios de 
la región de Barcelona, mediante un análisis de frecuencias de las variables cualitativas 
y calculando los estadísticos de tendencia central y dispersión de las variables 
cuantitativas. Los resultados de las variables categóricas se presentan como porcentaje 
y las de las variables cuantitativas como media y desviación estándar. Para el análisis 
territorial se calculó la media de espirometrías por cada 100 habitantes y añ, el índice 
de espirometría por mes y ABS y también por mes y habitante por ABS, todo ello para 
la descripción de su distribución territorial. Para explorar la posible relación entre el 
grado de prioridad del EAP en la mejora del proceso de las espirometrías y la actividad 
realizada (N de espirometrías mensuales) en las diferentes regiones sanitarias, se 
estudió la correlación de ambas variables ponderadas de acuerdo con el número de 
espirómetros existentes en cada región. Se realizó el test de chi-cuadrado para valorar 
la correlación entre el grado de prioridad y otras variables de la encuesta 
potencialmente relacionadas con el mismo, como la formación reglada del personal, la 
existencia de protocolo de mantenimiento del espirómetro, el registro de la 
espirometría en las historias clínicas informatizadas y el control de calidad.
Resultados
Respuestas
De las 366 ABS a las que se envió la encuesta, respondieron un 75% (275 ABS). En la 
tabla 1 se muestra una relación del índice de respuesta de cada territorio en función 
de las ABS existentes. Para el análisis de las respuestas, se excluyeron los resultados 
de los consultorios locales, por su bajo peso sobre el volumen total de centros 
estudiados y por su diferente estructura. Los resultados se expresan sobre las 275 
ABS que contestaron la encuesta.
Dotación de las ABS
Un 97,5% de los EAP que respondieron a la encuesta declara tener espirómetro en su 
CAP. Un 67,8% declara tener un espirómetro, mientras que un 21,7% declara tener 
dos. Sólo un 4,7% de los centros dispone de 3 espirómetros. A pesar de la existencia 
de variedad de marcas y modelos, en un 99,6% de casos el modelo es un Datospir 120 
(Sibelmed, Barcelona, España).
Actividad
En relación al número de EF mensuales, los datos son variables y se precisa ajustar al 
número de habitantes asignados o bien a la población con cobertura sanitaria
pública en cada territorio. Lo mismo ocurre en cuanto a la variable sobre el número 
de citas semanales para hacer espirometrías. Con el objetivo de poder comparar el 
volumen de actividad, se ha calculado un indicador que mide el promedio de 
espirometrías realizadas anualmente en cada centro por cada 100 habitantes 
asignados. Durante 2009 se realizaron en la AP de Cataluña un promedio de 2,01 
espirometrías por cada 100 habitantes (Tabla 2).
Población pediátrica
Durante el año 2009 se realizaron en Cataluña espirometrías a niños entre 10 y 15 
años en un 68,2% de los centros. En el 47,3% de los casos estas pruebas se 
practicaron en niños menores de 10 años.
Profesionales técnicos
En 213 centros (83%) refieren tener entre una y cuatro enfermeras de referencia 
capacitadas para hacer espirometrías. En 7 (2,7%) centros no hay ninguna y en 37 (14,4%) 
hay más de cuatro. En la mayoría de EAP (62,9%) las mismas enfermeras hacen las 
espirometrías a los menores de 15 años. En cuanto a la ejecución de las pruebas en 
ausencia de los profesionales habituales, en más de la mitad de los EAP (51,7%) se 
desprograma la actividad, mientras que en un 41,8% las realiza otro profesional.
Formación
Un 77% de los EAP declara que sus profesionales que realizan la EF han recibido 
formación reglada, es decir, algún curso o taller específico sobre EF. El 60% de los EAP 
declara que la formación es no reglada (sesiones clínicas, prácticas EF), mientras
que el 23% declara ambos tipos de formación. Aproximadamente la mitad 
(50,5%) de la formación reglada se realiza en el propio centro, mientras que la no
reglada es predominantemente externa (69%). Cerca de un 42% de los EAP declaran 




del centro. El 52% de los EAP declara que la formación continuada para la realización 
de EF es de tipo esporádica, es decir a elección de cada profesional, mientras que sólo 
se declara formación periódica (una vez al año) en uno de cada cuatro centros.
Mantenimiento y calibración
Un 70% de los EAP afirman que se efectúa la calibración de los equipos, 
diariamente o cada vez que se usa el utillaje. En un 21,6% de los casos se realiza de 
forma periódica, pero no diaria. Destaca que en 17 centros no se realiza ningún 
tipo de calibración o bien se hace de forma incorrecta. Sólo un 52,7% de los 
centros afirman tener un protocolo de mantenimiento, cuyo personal responsable 
suele ser la enfermera responsable de la técnica.
Interpretación
En el 87,3% de los EAP la interpretación de la espirometría la hace el médico de 
familia de cada paciente. En 9 equipos (3,4%) interpreta la espirometría un médico 
referente del equipo, y en 14 (5,2%) los neumólogos de referencia. Por otro lado, 
la formación en interpretación de las espirometrías es escasa dado que casi una 
cuarta parte de los equipos declara no tener ningún tipo de formación específica al 
respecto, mientras que en un 43,3% de los casos responde haber recibido alguna 
sesión formativa.
Control de calidad
Prácticamente tres cuartas partes de los equipos (68,4%) no realizan ningún tipo de 
control de calidad.
Grabación de los datos 
Dos terceras partes de los equipos, introducen manualmente los resultados de la 
espirometría en la historia clínica del paciente. En un 14,7% de los casos se 
incorporan de forma automática desde el programa del espirómetro , en formato de 
base de datos y en un 16,5% se efectúa como PDF o texto libre.
Prioridad
En respuesta al grado de prioridad asignado a la mejora en la elaboración de 
espirometrías , en una escala de gradación de 1 a 5, la moda y la media es de 3 y 
2,40 respectivamente. En el 53,3% la prioridad para la mejora en la elaboración de 
espirometrías se sitúa en 4 ó 5. Las respuestas a la variable que preguntó sobre la 
prioridad en la mejora de la realización de las es pirometrías se recodificaron en tres 
categorías agrupando el valor 1 para definir poca o baja prioridad, los valores 2 ó 3 
para definir un grado de prioridad regular, y los valores 4 ó 5 para definir mucha o 
elevada prioridad.
En el 33,9% de los casos la prioridad es regular, mientras que en el 12,8% de los 
equipos la prioridad se categoriza como baja. En el análisis bivariado se observa 
una asociación entre la valoración del grado de prioridad de la realización de las 
espirometrías con la formación del personal (x2=6,50; p= 0.038). La misma relación 
se observa con la existencia de un protocolo de mantenimiento para los 
espirómetros (x2=13,2; p= 0.001). Sin embargo, dicha asociación no se observa si se
analiza la correlación del grado de prioridad para la realización de espirometrías con el 
control de calidad ni con el registro de la espirometría en la historia clínica. La
distribución territorial del grado de prioridad y la del número de espirometrías 
realizadas mensualmente por equipo y habitantes, ponderada por el número de 
centros de cada región sanitaria muestra una fuerte correlación con un coeficiente de 
0,86 (p<0,05).
Discusión
El acceso a una espirometría de calidad es una necesidad inexcusable para la atención 
a los pacientes con enfermedades respiratorias en la AP18. Diversos estudios han 
puesto de manifiesto los problemas relacionados con la espirometría en AP en nuestro 
medio. Hueto et al19 constata la disponibilidad de espirómetros aunque el 22% de los 
centros no los utilizan. Pellicer et al20 observan que, incluso en el medio hospitalario, 
la falta de espirometría es el factor más importante para explicar el mal diagnóstico de 
la EPOC.
En comparación con los pacientes con insuficiencia cardiaca crónica, los pacientes 
con EPOC tienen menor probabilidad de disponer una prueba confirmatoria, incluso 
si ambas condiciones coexisten21. Estos hechos ponen de manifiesto la necesidad de 
garantizar a los clínicos el acceso a una espirometría de calidad, independientemente 
del ámbito asistencial en el que trabajen22.
En el presente estudio analizamos la utilización de la espirometría en los equipos de 
AP, haciendo hincapié en la disponibilidad, la frecuencia de realización, la formación de 
los profesionales, el control de calidad, y la interoperabilidad.
Disponibilidad
Un cambio significativo muy positivo respecto a años anteriores es constatar el hecho 
que prácticamente todos los centros de AP disponen de un espirómetro. Esto es 
imprescindible para el diagnóstico de las enfermedades respiratorias23, y puede ser un 
refuerzo en la estrategia de deshabituación tabáquica24. Hay dudas razonables sobre 
los beneficios de la espirometría como herramienta de cribado poblacional25 26. Sin 
embargo, estas evidencias no se contradicen con la necesidad que tiene el clínico de 
utilizar la espirometría para diagnosticar a los pacientes que acuden a la consulta y 
presentan factores de riesgo (principalmente tabaquismo) y/o síntomas sugestivos de 
enfermedades respiratorias (case finding)27.
Utilización
La utilización contrasta con la disponibilidad. A pesar de disponer de espirómetros, la 
mayoría de centros de AP realizan menos de dos espirometrías diarias. No se conoce la 
cifra de espirometrías en base poblacional, pero atendiendo al infradiagnóstico de la 
EPOC es razonable pensar que esta cifra es muy baja. En el presente estudio se 
constata que en el ámbito de la AP se hacen 2 espirometrías por 100 habitantes, pero 
con un rango entre 1,39 y 2,71. En el área metropolitana de Barcelona en la zona sur
se hacen casi el doble de espirometrías que en la zona norte. Es difícil encontrar 
razones que justifiquen estas variaciones. La realización de un bajo número de 
espirometrías o su realización de forma muy esporádica, dificulta mantener las 





Aunque hay profesionales formados, en su ausencia se suspende la programación
en lugar de sustituir al profesional por otro formado en más de la mitad de los casos, lo 
que podría dificultar el acceso a la exploración. Este hecho es especialmente 
importante ante el problema del infradiagnóstico. No conocemos con precisión el tipo 
de formación reglada que reciben los profesionales. En cualquier caso, únicamente un 
pequeño porcentaje de profesionales recibe la formación reglada propuesta por el 
PDMAR28. La formación continuada es esporádica. Esta situación no es muy distinta a 
la observada en la encuesta sobre la utilización de la función pulmonar en los 
hospitales públicos de Cataluña, en la que se aprecia que en el 44% de los hospitales 
los profesionales reciben formación interna no reglada29.
Eaton et al han puesto de manifiesto la importancia de la formación reglada30. Esta 
formación debería realizarse a nivel territorial y estar incentivada por los sistemas de 
financiación que compran los servicios sanitarios. El escaso número de pruebas que 
realiza cada profesional y las lagunas formativas permiten suponer que el 
mantenimiento de las habilidades técnicas para realizar espirometrías es, como 
mínimo, difícil de asegurar.
Interpretación
La mayor parte de las espirometrías realizadas en AP las interpreta el médico de 
familia, pero únicamente una cuarta parte de los profesionales reconoce haber 
recibido formación específica en interpretación. Para interpretar correctamente las 
espirometrías31, es preciso disponer de tiempo y enfrentarse al número suficiente 
para mantener las habilidades32. La formación y el e-learning33 pueden jugar un papel 
pero no sustituyen una formación rigurosa.
Control de calidad
La EF de calidad es un objetivo asumible, tal como se ha demostrado en estudios
en los que han participado diferentes observadores34. Por lo tanto, es posible aspirar 
a obtener una espirometría de calidad en todos los ámbitos asistenciales, incluso en 
medios no sanitarios, como el domicilio del propio paciente35 y oficinas de farmacia36.
Sin embargo, casi tres cuartas partes de los puntos de realización de la espirometría 
no se someten a controles de calidad periódicos.
Interoperabilidad
El hecho de que, en el momento de la encuesta, dos terceras partes de los equipos 
introducían manualmente los datos de la espirometría en la historia clínica dificultaba 
la valoración de la calidad de la exploración. Además, la introducción manual es una 
fuente potencial de errores en la transcripción de los datos.
Para conseguir la normalización de un conjunto completo de datos relacionados con la 
espirometría la Oficina de Estándares e Interoperabilidad de TicSalut (Departamento 
de Salud) y el Plan para la Digitalización de la Imagen Médica del Departamento de 
Salud de la Generalitat, han creado un estándar basado en la versión 3 de HL7 (Health
Level Seven), CDA R2 (Clinical Document Architecture, Release 2). El CDA37
define la estructura de un documento clínico y utiliza un estándar para el intercambio 
de información estructurada entre aplicaciones (XML) y es independiente de la 
plataforma tecnológica utilizada. La disponibilidad del CDA de espirometría permite el 
intercambio de información de manera estándar, posibilita la interoperabilidad entre
diferentes proveedores de salud y ámbitos asistenciales, explotación de datos sobre el 
informe de espirometría estandarizado resultante (muy importantes para la 
investigación) y facilita la implantación de procesos sistemáticos de control calidad38 39.
Además, la disponibilidad de un estándar posibilita incorporar directamente
los resultados de la espirometría a la historia clínica electrónica.
La necesidad de reducir el infradiagnóstico de las enfermedades respiratorias crónicas 
y en especial el asma y la EPOC, la mejora del tratamiento y su seguimiento adecuado, 
hace que la obtención de espirometrías de calidad sea un objetivo estratégico. Para 
ello, conocer los datos que provee esta encuesta es fundamental para el PDMAR y 
complementa la información obtenida en la encuesta realizada recientemente en el 
ámbito hospitalario proveyendo de un mapa más preciso sobre la utilización de la EF 
en el territorio. Los resultados de este estudio han permitido identificar áreas de 
mejora que permitirán desarrollar programas orientados a solventar carencias del 
sistema sanitario.
El grado de prioridad otorgado por cada EAP a la mejora del proceso de las 
espirometrías puede significar un buen indicador del interés en este proceso y de la 
posibilidad de mejora. El hecho que más de la mitad de EAP manifiesten una prioridad 
alta, y sólo un pequeño porcentaje una baja, puede reflejar una oportunidad para la 
actuación formativa, organizativa y contractual.
En definitiva, los datos de esta encuesta ponen de manifiesto que el acceso al espirómetro 
es casi universal pero que se debería aumentar el número de espirometrías que se realiza. 
No hay datos que confirmen las características de la formación que reciben los 
profesionales y parece necesario mejorar la formación en la interpretación de las 
espirometrías así como instaurar estrategias de formación de técnicos en todos los EAP. El 
control de calidad es francamente mejorable y no podrá conseguirse sin la plena 
interoperabilidad entre los datos que ofrecen los espirómetros y los sistemas de 
información relacionados con la historia clínica electrónica.
La prioridad con la que se aborda la espirometría es un buen parámetro para 
conseguir incrementar el número de exploraciones de calidad. En definitiva, mejorar la 
realización de la espirometría sirve para mejorar la atención a los pacientes con 
enfermedades respiratorias crónicas40.
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Tabla 1. Índice de respuesta a la encuesta según el territorio. Cataluña, 2010.
ABS existentes
N respuesta en
Región sanitaria (RS) cada RS (%)
Alt Pirineu i Aran 8 8 (100)
Barcelona
213 157 (74)
Catalunya Central 37 24 (65)
Girona 42 37 (88)
Lleida 22 21(95)
Camp de Tarragona 33 20 (61)
Terres de l'Ebre 11 8 (73)
Total 366 275 (75)
ABS N respuesta en
Región sanitaria de Barcelona existentes cada sector (%)
Barcelona: Garraf i Alt Penedès 9 8 (89)
Barcelona: Baix Llobregat (Metropolitana Sud) 51 41 (80)
Barcelona: Barcelonès Nord- Maresme 38 29 (76)
Barcelona: Vallès 48 41 (85)
Barcelona ciutat 67 38 (57)
Nota: Los datos provienen de la declaración de los diversos proveedore1.
1 El Departament de Salut considera que un proveedor sanitario es una empresa 
pública o privada (con o sin ánimo de lucro) que presta servicios asistenciales de forma 
concertada (a través de un contrato con el CatSalut).
Tabla 2. Número absoluto, media, desviación estándar de las espirometrías anuales 
realizadas en la atención primaria y promedio por mes y equipo y población de 
referencia del equipo. Cataluña, 2009.
MEDIA
DESVIACIÓ ESPIROMETRÍA ESPIROMETRÍAS
TOTAL N S POR MES Y POR MES YESPIROMETRÍAS HABITANTES
REGIÓN SANITARIA ESPIROMETRÍA ESTÁNDAR ABSPOR CADA 100 ABSS AÑO
HAB (DE) (%)
(10.000 hab)
ALT PIRINEU I ARAN 1.456 2,08 2,52 15,17 17,34
BARCELONA 73.216 1,97 2,11 38,86 16,39
Garraf i Alt Penedès 3.276 1,44 1,43 34,13 11,98
Baix Llobregat 21.944 2,46 1,44 44,60 20,54
Barcelonès Nord i 12.792 2,18 1,17 36,76 18,16
Maresme
Vallès Oriental i 30,54 11,55
Occidental 15.028 1,39 0,71
Barcelona ciutat 20.176 2,16 2,08 44,25 18,01
CATALUNYA 22,75 15,20
CENTRAL 6.552 1,82 0,54
GIRONA 13.000 1,89 1,13 29,28 15,71
LLEIDA 7.124 2,22 4,05 28,27 18,53
CAMP DE 38,78 19,56
TARRAGONA 9.308 2,35 1,99
TERRES DE L’EBRE 3.796 2,71 5,55 39,54 22,59
TOTAL CATALUNYA 114.452 2,01 2,60 34,68 16,74





Tabla 3. Prioridad para la realización de las espirometrías, según región Cataluña,
2009.
PRIORIDAD (%) N ESPIROMETRÍASREGIÓN SANITARIA
(100/habitantes)POCA REGULAR MUCHA
ALT PIRINEU I ARAN 14,3 28,6 57,1 2,08
BARCELONA 13,1 32,4 54,5 1,97
Garraf i Alt Penedès 0 62,5 37,5 1,44





Valles Oriental i Occ. 2,8 30,6 66,7 1,39
Barcelona ciutat 5,7 40,0 54,3 2,16
CATALUNYA CENTRAL 25,0 41,7 33,3 1,82
GIRONA 11,8 35,3 52,9 1,89




TERRES DE L’EBRE 25,0 25,0 50,0 2,71
TOTAL CATALUNYA 12,8 33,9 53,3 2,01
Nota: Los datos provienen de la declaración de los proveedores que respondieron a la
encuesta.
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Puntos clave
Lo conocido del tema
 Las enfermedades respiratorias crónicas representan un problema da salud muy 
importante pero existe un infradiagnóstico considerable. 

 La espirometría es la exploración fundamental en el diagnóstico de estas enfermedades, y 
es conocida su utilización escasa, muy especialmente en el ámbito de la atención primaria. 

 Un análisis detallado sobre la accesibilidad y utilización de esta exploración en los centros 
de atención primaria de todo un territorio, es necesario para poder diseñar estrategias de 
mejora en la atención a estos pacientes. 
Qué aporta este estudio
 La accesibilidad a la espirometría en los centros de atención pri maria es elevada, lo que 
supone un punto fuerte en las posibilidades de mejorar el diagnóstico y seguimiento de los 
pacientes respiratorios crónicos.
 Algunas áreas de mejora son el aumento del número de exploraciones, la estandarización de la 
formación de los profesionales, la interoperabilidad entre los datos de los espirómetros y los 
sistemas de información de las historias clínicas electrónicas, y el control de calidad 
sistemático. 

 Los equipos de atención primaria manifiestan en general una prioridad alta a la mejora del 
proceso de las espirometrías, lo que supone una oportunidad para incidir en los puntos débiles 
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		 Forced spirometry (FS) is a simple and noninvasive test to assess lung function. 
Obtaining high quality FS requires training, appropriate technical conditions (calibration, main-
tenance and availability of equipment), and patient cooperation.  Several studies have found 
professional training deficits related to a high turnover in the same place, the lack of system-
atic training when new professionals performing spirometry are incorporated and the lack of 
periodic evaluation of responsibilities.
*  	 The Master Plan for Respiratory Diseases (PDMAR) has designed a 
minimum mixed practical/theoretical training program (16 hours) based on the training pro-
gram of the National Institute for Occupational Safety and Health and the European Respira-
tory Society initiatives (HERMES). In 2010, 13 courses have been offered to 307 professionals.
 During the year 2010, we organized a total of 13 training courses with a standardized 
program. Eleven courses were general, one was focused on pediatrics and another was a “Train 
the Trainer Program” course. In total, 307 professionals participated: nurses (68%), physicians 
(2%), pharmacists (21%), pediatric nurses (8%) and other (1%). The mean score at the beginning 
of the course was of 5 ± 2; 37% of the students had an initial score lower than  5 points.  At 
the end of the training course the evaluation was repeated, resulting in a score of 8 ± 2 points, 
with only 15% of the students obtaining less than 5 points.  The differences observed between 
baseline and post-assessment of FS knowledge were statistically significant (p < 0.001).
		 Training must be organized on a decentralized and territorial basis in order to 
ensure access for all professionals performing spirometry. Moreover, a quality FS will only be 
achieved when all key components are integrated (training, technical aspects and interpreta-
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Introducción
El impacto de las enfermedades respiratorias en 
nuestro medio resulta muy elevado tanto desde el 
punto de vista de la mortalidad (tercera causa de 
muerte) [1] como en lo que se reﬁere al consumo 
de recursos (en nuestro medio causan el 10% de los 
ingresos hospitalarios y comportan el gasto de al-
rededor del 8,5% del presupuesto total del Servei 
Català de la Salut) [2]. La enfermedad pulmonar 
obstructiva crónica (EPOC) afecta al 10% de per-
sonas de más de 40 años [3,4] y constituye la afec-
tación respiratoria no neoplásica con mayor carga 
asistencial. 
Diseño de un programa de formación básico  
para conseguir espirometrías de calidad
Joan Escarrabill, Núria Roger, Felip Burgos, Jordi Giner, Ainhoa Molins, Ricard Tresserras,  
en nombre del Grupo de Función Pulmonar y del equipo directivo del PDMAR
Introducción. La espirometría forzada es una manera sencilla y no invasiva de valorar la función pulmonar. La obtención 
de una espirometría de calidad requiere formación, condiciones técnicas adecuadas (calibración, mantenimiento y ubica-
ción del aparato) y colaboración del paciente. Diversos trabajos han constatado déﬁcits formativos de los profesionales, 
relacionados en parte con la elevada rotación en un mismo puesto, la falta de sistemática en la incorporación de nuevos 
profesionales que realizan espirometrías y la ausencia de planes de evaluación periódica de competencias. 
Materiales y métodos. En el marco del Plan Director de Enfermedades del Aparato Respiratorio (PDMAR) se ha diseñado 
un programa formativo mínimo teórico-práctico de 16 horas de duración, basado en el programa de formación del Na-
tional Institute for Occupational Safety and Health y de las iniciativas que surgen en el marco de la European Respiratory 
Society. Durante el año 2010 se realizaron 13 cursos en los que participaron 307 profesionales. 
Resultados. Las diferencias observadas entre la evaluación de conocimientos previos y la evaluación ﬁnal fue estadística-
mente signiﬁcativa (p < 0,001). 
Conclusiones. La formación debe organizarse de modo descentralizado y con base territorial con el ﬁn de garantizar el ac-
ceso de todos los profesionales que deben realizar espirometrías. La espirometría de calidad únicamente podrá conseguir-
se si se integran todos los elementos clave (formación, aspectos técnicos e interpretación), por lo que es imprescindible la 
interoperabilidad entre los diferentes ámbitos asistenciales.
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Design of a basic training program to get quality spirometry
Introduction. The spirometry is a simple and noninvasive test to assess lung function. Obtaining a spirometry of quality 
requires training, appropriate technical conditions (calibration, maintenance and location of the device), and patient cooperation. 
Several studies have found professional training deﬁcits related to a high turnover in the same place, the lack of systematic 
training when new professionals performing spirometry are incorporated and the lack of competences’ periodic evaluation. 
Materials and methods. The Master Plan for respiratory diseases (PDMAR) has designed a minimum practical/theoretical 
training program (16 hours) based on the training program of the National Institute for Occupational Safety and Health 
and the European Respiratory Society initiatives. In 2010, 13 courses have been oﬀered to 307 professionals. 
Results. The diﬀerences observed between the initial assessment and post evaluation knowledge was statistically signiﬁcant 
(p < 0.001). 
Conclusions. Training must be organized in a decentralized and territorial basis in order to ensure access for all professionals 
performing spirometry. Moreover, a spirometry of quality will only be achieved when all key components are integrated 
(training, technical aspects and interpretation) which requires interoperability between diﬀerent levels of care. 
Key words. Lung function test. Spirometry of quality. Training.
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Las enfermedades respiratorias pueden diagnos-
ticarse mediante una prueba no invasiva y de bajo 
coste: la espirometría forzada. Existe un amplio con-
senso sobre la estandarización de la prueba [5,6], 
pero como su realización requiere la colaboración 
del paciente, los resultados obtenidos son muy va-
riables. Para conseguir una prueba de calidad se re-
quiere disponer de aparatos ﬁables y calibrados, un 
ambiente apropiado, profesionales entrenados y pa-
cientes adecuadamente informados y dispuestos a 
colaborar. Naberan et al [7] muestran que la falta de 
entrenamiento de los profesionales es un factor muy 
importante en el número y calidad de las espirome-
trías realizadas en atención primaria. Hueto et al [8] 
observan que en Navarra, a pesar de que la mayor 
parte de los centros de atención primaria tienen es-
pirómetro, el 22% no lo utilizan. Este hecho no quie-
re signiﬁcar que la espirometría en la atención pri-
maria no sea posible [9,10]. Uno de los problemas 
más frecuentes, además de los déﬁcits formativos, 
es el alto grado de rotación en los puestos de trabajo 
de los profesionales de enfermería entrenados.
El infradiagnóstico constituye uno de los proble-
mas más graves en el manejo de las enfermedades 
respiratorias, especialmente de la EPOC [11], que 
junto al ‘mal diagnóstico’ [12,13] se observa incluso 
en el medio hospitalario [14]. La reducción del in-
fradiagnóstico y el diagnóstico apropiado requieren 
intervenciones especíﬁcas, pero sobre todo garanti-
zar el acceso a una espirometría de calidad [15-17]. 
El Departament de Salut de la Generalitat de Ca-
talunya se sirve de los planes directores [18] para 
acercar los planteamientos estratégicos a los opera-
tivos con el ﬁn de mejorar la atención al paciente. 
En este contexto, uno de los objetivos prioritarios 
del Plan Director de Enfermedades del Aparato 
Respiratorio (PDMAR) es garantizar al clínico el 
acceso a una espirometría de calidad independien-
temente del ámbito asistencial en el que trabaje 
[19]. Dado que se ha constatado el déﬁcit formativo 
de muchos profesionales, parece razonable plantear-
se el diseño de un programa formativo general, en-
tendiéndolo como una estrategia para conseguir la 
espirometría de calidad.
Materiales y métodos
La propuesta formativa se ha diseñado a partir del 
programa de formación del National Institute for 
Occupational Safety and Health (NIOSH) [20] y de 
las iniciativas que surgen en el marco de la European 
Respiratory Society [21]. La formación básica debe 
comprender aspectos teóricos y prácticos en un for-
mato de cursos de 2-4 días, en función de la distri-
bución de las clases. A través de un grupo de trabajo 
multidisciplinar se ha consensuado un programa 
teórico-práctico de 16 horas que se recomienda de-
sarrollar a lo largo de dos días consecutivos. Los 
contenidos del programa se resumen en la tabla.
Los organizadores de los cursos recibieron, jun-
to al programa, el desarrollo de los contenidos en 
versión PowerPoint, para que pudieran adaptarlos a 
sus necesidades. 
Resultados
Durante el año 2010 se acreditaron 13 cursos de 
formación que siguieron el programa formativo di-
señado en el marco del PDMAR. Once cursos fue-
ron ‘generales’ (según el programa descrito en la 
tabla), uno se centró en pediatría y otro fue un cur-
so de ‘formación de formadores’. En total participa-
ron 307 profesionales: enfermeras (68%), médicos 
(2%), farmacéuticos (21%), enfermeras pediátricas 
(8%) y otros (1%).
Valoración de conocimientos
Los asistentes a los cursos realizaron una evalua-
ción inicial de conocimientos mediante 10 pregun-
tas sobre aspectos básicos de la realización de la 
espirometría, que debían responder antes de iniciar 
el curso.
La media de puntos obtenida fue de 5 ± 2; el 37% 
de los alumnos alcanzó una puntuación inferior a 5 
puntos.
Al ﬁnal del curso se realizó una nueva evalua-
ción con el mismo cuestionario, al cual se añadie-
ron cinco preguntas más. El resultado obtenido 
(sobre 10 puntos) fue de 8 ± 2 puntos y únicamente 
el 15% de los alumnos obtuvo una puntuación infe-
rior a 5 puntos. Las diferencias observadas entre la 
puntuación inicial y la ﬁnal fueron estadísticamente 
signiﬁcativas (p < 0,001).
Valoración de los alumnos
La valoración cualitativa de los cursos se resume en 
la ﬁgura.
Las puntuaciones más bajas en los aspectos or-
ganizativos y de calidad del material se relacionan 
con las valoraciones de los primeros cursos, en los 
que todavía se utilizaban materiales provisionales. 
A partir del cuarto curso, en el que ya se dispuso 
del material deﬁnitivo, las valoraciones medias fue-
ron superiores a 8,7.
E-mail: 
jescarrabill@gencat.cat.
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Tabla. Contenidos del programa.
                                                                     Contenido Duración
Módulo 1
Anatomía y ﬁsiología pulmonar  
relacionada con la espirometría
Sistema respiratorio: aspectos básicos de anatomía y ﬁsiología
Mecanismos de la respiración: la bomba respiratoria, aspectos básicos de la mecánica respiratoria
1,5 h
Módulo 2
Historia de la espirometría.  
La espirometría en neumología
Breve reseña histórica de la espirometría.
La espirometría en las normativas de las enfermedades respiratorias (asma y EPOC)
0,5 h
Módulo 3 Aspectos básicos de la espirometría 
Deﬁnición de espirometría
Tipos de espirómetro 
 Cómo hacen las medidas
Representación de la espirometría 
 Volumen/tiempo 
 Flujo/volumen 
 Alteraciones funcionales pulmonares (obstrucción y no obstrucción) en la espirometría  
 Control y calibración de los espirómetros
1,0 h
Módulo 4 Técnica de la espirometría I
Indicaciones y limitaciones de la espirometría
Valores de referencia
Formas de medición de los parámetros observados respecto a la referencia
Preparación del sujeto para realizar la espirometría 
Instrucciones 
Realización de la prueba
Criterios de aceptabilidad y reproducibilidad de las maniobras 
Número de maniobras a realizar
1,0 h
Módulo 5 Técnica de la espirometría II
¿Qué hay que mirar de cada maniobra? 
 Gráﬁca 
 Números
Inicio de la maniobra, extrapolación retrógrada
Transcurso de la maniobra
Final de la maniobra
Maniobra inspiratoria
Utilización de los rangos de referencia (LMN, LLN)
1,0 h
Módulo 6 Control de calidad
Componentes de un programa de control de calidad
Veriﬁcaciones de la calibración y otras medidas de control de calidad de los equipos
Contaminación de los equipos y control de las infecciones
1,0 h
Módulo 7 Práctica en la espirometría
Práctica conjunta con todos los asistentes. Realización de espirometrías en formato  
de rol-play con diferentes circunstancias
Práctica en grupos pequeños. Práctica donde se hacen espirometrías a todos los participantes
5,0 h
Módulo 8
Valoración de la calidad de la espirometría. 
Sesión práctica para trabajar
Clasiﬁcación de la espirometría
Errores más frecuentes: del sujeto y del técnico
Valoración de les maniobras
1,0 h
Módulo 9 Espirometría en niños 0,5 h
Módulo 10 Otras aplicaciones de la espirometría
Valoración de les maniobres inspirométricas




Pruebas de provocación bronquial
Otras aplicaciones
1,0 h
Módulo 11 Interpretación de la espirometría
Sesión práctica en la que se valoran conjuntamente los aspectos gráﬁcos y numéricos  
de las maniobras espirométricas
2,0 h
Módulo 12 Valoración ﬁnal 0,5 h
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Discusión
La propuesta formativa es factible. En ningún caso 
el curso propuesto se debió anular por problemas 
técnicos, aunque en algunos casos desde el PDMAR 
se colaboró facilitando el contacto con el profesora-
do experto. 
Este tipo de formación plantea tres problemas im-
portantes:
– Si los cursos se ofrecen de una manera espontá-
nea es poco probable que se produzca una co-
bertura homogénea del territorio.
– Se requiere la implicación de los proveedores de 
servicios sanitarios para garantizar que las per-
sonas preparadas serán las que se destinarán a 
los lugares de trabajo en los que se realizan las 
espirometrías (lo cual no quiere decir que hagan 
espirometrías de una manera exclusiva).
– La formación básica no garantiza el manteni-
miento de las habilidades, especialmente en los 
casos en los que los profesionales realizan pocas 
pruebas (o las realizan de una manera intermi-
tente) [22].
En este sentido, desde el PDMAR se trabaja para 
que el Servei Català de la Salut incluya en el contra-
to de servicios la formación en espirometría, pro-
moviendo la realización de cursos en los territorios 
donde todavía no se ha realizado esta formación.
La formación de profesionales que han de reali-




– Con un gran componente práctico.
– Con cobertura territorial.
– Debe contemplar la recertiﬁcación (o revalidación 
de competencias) [23].
– Formación continuada para mantener la calidad 
y programas de autocontrol de lo que cada uno 
sabe (programa que de una manera anónima per-
mita contrastar los conocimientos personales).
Estos objetivos no se conseguirán con programas 
de formación puntuales y centralizados. Es necesa-
rio promover la formación de formadores en cada 
territorio para que puedan asumir esta perspectiva 
más amplia de la formación, que va más allá de la 
realización de cursos.
Steenbruggen et al [24] señalan que la formación 
es un elemento crucial para mejorar la práctica de 
la espirometría, pero en ningún caso es el objetivo 
ﬁnal. Borg et al [22] presentan datos acerca de que 
la formación de 14 horas no es suﬁciente para ga-
rantizar espirometrías de calidad a los cinco meses 
de la formación y ponen énfasis en la necesidad de 
efectuar una revisión activa de las espirometrías 
para el mantenimiento de las competencias. No 
tendría demasiado sentido separar la formación de 
la calidad. Formamos profesionales para que sean 
capaces de obtener espirometrías de calidad. Ese es 
el objetivo: el acceso fácil por parte del clínico a es-
pirometrías de calidad. Por lo tanto, los proveedo-
res de servicios deberían promover sistemas de ﬁ-
nanciación que garantizaran la cobertura de las ne-
cesidades (es decir, incrementar el número de espi-
rometrías) con garantías de calidad (pagar por prue-
bas bien hechas).
Los elementos para conseguir una espirometría 
de calidad son:
– Disponer de aparatos ﬁables y calibrados.
– Programas formativos adecuados para los profe-
sionales que deben realizar espirometrías y que 
incluyan: formación básica, formación avanzada, 
formación especíﬁca para la edad pediátrica (in-
cluida en el módulo general y, además, mediante 
un módulo especíﬁco pediátrico), formación de 
formadores y programas de revalidación de com-
petencias.
– Los programas formativos deben incluirse en la 
compra de servicios a los proveedores.
– La interoperabilidad entre los distintos ámbitos 
asistenciales es imprescindible para permitir el 
control de calidad.
– Formación para la correcta interpretación de re-
sultados [25].
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– Formulación de objetivos individuales que in-
centiven a los profesionales a la realización de 
espirometrías de calidad: porcentaje de pacien-
tes con EPOC y otras enfermedades respirato-
rias como el asma, en los que se ha practicado 
espirometría en un periodo dado.
– Deﬁnición de los criterios mínimos que deben 
reunir los centros sanitarios para realizar correc-
tamente las espirometrías: identiﬁcación de los 
responsables de la calibración y el mantenimien-
to, condiciones mínimas del lugar donde se rea-
lizan las espirometrías y capacitación de los pro-
fesionales que deben realizar espirometrías.
Un tema abierto al debate se centra en la organiza-
ción del control de calidad. En los estudios multi-
céntricos está claro que la mejor opción es un con-
trol de calidad centralizado [26], pero se requieren 
más estudios para poder aplicar este criterio a la 
práctica cotidiana.
En un futuro inmediato, para conseguir estos 
objetivos deberán utilizarse tecnologías de la infor-
mación y de la comunicación que permitan la for-
mación online y proporcionen soporte a la toma de 
decisiones, tanto organizativas y técnicas (calibra-
ción o control de calidad, por ejemplo) como asis-
tenciales (indicación e interpretación).
Bibliografía 
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. 1. 
Global and regional burden of disease and risk factors, 2001: 
systematic analysis of population health data. Lancet 2006; 
367: 1747-57.
Gibert R, Brosa M. Avaluació de la participació del plans 2. 
directors en la despesa sanitària del CatSalut. Estudis 
d’Economia de la Salut. Barcelona: Generalitat de Catalunya, 
Departament de Salut; 2006.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, 3. 
Mannino DM. Global burden of COPD: systematic review 
and meta-analysis. Eur Respir J 2006; 28: 523-32.
Miravitlles M, Soriano JB, García-Río F, Muñoz L, Durán- 4. 
Taulería E, Sánchez G, et al. Prevalence of COPD in Spain: 
impact of undiagnosed COPD on quality of life and daily  
life activities. Thorax 2009; 64: 863-8. 
Ferguson GT, Enright PL, Buist AS, Higgins MW. Oﬃce 5. 
spirometry for lung health assessment in adults: a consensus 
statement from the National Lung Health Education Program. 
Chest 2000; 117: 1146-61.
Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, 6. 
Small I; General Practice Airways Group. Diagnostic spirometry 
in primary care: proposed standards for general practice 
compliant with American Thoracic Society and European 
Respiratory Society recommendations –a General Practice 
Airways Group (GPIAG) document, in association with the 
Association for Respiratory Technology & Physiology (ARTP) 
and Education for Health. Prim Care Respir J 2009; 18: 130-47. 
Naberan K, De la Roza C, Lamban M, Gobartt E, Martín A, 7. 
Miravitlles M. Utilización de la espirometría en el diagnóstico 
y tratamiento de la EPOC en atención primaria. Arch 
Bronconeumol 2006; 42: 638-44. 
Hueto J, Cebollero P, Pascal I, Cascante JA, Eguía VM, 8. 
Teruel F, et al. Spirometry in primary care in Navarre, Spain. 
Arch Bronconeumol 2006; 42: 326-31.
Poels PJ, Schermer TR. Good wine needs no bush:  9. 
quality spirometry in a primary care setting is possible. 
Arch Bronconeumol 2007; 43: 473.
Yawn BP, Enright PL, Lemanske RF Jr, Israel E, Pace W, 10. 
Wollan P, et al. Spirometry can be done in family physicians’ 
oﬃces and alters clinical decision in management of asthma 
and COPD. Chest 2007; 132: 1162-8.
Soriano JB, Ancochea J, Miravitlles M, García-Río F, Durán- 11. 
Taulería E, Muñoz L, et al. Recent trends in COPD prevalence 
in Spain: a repeated cross-sectional survey 1997-2007.  
Eur Respir J 2010; 36: 758-65.
Menezes AM, Pérez-Padilla R, Jardim JR, Muiño A, López MV, 12. 
Valdivia G, et al; PLATINO Team. Chronic obstructive 
pulmonary disease in ﬁve Latin American cities (the PLATINO 
study): a prevalence study. Lancet 2005; 366: 1875-8.
Proyecto Latinoamericano de Investigación en Obstrucción 13. 
Pulmonar (PLATINO). URL: http://www.platino-alat.org. 
[02.02.2011].
Pellicer-Císcar C, Soler-Cataluña JJ, Andreu-Rodríguez AL, 14. 
Bueso-Fabra J; en representación del Grupo EPOC de la 
Sociedad Valenciana de Neumología. Calidad del diagnóstico 
de enfermedad pulmonar obstructiva crónica en el ámbito 
hospitalario. Arch Bronconeumol 2010; 46: 64-9.
Clotet J, Gómez-Arbonés X, Ciria C, Albalad JM. 15. 
Spirometry is a good method for detecting and monitoring 
chronic obstructive pulmonary disease in high-risk smokers 
in primary health care. Arch Bronconeumol 2004; 40: 155-9. 
Soriano JB, Zielinski J, Price D. Screening for and early 16. 
detection of chronic obstructive pulmonary disease.  
Lancet 2009; 374: 721-32.
Schirnhofer L, Lamprecht B, Firlei N, Kaiser B, Buist AS, 17. 
Halbert RJ, et al. Using targeted spirometry to reduce 
non-diagnosed chronic obstructive pulmonary disease. 
Respiration 2011; 81: 476-82.
Tresserras R. Planiﬁcación según prioridades de salud. 18. 
Criterios de planiﬁcación relacionados con los planes 
directores. Med Clin (Barc) 2008; 131 (Supl 4): 42-6.
Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, 19. 
Small I. Diagnostic spirometry in primary care: proposed 
standards for general practice compliant with American 
Thoracic Society and European Respiratory Society 
recommendations –a General Practice Airways Group 
(GPIAG). Prim Care Respir J 2009; 18: 130-47.
Centers for Disease Control and Prevention. Spirometry 20. 
Training Program. URL: http://www.cdc.gov/niosh/topics/
spirometry/training.html. [01.03.2011].
Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, 21. 
Casaburi R, et al; ATS/ERS Task Force. General considerations 
for lung function testing. Eur Respir J 2005; 26: 153-61.
Borg BM, Hartley MF, Fisher MT, Thompson BR. Spirometry 22. 
training does not guarantee valid results. Respir Care 2010; 
55: 689-94.
Derom E, Van Weel C, Liistro G, Buﬀels J, Schermer T, 23. 
Lammers E, et al. Primary care spirometry. Eur Respir J 2008; 
31: 197-203.
Steenbruggen I, Mitchell S, Severin T, Palange P, Cooper BG; 24. 
on behalf of the Spirometry HERMES Task Force. 
Harmonising spirometry education with HERMES: training 
a new generation of qualiﬁed spirometry practitioners 
across Europe. Eur Respir J 2011; 37: 479-81.
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, 25. 
Casaburi R, et al. Interpretative strategies for lung function 
tests. Eur Respir J 2005; 26: 948-68.
Pérez-Padilla R, Vázquez-García JC, Márquez MN,  26. 
Menezes AM; PLATINO Group. Spirometry quality-control 
strategies in a multinational study of the prevalence of 







B.G. Cooper, I. Steenbruggen, S. Mitchell, T. Séverin, E. Oostveen, F. Burgos, H. Matthys, H. 
Normand, J. Kivastik, J. Leuppi, M. Flezar, M. Agnew,O. Pedersen, S. Sorichter, V. Brusasco, W. 
Tomalak, P. Palange.
Published in Breathe.








Spirometry testing is the most widely prac-
ticed, most common and adaptable of all lung
function tests and spirometers are used as a
key instrument in the diagnosis of patients
with respiratory disease [1]. As a leading
cause of death worldwide responsible for
some 9.4 million deaths [2], and further
increases predicted by 2020, the manage-
ment of lung disease becomes even more
dependent on spirometry testing. Yet evidence
of widespread under-diagnosis [3] and, as a
consequence, reduced quality of life and
premature death [4] present cause for
concern.
The grim reality evident in the presented
studies highlights a real lack of training [5],
under-utilisation of spirometers [6] and diag-
nosis based on inaccurate results [7]. It is
reported that chronic obstructive pulmonary
disease (COPD), the most prevalent of the
lung diseases, is under-diagnosed in 75% of
cases [3]. The outcome of delayed diagnosis
deters effective management and treatment,
which ultimately aims to relieve symptoms,
prevent disease progression, improve health
status and prevent premature death [4]. While
educational modalities were introduced at a
national level to train spirometry practice in
some European countries, a survey carried out
by the European Respiratory Society (ERS) in
2008 confirms that no formal training in,
assessment of, or qualification in spirometry
takes place in many other countries. Using the
HERMES project framework (Harmonised
Education of Respiratory Medicine in
European Specialties), a new Spirometry initia-
tive aspires to train and qualify healthcare
professionals best able to deliver high-quality
spirometry. The potential benefits of standar-
dised educational documents and training in
the practice of spirometry are real and
significant, strengthening patient care and
improving quality of life for respiratory disease
patients.
HERMES
Begun in 2005, the value of the HERMES
initiative is that it provides consensus-based
standards and indicators to improve quality
and practice of education and healthcare, and
establishes a guide for teachers and students
of sub-speciality respiratory medicine. To date,
the Adult HERMES and Paediatric HERMES
projects have produced internationally recog-
nised educational documents and activities. If
we consider the nature of these projects, it is
clear that both the Adult and Paediatric
projects appeal to a specific target audience,
specialising in precise fields of respiratory
medicine. The very essence of the Spirometry
HERMES project is, in fact, different. For this
purpose, a new proposed structure of four key
development areas shall be implemented to
ensure all facets of the educational cycle are
covered (fig. 1)
1. Complete Training Programmes
2. Guidelines for certification of ERS Spiro-
metry Training Programmes
3. Development of educational materials
including training manuals, supporting online
modules, videos and a knowledge test for part I
4. Assessment guidelines, production of
assessments and assessment criteria to test
Spirometry Theory and Spirometry Practice
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This process of establishing ERS educational
standards in spirometry are international in their
development and actively overseen by an expert
Task Force representing 13 countries across
Europe (fig. 2). The very essence of the
HERMES initiative is to offer structured support
for educational reform to take place. Evolution of
the HERMES ideology presupposes that each
project phase recommends uniform educational
criteria to be adopted and considered as best
practice in training. Considering the statistical
data confirming the gravity of lung disease
worldwide, the mission of the HERMES spiro-
metry project is to follow this intricate path to
train and qualify health professionals to perform
high-quality spirometry tests as well as increasing
the number of accurate and repeatable spiro-
metric measurements to be used in the diagnosis
of patients with respiratory symptoms. The
purpose of this publication is to present the
outcome of the first two phases of the HERMES
Spirometry Driving Licence project.
Historical background
Standardisation of spirometry [8], access to spiro-
meters [4] and use of accurate and repeatable
spirometry measurements [3] are requirements
central to the diagnosis, management and treat-
ment of lung diseases. The scale of the role
spirometry plays in identifying patients at risk of
disease or of perioperative pulmonary complica-
tions such as COPD, lung cancer, heart attack,
stroke and asthma [9] dictates that the tools
required to practice spirometry be given pre-
cedence within the medical arena. The available
statistics echo the true reality that spirometers
are under-utilised due to absence of teaching
practices [6], and there is an extensive call for
educational reform in the training of spirometry
within this medical domain [1, 3–7, 10].
If the aforementioned requirements to
practice quality spirometry are considered, to
some extent the ERS/American Thoracic Society
2005 Guidelines in Spirometry Practice and, in
recent years, development of the spirometer,
guaranteeing widespread distribution, offer some
relief to spirometry practitioners. Yet, based on
analysis of 14 countries within Europe, only four
reported the opportunity to attend a spirometry
training course approved by a professional body
(fig. 3).
With the intention of producing a driving
licence in spirometry for health professionals
to reach competency level, the Task Force
presents the first of the educational docu-
ments; Part I Spirometry Knowledge and Skills,
Part II Knowledge and Competence in Spiro-
metry Measurement (leading to the European
Spirometry Driving Licence Level II) and
Guidelines for the Certification of ERS
Spirometry Training Programmes.
Methodology
The HERMES European Spirometry Driving
Licence (ESDL) project was officially launched
at the ERS Annual Congress in Berlin 2008 with
the aim of harmonising training in spirometry
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European standards in the skills required to
qualify and practice as an expert in this field.
Rationale for the project was justified following
results of the ERS benchmark analysis carried out
in 2008. As well as confirming a clear disconnect
in spirometry training practices, insight into
expectations of structure, duration, delivery and
assessment that a spirometry training programme
should possess were offered. Laying the founda-
tions to move forward, the first step the Task Force
would take was to produce a training programme
outline utilising the well established consensus
process, the Delphi technique [11].
Phase 1 – Development of the
Training Programme Outline
Within the framework of the Delphi methodology,
and following the steps taken by the HERMES
giants, Adult and Paediatric, the Task Force began
the process of designing knowledge items which
should be included in a training programme for
spirometry. A further panel of experts from 10
European countries was also identified as key
contributors to project development. In line with
the Delphi technique, the Task Force prepared a
first survey round and received responses from
673 experts. The aim of this survey was to gather
a larger representation from spirometry practi-
tioners of both qualitative and quantitative data
on the perceived skills required for training to
endorse a qualification in spirometry practice.
At the ERS Annual Congress in 2009 in
Vienna, results of the first survey round were
presented during a plenary session including all
Task Force and national respondents. High
consensus levels for each of the items assume
that the target of the survey was reached. With the
inclusion of some new items and modification of
existing items based on comments within the
survey, a second Delphi round of 230 experts
confirmed the final training programme outline
which was approved by the Task Force in May
2010.
As the training programme items were now
in place, a new process of developing rationale
for training including the course aim, target
audience, pre-requisites for training and teaching
format would need to be developed. A skeleton
structure utilising a number of references [12,13],
was presented to the Task Force in May 2010
and so began the final steps in the development
of the European Spirometry Driving Licence
Training Programme (fig. 4).
Phase 2 – Development
guidelines for certification of
ERS Spirometry Training
Programmes document
A further output from this landmark May 2010
Task Force meeting was the generation of a
number of operational issues relating to the
Spirometry Training Programme. Questions sur-
rounding venue specifications, trainer qualifica-
tions and minimum numbers of spirometry tests to
be performed, only served to highlight imminent
complexities that would need to be addressed.
Between May and the upcoming September























































Phase 1 - Training Programme Outline
September 2009: Plenary Workshop
September 2008: Launch of HERMES spirometry project
Finalise knowledge items Training rationale composed and 
approved by Task Force
May 2010: Task Force Workshop
ERS European Spirometry Training Programme
Part I - Spirometry Knowledge and Skills
Part II - Knowledge and Competence in Spirometry Measurement
Figure 4
The first phase in the European Spirometry Driving Licence Training Programme.
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robust structure including measurable elements
and criteria to ensure best practices in training
and dissemination of the ESDL became obvious.
Guided by the Criteria for Accreditation
of ERS European Training Centres in Adult
Respiratory Medicine document generated from
the Adult HERMES Task Force [14], the frame-
work provided fundamental standards for train-
ing programmes to follow. By September 2010,
six sections were presented and approved and
the Guidelines for the certification of ERS
Spirometry Training Programmes document was
established (fig. 5).
Results
If we consider the objective of the first two
project phases to produce a training programme
outline and the rationale and guidelines to
launch a complete spirometry training pro-
gramme, the presented documents symbolise
the first challenge to lead this initiative toward
its end goal, each constituting the minimum
recommended criteria that training programmes
should consist of for the training of spirometry at
a European level.
Phase 1 – Development of the
Training Programme Outline
Drafted by the Task Force during the first of their
meetings, 47 knowledge items and skills were
presented and included in the first Delphi round.
Slight modifications and the addition of new
items were made following the first Delphi.
Following a second survey round, the training
programme was agreed by the Task Force in May
2010, consisting of eight modules and 63 items
including prerequisites for training. To ensure all
components of an educational training pro-
gramme were covered, and supported by the ERS
education department, further development of
the rationale for training was completed by the
Task Force during the May meeting.
In order to train practically competent health
professionals, it was necessary that the training
programme be divided into two distinct training
parts:
1. Part I Spirometry Knowledge and Skills
covering important spirometry theory and
demonstrate best practices in spirometry technique
2. Part II Knowledge and Competence in
Spirometry Measurement will ensure participants
perfect technique, consider pitfalls and errors in
spirometric measurements and award a qualifi-
cation to merit participants as practically
competent to perform high quality spirometry
tests
In order to prepare for Part II, the Task Force
recognised the need to allow time for practical
experience and first hand exposure between
training programmes and so have stipulated in
the guidelines that all participants must com-
plete the ERS Spirometry Workbook before
attending Part II.
Published documents on the complete
Training Programme of both Part I Spirometry
Knowledge and Skills and Part II Knowledge and
Competence in Spirometry Measurement are the
result of the first project phase.
Phase 2 – Development
guidelines for accreditation of
ERS Spirometry Training
Programmes document
The objective of this phase was to generate a
structured, simple and flexible model to allow
dissemination of training across all health
professional settings who practice and teach
spirometry across Europe. Utilising specifications
within the training programme outline, each of
the six sections within the document lists the
minimum measurable elements for training
programmes to follow to qualify certification
HERMES syllabus link: module
D.1
Identification of key criteria
Development of document content
Phase 2 - Guidelines for Certification
September 2010: Task Force Workshop
May 2010: Task Force meeting
Finalise criteria for certification
September – December 2010
Guidelines for the certification of ERS Spirometry
Training Programme document
Figure 5
The second phase in the European Spirometry Driving Licence Training Programme.
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and award ERS European Spirometry Driving
Licence. In September 2010, the document
sections were approved and a comprehensive
document outlining Guidelines for the certifica-
tion of ERS Spirometry Training Programmes was
completed.
Discussion
The variety of HERMES initiatives are evolving
based on an increasing demand for improved
and systematic practices of education in
specialist areas of respiratory medicine.
Evidence of a current gap in training needs for
medical practitioners merely offer conviction to
the HERMES Task Forces and remind them of the
need to supply this demand. The HERMES
spirometry initiative is also the product of this
inherent path, emerging from an evident
disparity in training criteria in the training of
spirometry. Yet producing, implementing and
maintaining robust educational activities and





Ensuring all healthcare institutions demonstrate
the ability to apply predetermined standards set
out within the HERMES documents is embedded
in complexity. The overarching goal of this
project milestone, phase 2, was to produce a
solid foundation of structured guidelines for
certification of spirometry training programmes
to follow. As the Task Force progresses through
the project continuum, a new emphasis moves
from documenting minimum criteria to applica-
tion. In fact, the final section of the Guidelines
for certification of ERS Spirometry Training
Programmes was established to produce those
procedures required for the certification process.
For the first time, consideration of the approval
body, the application process, the certification
process and costs is realised, project success
demands a vigorous, adaptable and inexpensive
model.
To certify is to apply standards as a basis of
quality assurance. Traditionally, accreditation or
certification of educational programmes within
the medical arena has been based on the
well-established practice of site visitation [15].
However, site visitation is a resource-dependant
process, the costs beared by the training centre
and, as a consequence, too often excluding
those unable to afford external and voluntary
certification. The next stages will address this
process of certification and it is the intention of
the Task Force to publish Section 7 Approval
Process and Distribution of ESDL Certificates at a
later date which will employ new and diverse
methods of quality assurance including prepara-
tion of standardised educational materials to be
used during training, online training modules,
and use of generic assessment methods all
contributing as a means of quality control.
Dissemination of the European
Spirometry Training Programme
Applying minimum standards not only offers
guidance for trainers of spirometry to follow but
also present an incentive to improve, or for some
countries introduce, structured training and
consequently dissemination of a European
spirometry qualification. To accomplish success
at this project step and indeed looking to future
developments for the project, the initiative
necessitates distribution to a wide audience of
health professionals across a number of medical
settings. Consequently, achievement demands
educational documents which are simple, robust
and adaptable. It is intended that the documents
provide a guideline for training programmes of
spirometry to follow and to allow flexibility
across international, cultural and regional
boundaries, which will allow delivery at local
level. Support for ESDL trainers will be provided
through standardised educational materials as
well as a ‘‘Train-the-Trainer’’ course, which will be
held each year at the ERS Annual Congress.
Moreover, this HERMES project finds itself
confronted with the fresh challenge of transla-
tion. A new wave of HERMES now looks towards
distributing educational documents and activities
to national delegates and respondents for
translation. Reaching the intended audience
requires coherence within ERS and across
national societies.
Conclusion
Spirometry practitioners have the opportunity to
take ownership to improve and measure their
knowledge and practice of spirometry, emphasis-
ing commitment to education and value of
attaining a European qualification. For the first
time, harmonisation of training in spirometry
offers an objective process for evaluation within
Europe. With a training programme outline and
HERMES syllabus link: module
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guidelines for certification of ERS training
programmes now in place, the Task Force looks
to putting theory into practice with a real focus
on application. To facilitate a training model, the
next project steps intend to design and utilise
educational materials, online modules and
assessment criteria aligned to concrete standards
set out by the Task Force, further strengthening
the value of the spirometry HERMES project.
The significance and impact of spirometry as
a measure of global health and a predictor of
morbidity and mortality resonate throughout the
literature [16], and presuppose that spirometry
testing receive priority within the medical arena.
Yet evidence of a substantial lack of training and
inconsistencies in standards across many
European countries, there is most certainly scope
to improve spirometry practice and reinforce
quality patient care. At the core of this
impending challenge, the Spirometry HERMES
initiative attempts to produce consensus-based
documents and guidelines fundamental to the
delivery of best practices in spirometry training. It
is hoped that project potential will be realised,
establishing coherence across national societies,
ERS members and all practitioners of spirometry.
Building on the shoulders of the previous
HERMES projects, with confidence the Spiro-
metry HERMES Task Force takes the first step
towards attaining their final mission: delivery of
the best possible training to certify spirometry
practitioners and improving quality health care
for respiratory disease patients.
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a b s t r a c t
Access to quality spirometry is an essential objective in order to be able to minimize the underdiagnosis
of respiratory diseases, especially that are most frequent, such as COPD and asthma. This objective can
be reached in the short term, but it requires the simultaneous integration of different strategies: training
of the health-care professionals who perform spirometry, deﬁnition of standards for the transmission of
the information, technical requirements for acquiring apparatuses and the correct interpretation of the
results.
This present study shows the use of standards for the electronic exchange of clinical information.
In order to normalize the treatment of the data related with spirometry and to enable the exchange
of information, we have used the standard CDA R2 (Clinical Document Architecture, Release 2) of HL7
(Health Level Seven), version 3. HL7 is a product by HL7 International, a non-proﬁt organization that
deals in the production of standards in the health-care setting in order to facilitate interoperability.
Furthermore, deﬁning these standards is essential for ensuring that they are adopted by spirometer
manufacturers. By means of this process, the base is set for facilitating access to spirometry at the health-
care level, while at the same time it is a fundamental technical element for designing quality control
programs of the explorations.
© 2011 SEPAR. Published by Elsevier España, S.L. All rights reserved.
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Pruebas de función pulmonar
Estándares
r e s u m e n
El acceso a una espirometría de calidad es un objetivo imprescindible para poder minimizar el infra-
diagnóstico de las enfermedades respiratorias, especialmente en las más frecuentes como la EPOC y el
asma. Este objetivo es alcanzable a corto plazo, pero requiere la integración simultánea de estrategias
diversas: formación de los profesionales que deben realizar la espirometría, deﬁnición de estándares para
la transmisión de la información, requerimientos técnicos en las adquisiciones de aparatos y la correcta
interpretación de los resultados.
El presente trabajomuestra la utilización de estándares para el intercambio electrónico de información
clínica. Para normalizar el tratamiento de los datos relacionados con la espirometría y permitir el inter-
cambio de información se ha utilizado el estándar CDA R2 (Clinical Document Architecture, Release 2) de
HL7 (HealthLevel Seven)versión3.HL7esunproductodeHL7 international, unaorganizaciónno lucrativa
que se dedica a la producción de estándares en el ámbito de la salud para facilitar la interoperabilidad.
La deﬁnición de este estándar, además, es imprescindible para asegurar la adopción del mismo por
parte de los fabricantes de espirómetros. Mediante este proceso se ponen las bases para facilitar el acceso
a la espirometría desde todos los ámbitos asistenciales y, a su vez, es un elemento técnico fundamental
para disen˜ar los programas de control de calidad de las exploraciones.
© 2011 SEPAR. Publicado por Elsevier España, S.L. Todos los derechos reservados.
 Please cite this article as: Salas T, et al. Requerimientos técnicos de los espirómetros en la estrategia para garantizar el acceso a una espirometría de calidad. Arch
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Introduction
More than 150 years ago, John Hutchinson became interested
in the value of the volume of air that humans could exchange with
the environment.1,2 Since then, spirometry (the systematic and
standardized measurement of this capacity to mobilize air) has
become a key piece in the detection, diagnosis, prognosis and the
follow-up of respiratory diseases. Spirometry does not provide
the etiologic diagnosis, but it enables us to observe the
physiopathological basis of the process and in this manner to
approximate the diagnosis by means of signs which are easy
to detect: ﬂow and volume.3
Although spirometry is a non-invasive test that is relatively
easy to carry out, several studies give evidence of difﬁculties to
access the test and the problems related with the quality of the
data collected. In part, the problems related with spirometry are
due to the fact that it is a test that requires complete patient
cooperation. The expiration maneuver requires intensity, time and
coordination in order to obtainmeasurable valueswith clinical sig-
niﬁcance. In order to achieve this, it is crucial for the professionals
performing the test to be properly trained. But, moreover, it has
been repeatedly observed that the availability of a spirometer does
not guarantee its routine use.4 In addition to its underuse, Mon-
teagudo et al.5 observed the incorrect register of spirometric data
and their limited impact on treatment changes over the course of
patient follow-up.
Despite everything, quality spirometry is a reachable objective,
as has been demonstrated in epidemiological studies with differ-
ent participating observers.6 Therefore, it is possible to aspire to
quality spirometry in all health-care settings and even in non-
health-care settings, such as in the homes of patients themselves7
and in pharmacies.8
One of the challenges of all health-care systems is the imple-
mentation of strategies that promote the change of clinical
practices in accordance with the evidence available. The Health
Department Directives (Planes Directores del Departamento de
Salud)9 intend to make decisions on strategic planning with tech-
nicians in order to improve the service provided. Thus, the Master
Plan for Respiratory Diseases (Plan Director de las Enfermedades
Respiratorias–PDMAR) was created in 2010, after a prior study of
nearly two years, in order to improve the care of patients with
respiratory diseases.
Since its inception, the PDMAR considered it as priority to guar-
antee the access to quality spirometry in all health-care settings.
Quality spirometry is an essential tool for dealingwith the problem
of the underdiagnosis of respiratory diseases, especially chronic
obstructive pulmonary disease (COPD).10 A favorable element was
the conﬁrmation of the availability of spirometers in practically
all primary care centers, but the problems described in the liter-
ature were likewise conﬁrmed: little regulated training, rotation
of the professionals, underuse of the spirometer and limited sys-
tematic quality control, both of the apparatuses as well as of the
explorations carried out.
Basedon the recommendations of experts, a speciﬁcworkgroup,
contributions of scientiﬁc societies and the evidence in the lit-
erature, these initial proposals for quality spirometry have been
deﬁned:
• From the outset, attempts made at promoting quality spirome-
try should be a group effort based on the participation of all the
professionals involved, both from the specialized setting as well
as from primary care.
• The training of the health-care professionals that perform
spirometries is crucial and should be accompanied by manage-
ment policies for the workplace that avoid excessive rotation.
Table 1
Key Elements for Achieving Quality Spirometry.
Elements Actions
1. Precise and reliable local
information
Surveys have been done about
carrying out spirometries in hospitals
and in primary care
2. Design a training program Training program of a minimum
of 16h of theoretical and practical
training, with a speciﬁc additional
training for testing in pediatrics
3. Design of a training program
for trainers
There, the objective is to have training
offered in different regions and,
in order to decentralize it, and it is
necessary to train trainers.
4. Standardization of the values
obtained by the spirometers
Creation of the CDA for spirometry
and the guidelines for its
implementation
5. Interoperability among different
health-care settings
Design of projects for solution
validation, with the collaboration
among health-care centers, PDMAR,
Oﬁcina d’Estàndards and Pla de
digitalització de la imatge mèdica
6. Design of a systematic control
mechanism for spirometry
Standardization and interoperability
are essential to guarantee quality
control
7. Deﬁnition of the practical rules of
organization and implementation
of spirometry in the different
health-care settings
These rules should include aspects
of placement, conditions of the
installation and use as well as the
systemic control of the apparatuses
8. Training program for spirometry
interpretation
Design of an on-line training program
• Quality control for spirometry implicates the standardization of
the values obtained and the systematic analysis of the explo-
rations. Both elements require communication technologies and
guaranteed interoperability among the different apparatuses
and the information systems of all the health-care settings.
Table 1 summarizes the actions that PDMAR promotes with the
aim of providing quality spirometry.
Standarization
Promoted by the Ofﬁce for Standards and Interoperability of
the Catalonian Department of Health (Oﬁcina de Estándares e Inter-
operabilidad de TicSalut, Departamento de Salud) and by the Plan
for the Digitalization of Medical Images (Plan para la Digitalización
de la Imagen Médica del Departamento de Salud de la Generalitat
de Catalun˜a), standards have been created in order to achieve the
normalization of a complete group of data related with spirom-
etry. These standards have been based on version 3 of HL7, CDA
R2. The CDA R2 (Clinical Document Architecture, Release 2) stan-
dard by HL7 (Health Level Seven) (version 3) is a product of HL7
International, a non-proﬁtable organization that is dedicated to
the production of standards in health care in order to facilitate
interoperability. CDA11 deﬁnes the structure of a clinical document
and uses XML to label the different categories of information. XML
is the standard for the structured information exchange between
applications, regardless of the technological platform used. A CDA
can be viewed from any computer using a web navigator. The
CDA for spirometry includes the data of the patient, the informa-
tion of the context of the test, the resulting clinical parameters,
the ﬂow-volume and volume-time charts as well as the origi-
nal signal captured by the spirometer. Likewise, it includes data
about the origin of the request obtained from the electronic med-
ical ﬁles of the hospital or the health-care center. The clinical
information is coded using SNOMED CT (Systematized Nomencla-
ture of Medicine—Clinical Terms), which allows it to be processed
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automatically and incorporated into the patient medical ﬁles in a
structured manner.
Interoperability
The Ofﬁce for Standards and the Plan for Digitalization of the
Department ofHealth have elaborated the guidelines for the imple-
mentation of the spirometry CDA in collaboration with the Master
Plan for Respiratory Diseases (PDMAR).
The availability of the CDA for spirometry allows for information
to be exchanged in a standard manner, making the interoperabil-
ity between different health-care providers and settings possible,
executing exploitation services with the data from the resulting
standardized spirometry report (very important for research pro-
cesses) and facilitating the implementation of systematic control
processes that guarantee the objective of obtaining quality spirom-
etry.
The suitability of this standard as amechanism for the exchange
of informationwill be evaluated in various projectswith the partic-
ipation of different service providers and professionals of different
health-care settings.
Spirometer Requirements
The inclusion of this CDA as a technical requirement for acquir-
ing spirometers is essential for ensuring that it is adopted by the
manufacturers and for its mid-term generalized use. The Ofﬁce for
Standards has likewise established a procedure for homologation,
through which the manufacturers can certify that their equipment
conforms to this standard proposed.
The Plan for the Digitalization of Medical Images has proposed
to the Catalonian Health Administration (Servicio Catalán de la
Salut–CatSalut) the requirements that the spirometers shouldmeet
to guarantee interoperability. Table2describes the requirements as
they appear in the public tender for the acquisition of spirometries.
These requirements, which meet a general consensus, are essential
to achieve the objectives set by the PDMAR for access to quality
spirometry.
In short, the ﬁnal objective of quality spirometry requires the
integration of several strategies: training, deﬁnition of standards
for the transmission of the data, technical requirements for the
acquisition of spirometers, interpretation of results, etc. Each one
of these strategies is fundamental, but their isolated impact is min-
imal if they are not properly integrated. All these should be done
in response to a key health-care challenge: early diagnosis of res-
piratory diseases, particularly the most prevalent such as COPD
and asthma. The dissemination of quality spirometry is a goal that
is within our grasp in the near future. The previously explained
technical requirements will allow us to make forced spirome-
try a reliable procedure, giving access the numerical as well as
charted data, and quality spirometry will become compatible with
its extensive use in all health-care settings.
Quality spirometry is a reachable objective.12 The technologi-
cal elements related with standardization and interoperability are
the foundation on which quality spirometry is based. In the ﬁrst
place, without standardization and interoperability, it is very dif-
ﬁcult to exchange data among providers with different computing
platforms. Furthermore, by means of these technical elements, it is
possible to propose performing spirometry outside the health-care
system setting, for instance in patients’ homes. But themost impor-
tant challenge is quality control. All these technological advances
should enable routine quality control of the procedures that are
performed and, consequently, allow room for improvement. In any
given territory, the ﬁnal objective should be to guarantee the access
of all the clinicians to quality spirometry, regardless of the type of
Table 2
Requirements of CatSalut for Spirometries and Calibration Syringes (2011).
Deﬁnition
Spirometer with microprocessor and printer for lung function
and bronchodilation tests, with memory for storing tests
Basic characteristics
• Provides spirometry testing in both adults and children
• Has graphic incentives
• Provides volume-time or ﬂow-time charts of a complete breathing cycle,
both forced as well as slow
• Provides real-time viewing of the ﬂow/volume and/or volume/time curves
on a screen during forced spirometry
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• Memorizes the results from a minimum of 6 tests (6 baseline tests
and 6 post-bronchodilation tests)
• Provides the possibility for add-ons, such as SaO2 modules, etc.
• Has exterior ﬁnishes that are chip-resistant, hard and color-fast
• Incorporates antibacterial ﬁlters
• Adapted for electric power supply and/or rechargeable batteries
• Includes printer for curves and parameters
• Exports data in a structured format; all information necessary should be
provided in order to integrate these data with the health-care facility’s
information systems
Other characteristics to consider
• Interoperable with e-CAP systems (electronic clinical history)
• Integrated with the HIS of the centers by means of HL7 messaging in order
to receive the activity program
• Exports data in the standard format of the Department of Health (CDA R2
for spirometry)
• Has Encapsulated CDA Storage, SOP Class 1.2.840.10008.5.1.4.1.1.104.2
• Provides the necessary software, server or client licensing to meet the
interoperability requirements as well as the installation and conﬁguration
of the software included. In cases when a central server is necessary,
it will not be included in the proposal
• Saves the different tests of a patient in order to choose the best
• Low-cost disposable parts and maintenance
• Low risk for contamination; maximum simplicity for sterilization
and disinfection of the respiratory circuit; possibility for a disposable
transducer




• Case for the equipment
• 3-L calibration syringe
Regulations
Mandatory
• Meets current legislation and other applicable regulations
health-care center. It is not a fantasy, as it is already possible with
chest radiography or electrocardiography, for example. Technology
and an integral,multidisciplinary approach is essential for reaching
this goal.
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Background. We recently demonstrated that quality of forced 
spirometry (FS) in primary care can markedly improve with remote 
off-line support from specialized professionals (Burgos et al Eur 
Respir J 2012; 39: 1313-1318). It is hypothesized that 
implementation of automatic on-line assessment of quality of FS may 
significantly enhance the potential for extensive deployment of a high 
quality FS program.  
Aims. To elaborate and validate a Clinical Decision Support System 
(CDSS) for automatic on-line quality assessment of FS.  
Method. The CDSS was done through a three-step process including: 
i) identification of optimal sampling frequency; ii) iterations to build-
up an initial version using the 24 standard FS curves recommended 
by the American Thoracic Society; and, iii) iterations to refine the 
CDSS using 270 curves from 90 patients. In each of these steps the 
results were checked against one expert. Finally, 778 FS curves from 
291 patients were analyzed for validation purposes.  
Results. The CDSS generated appropriate on-line classification and 
certification in 88% of FS testing with 96% sensitivity and 95% 
specificity. 
Conclusions. Consequently, only 12% of FS testing required off-line 
remote classification by an expert indicating a potential positive role 










High Quality Forced Spirometry (FS) testing across healthcare levels 
is pivotal for proper management of patients with prevalent chronic 
respiratory disorders, namely asthma and COPD(1).  
We have recently reported effectiveness of a web-based application 
for remote off-line expert support to enhance quality of FS in primary 
care. High quality testing improved in a sustainable manner with the 
remote support(2). A relevant difference was observed between the 
intervention group, 71.5% high-quality FS, and the control group, 
59.5% high- quality FS, throughout the 12-month follow-up period 
(p<0.001). Similar figures have been reported in pharmacy offices, 
as part of a COPD case finding program (3).  
Extensive deployment of the web-based remote support from 
specialists to primary care is progressing in the Basque Country 
(Spain), wherein the program is planned to cover the whole 
population of the region, 2,2 million inhabitants, by 2014(4;5). 
Automatic assessment of quality of FS testing should enhance the 
efficiency of the program. Unfortunately, current applications for on-
line assessment of quality of FS misclassify the tests, as compared 
with examinations done by expert professionals (2).  
We hypothesize that elaboration and validation of a Clinical Decision 
Support System (CDSS) for on-line automatic assessment and 
certification of quality of FS in primary care may represent a pivotal 
step toward adoption of the high quality FS program in large regions. 
The current study is part of the refinement of the ongoing 
deployment of the high quality FS program in Catalonia (6), an 




Building-up the CDSS 
 
As displayed in Figure 1, the initial step in the process for 
elaboration of the CDSS was the identification of the optimal sampling 
frequency to achieve highest sensitivity and specificity in the analysis 
of the spirometric curves. The process was done using the 24 
standard flow-volume (F/V) and volume-time (V/T) curves from the 
pulmonary waveform generator recommended by the European 
Respiratory Society/American Thoracic Society(7). To this end, a 
systematic examination of a large range of sampling frequencies, 
from 6.25 to 100 Hz, was done during the first iterative process 
indicated in the figure.  
The construction of an initial version of the CDSS was carried out 
using the 24 standard FS curves (8;9) following an iterative process, 
as displayed in Figure 1. In each step, the results generated by the 
CDSS were compared with the criteria of one expert in the field of 
lung function testing (FB) and the iterative process was maintained 
until sensitivity and specificity of the results generated by the CDSS 
showed 100% agreement with the expert.  
The CDSS combines the different aspects assessed on the FS curve  
in one score with three different categories: i) Grade 0, rejected due 
to unacceptable morphology of the FS curve; ii) Grade 1, acceptable 
for further classification according to Table 1; or, iii) Grade 2, 
undefined characteristics of the FS. The two first categories, Grades 0 
and 1 allow proper on-line automatic classification of FS testing as 
well as the generation of a certified FS curve to be potentially shared 
across healthcare tiers; whereas Grade 2 requires off-line expert 
assessment.  
The CDSS systematically assessed 27 different characteristics of each 




defined specific algorithm for calculations with initial parameters that 
were refined through successive iterations until the final version of 
the CDSS was obtained (Figure 1). As indicated above, the 
performance of each of the successive versions of the CDSS was 
compared with the results provided by the expert. A refined version 
of the CDSS (Figure 1) was achieved using 270 curves from 90 
patients from(2).  
 
CDSS validation  
The refined version of the CDSS was compared with a database of 
778 curves from 291 patients from one of the Primary Care centers in 
Barcelona. The FS testing was done using a spirometer (Sibel 120, 
SIBELMED, Barcelona Spain). Again, the score generated by the 
CDSS was compared with the one obtained from the same expert 
evaluator.  
The use of the two databases of FS curves from patients for 
refinement and validation purposes, respectively, was approved by 
the Ethical Committee of the Hospital Clínic i Provincial de Barcelona. 
 
Data analysis   
The ATS database (8) contains volume (V) values of each curve, from 
which flow (F) values were obtained by discrete differentiation. 
 
 
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
 (1) 
The two patient’s databases contain flow (F) values, from which 
volume (V) values were obtained by discrete integration. 
 






wherein i= 1,…,N, being N the length of the sequence. The sample 
period is = 0.01 s, so the sample frequency is 100 Hz. 
Sensitivity and specificity of the CDSS were calculated for all curves 







wherein TP (true positive) corresponds to curves classified as class 0 
by both CDSS and the evaluator; TN (true negative) corresponds to 
curves classified as class 1 by the CDSS and the by the evaluator; FP 
(false positive) indicates curves classified as class 0 by the CDSS, but 
classified in class 1 by the evaluator; and, FN (false negative) 
corresponds to curves classified as class 1 by the CDSS, but as class 







The sampling frequency that provided the highest sensitivity and 
specificity for the analysis carried out with the 24 standard FS curves 
recommended by the ATS was 100 Hz (Figure 1) (see Table 1, in the 
on-line supplement). This result was confirmed in the 270 curves 
from 90 subjects (2). 
Both sensitivity and specificity of the CDSS were initially calculated 
with the 24 standard FS curves recommended by the ATS(7) using 
only class 0 and class 1 curves. The results were as follows: class 0, 
n=15; class 1, n= 6; class 2, n= 3 with 100% sensitivity and 100% 
specificity. Up to five complete versions of the CDSS were generated 
in the two iterative processes indicated in Figure 1, until a final 
version of the CDSS was ready for validation.  
The validation study using 778 curves from 291 patients showed the 
following distribution of FS curves: 419 maneuvers (54%) were 
appropriately classified as bad curves (Class 0); 266 maneuvers 
(34%) were appropriately classified as good curves (Class 1); and, 
only 93 maneuvers (12%) needed an off-line review by a Lung 
Function expert to assess quality of the test (Class 2). Sensitivity and 
specificity calculations for Class 0 and Class 1 curves were 96.1 and 





The current research has generated and validated a CDSS showing 
ability to classify a reasonable percentage of FS curves, 88%, as 
either acceptable (class 1) or bad manoeuvres (class 0). Only 12% of 
the curves were classified as undefined (class 2) and were candidate 
for off-line remote validation by an expert. Moreover, we observed 
that both sensitivity and specificity of the CDSS were very high. 
Consequently, the results seem to indicate that a vast majority of FS 
testing carried out by non-specialized professionals in primary care 
can be reliably assessed on-line and, consequently, the high quality 
FS program partly based on remote automatic evaluation of the 
testing could be considered ready for regional scalability. Obviously, 
further steps toward extensive deployment of the program must 
planned with caution. A proper monitoring of the potential for 
generalization of the current results and the need for further 
refinements of the current CDSS should be taken into account. 
In the new scenario, as indicated by the BPMN (Bussiness Process 
Management Notation) diagram, displayed in Figure 1 of the on-line 
supplement, acceptable manoeuvres (class 1) will be automatically 
addressed to the algorithm indicated in Table 1 that classifies and 
certifies FS testing prior to its recording into the local (Electronic 
Health Record, HER) and regional  repositories. In contrast, those 
manoeuvres classified as bad curves (class 0) will generate an on-line 
specific error message to the professional indicating the need to 
perform additional testing until quality acceptance is reached. As 
indicated, we estimate that approximately 12% of the curves will not 
be properly classified (class 2) and they will need an off-line remote 
supervision by an expert professional. In this case, the FS testing of a 
given patients will need to be re-scheduled.           
Previous reports have indicated the potential of telemedicine to 




out by non-expert professionals(10-12), but the quality control in 
those studies was based on off-line analyses by expert professionals 
carried out in a time-consuming manner (13-15). Likewise, the need 
for an external, likely centralized, quality control program (12;14-17) 
is well established. The results of the current study refine previous 
achievements (2) and open the way to explore extensive and efficient 
adoption of this type of high quality FS programs.  
We acknowledge that high quality FS programs combine several 
different dimensions, namely: i) professional coaching (18;19), ii) 
remote support (2); iii) interoperability of testing across healthcare 
levels (20); iv) standards for procurement of equipment(7;21); and, 
v)  support to interpretation of testing (22;23). The current study 
provides pivotal results to efficiently address issues associated to 
remote support of FS testing. But, a proper integration of all the 
above elements needs to be considered in the process of shaping a 
successful high quality FS program for scalability at regional level.  
 
Limitations of the study  
We acknowledge two principal limitations of the study. Firstly, we 
included only one expert observed (FB). The CDSS should be re-
assessed in the future with the inclusion of at least 3 different 
experts. Moreover, the current study evaluates the CDSS in an 
isolated manner. But, further assessment of the whole clinical process 
as defined in the BPMN (see Figure 1 in the on-line supplement) 
should be done before specific plans for scalability are undertaken.  
 
Conclusions 
To our knowledge, the current study constitutes the first successful 
attempt to validate an automatic CDSS for large scale on-line 
assessment of quality of FS testing. The incorporation of the CDSS 
into the web-based application for remote assistance to primary care 
professionals (2) may facilitate sustainable high quality FS.  
The results indicate a high potential of the CDSS for discrimination 
between good and poor quality results of FS testing, but they require 
further independent validation before specific plans for 
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TABLES AND FIGURES 
 
 
Table 1.  Quality scores for spirometric manoeuvres according 
to ATS/ERS standardization (7) 
¢
 
High quality spirometries, A and B scores, correspond to, (A, 3 acceptable manoeuvres with 
differences in FVC and/or FEV1 <150 ml, and (B, 3 acceptable manoeuvres  with differences in 
FVC and/or FEV1 <200 ml); C to high variability among manoeuvres; D  only one acceptable 





A 3 acceptable  manoeuvres, and best 2 matched with differences in FVC and / or FEV1 
<150 ml 
B 3 acceptable  manoeuvres, and best 2 matched with differences in FVC and / or FEV1 
<200ml                     
C 2 acceptable  manoeuvres, and best 2 matched with differences in FVC and / or FEV1 
<250 ml                                     
D 1 acceptable  manoeuvre 




Table 2 – List of features of the forced spirometry curve 
explored by the CDSS  
 
BEV trad,                              Back extrapolation  >0.15 L or < 5% of FVC 
EOTV trad End of test criteria, volume < 0.025 L in time 1 s 
Tex                                       Time of end FVC (Tex>6 s)     
EOTV new  (5 criteria)      a) EOTV < 0.025 L or Tex>6 s;   
b) If Tex>6 s EOTV<0.025 L in time  0.5 s;  
c) If Tex>6 s, EOTV < 0.1 L;   
d) EOTV(Tex) = EOTV * 6/Tex;  
e) EOTV < 0.025 * Tex/6 L    
EOTV trad AND EOTV new EOTV trad and all EOTV new (a;b;c;d;e) 
EOTV trad OR EOTV new EOTV trad and some of EOTV new (a;b;c;d;e) 
Tex AND EOTV new Tex and all EOTV new (a;b;c;d;e) 
Tex OR EOTV new Tex and some EOTV new (a;b;c;d;e) 
Peak_Valley_Single,        High local maximum (peak) and minimum (valley) in FV curve 
Peak_Valley_Combined 
 
High local maximum (peak) and minimum (valley) in FV curve 
close to FEV1 
VT_end,         Irregularity or oscillation at the end of VT curve                         
FV_slope_single,   Variation of FV slope or high FV slope. 
FV_slope_combined,  Variation of FV slope and high FV slope. 
FVSlope_Test_Combo,  Irregularity and variation of FV slope or high FV slope 
FVSlope_Test_Combo_Area Under Rect,  Irregularity or variation of FV slope and high FV slope 
FVSlope_Test_Combo4,  Irregularity and variation of FV slope and high FV slope 
Diff_single,        
 
Irregular concavity - convexity before the PEF value in FV 
curve   
iff_combined,  
 
Irregular slope and irregular concavity-convexity before the 
PEF value in FV curve 
PEF TimeUp Time of archive PEF < 130 milliseconds 
PEF TimeDown,                  Time of archive PEF > 0.25 milliseconds 
PEF Cut,                       
 
PEF is not a peak in FV curve (is plane). Volume (F=PEF) > 15 
%  FVC 
PEF Cut2 FEV1,           PEF is not a peak in FV curve (is plane). Volume (F=PEF) > 
17.5 % FEV1 
PEF Peak_Test_Combo,  
 
Volume (F=PEF) > 15 % FVC and/or Volume (F=PEF) > 17.5 
% FEV1 
PEF Peak_Test_Combo2,  Volume (F=PEF) > 15 % FVC and Volume (F=PEF) > 17.5 % 
FEV1 
PEF DoublePeak,      PEF bimodal in FV curve 
PEF Double_Peak_Combo,  PEF bimodal and PEF is not a peak (is plane) in FV curve 
PEF Slow,                                  Volume of archive PEF < 20% FVC 
 
BEV (back extrapolation); EOTV (end of test criteria, volume); Tex (Time to end FVC); VT (volume/time 
curve);  FV (flow/volume curve);   PEF (peak expiratory flow); FVC (forced vital capacity) ; FEV1 (forced 



























The summary of the main findings and outcomes of the PhD thesis, grouped by each of the 






The first study clearly showed the potential of the web-based application to generate sustain-
able high-quality transfer of FS to inexperienced non-specialized primary care professionals 
from five different regions of Spain. The study showed that remote collaboration between pri-
mary care professionals and lung function specialists has a sustainable positive impact on qual-
ity assurance of FS performed by non-experts. A relevant difference was observed between 
the intervention group (71.5% high-quality FS) and the control group (59.5% high- quality FS) 
throughout the 12-month follow-up period (p<0.001). The study generated the seminal data 
that triggered the scalability program aimed at transferring FS to primary care professionals. 
Consolidation of such transferability, explored in other studies of this PhD thesis and in on-
going research, may pave the way for ICT-supported re-engineering of the management of 
patients with chronic respiratory diseases within a coordinated care scenario.
The second and third manuscripts tackled an innovative question, that is: 
Can pharmacy offices be main actors in a COPD case-finding program run in close coordination 
with primary care physicians?
The results of these two studies confirm positive results for this type of service. Moreover, 
beyond the COPD case-finding objective, the two studies seem to identify a high potential of 
pharmacy offices as health agents in the borderline area between formal and informal care. It 
should be acknowledged that the two studies fail to demonstrate effectiveness of the entire 
value chain of the service, including coordination with primary care physicians. The latter is 
being currently partly approached, beyond this PhD thesis, through the validation of a Clinical 
Decision Support System in the Synergy-COPD EU project(68) and in the Catalan Master Plan 




Manuscripts 4 and 5 analyze the current status of Lung Function Testing in Catalonia both at 
hospital level and at primary care level. They were carried out within the frame of PDMAR. The 
findings support the need for: 
     I) Expanding the role of FS beyond specialized care; and, 
     II) Achieving homogeneous distribution of lung function testing across the territory with   





Overall, the two analyses confirmed the need for the transferability program addressed in the 
PhD thesis.
Also within Objective 2, a second set of studies acknowledges the high relevance of the coach-
ing programs addressed to non-specialized professionals as one of the main components of 
the strategies for deployment of ICT-supported functional testing in coordinated care. Manu-
script 6 generates proposals in this area within the framework of PDMAR in Catalonia; whereas 
manuscript 7 describes the European situation, through the Hermes program for continuous 
professional development endorsed by the European Respiratory Society. 
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Two main outcomes must be highlighted within Objective 3:
Firstly, the connectivity of the measurement equipment had to be ensured through the elabora-
tion of a properly standardized transfer of the relevant FS data using HL7 v3 and CDA R2 standards. 
The initiative was promoted by the Office for Standards and Interoperability of the Catalonian 
Department of Health within the Plan for the Digitalization of Medical Images (69), as reported 
in manuscript 8. Some manufacturers have already implemented the design (70) that has be-
come a requirement for public procurement in Catalonia. Furthermore, the Spanish Respira-
tory Society (SEPAR) has recently included the CDA in its official recommendations for forced 
spirometry standards (71). Although this outcome represents a key step for interoperability of 
FS at health system level, we acknowledge that it is just one of the steps required to ensure ac-
cessibility of FS across healthcare tiers. Interoperability strategies are further discussed below. 
A second main outcome within Objective 3 was the validation of an algorithm for automatic 
assessment and certification of FS. The research included the design and validation of the new 
algorithm through the following steps: i) assess the optimal sampling frequency; ii) identify a 
novel quality criteria to be used in the algorithm, up to 27 characteristics of the FS curves were 
taken in to account to elaborate the new algorithm; iii) elaboration of a first version of the 
algorithm using the 24 standard Flow-Volume and Volume-Time curves recommended by the 
ATS (72;73); iv) elaboration of a refined version of the algorithm using 270 FS curves from 90 
patients from (74) through an iterative process wherein results were compared with an expert 
professionals; and, v) validation of the algorithm using a database of 778 FS curves from 291 

























The successful completion of the study (manuscript 9) constitutes a pivotal step toward scalability 
of the transfer of FS to primary care and pharmacy offices at regional level. Within the frame of 
the Synergy-COPD EU project, the algorithm has been integrated into the ICT-platform support-
ing coordinated care. One of the aims of this EU project is validation of the entire clinical process. 
Furthermore, scalability of the service is planned, as part of the PDMAR mainstream goals.
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All the documents on recommendations for FS standardization issued by international respira-
tory associations (49), primary care societies (58), as well as the contributions of numerous in-
dividual authors, emphasize the need for high quality FS. It is of note, however, that such a goal 
is only satisfactorily achieved in specific scenarios (75-79) such as clinical trials and controlled 
research studies, where tight centralized quality control of testing is in place. The logistics of 
the quality control is often done by a Contract Research Organization (CRO) that provides ICT-
support to the trial sponsor on a proprietary system. 
The challenge addressed in this PhD thesis is defined by the fact that the deployment must 
be carried out in a real clinical scenario in its transition from standard care to a coordinated 
care environment with ICT-support in which a substantial transfer of complexity from hospital-
based specialized care to primary care is envisaged. This rather gigantic operation required at 


























Consequently, the outcomes generated should provide entirely new solutions in a novel sce-
nario. The collection of studies of this PhD thesis should be envisaged as a coordinated effort 







Different authors (27;58;80) have elaborated on the need for transferring well- established qual-
ity assurance programs from lung function laboratories to the primary care setting to ensure 
the quality of the tests. There is evidence (55;56;79) suggesting that external quality assurance 
in primary care needs to be implemented. In an extensive review of FS performed in primary 
care, it was found that general practitioners identified approximately 90% of their own tests as 
acceptable; whereas the opinion of an expert decreased the acceptance rate to 63% (55). 
We acknowledge that traditional training constitutes a pivotal element in obtaining high-quali-
ty FS, but conventional training does not ensure the sustainability of high-quality testing. Novel 
training modalities are being explored. Recently, the European Respiratory Society has initi-
ated a certified e-learning training program for professionals (81). The impact of this program 
on high-quality FS should be evaluated over the coming years, but it does not seem to fulfill the 
coaching requirements of non-specialized health professionals.
The three studies under Objective 1 (manuscripts 1 to 3) demonstrate efficacy and potential 
for deployment of the high-quality FS program in the two scenarios assessed in this PhD thesis: 
primary care and pharmacy offices. Moreover, the design of the algorithm for automatic evalu-
ation of FS quality and its results in terms of sensitivity and specificity (manuscript 9) set the 
basis for the design of a realistic strategy aimed at the deployment of a high-quality FS service 
in these two scenarios.
The studies under Objective 2 confirm the need of such a high-quality FS program in Catalonia 
(manuscripts 4 and 5), but they also identified that there is a clear need for an efficient interplay 
between the web-based application assessed in this PhD thesis and proper coaching programs 
for non-specialized healthcare professionals working in different healthcare tiers. Among the 
lessons learnt during the development of the program is the need to combine classical training 
approaches together with coaching programs embedded into the web-based application. The 
current platform generates customized reports on the evolution of professional’s quality, as 
well as global trends at a health sector level indicating changes over time. 
The introduction of enhanced coaching programs into the ICT-platform, embedded into novel 
CDSS that could include feedback models might improve sustainability of training. Potential 
functionalities to be considered in the updated web-based application for high quality FS are: 
i) information on the testing at request, ii) individualized description of FS errors based on 
the analysis carried out using the algorithm for automatic assessment of quality of the test-
ing; iii) corrective actions to be performed;  iv) interactive educational material; and  v) self-
assessment tools. 
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The ICT-platform supporting coordinated care for chronic patients briefly described in the 
introduction and presented in detail by Cano et al(65): i) provides organizational interoper-
ability among actors across healthcare levels; ii) includes clinical decision support systems; 
and, iii) facilitates patient-centered management taking into account within the healthcare 
plan the patient’s co-morbid conditions. Moreover, the open, modular nature of the ICT-
platform (Linkcare®) together with its multicenter functionalities makes it a platform which 
offers adequate support for interoperability of the FS across the health system, despite the 
proprietary nature of most of the providers’ health information systems. The ICT-platform 
can provide support for organizational interoperability by itself or as an additional layer on 
top of a Health Information Exchange (HIE) platform, communicating providers from a given 
healthcare sector.  
The two technological outcomes of this PhD thesis: i) the  algorithm for automatic assessment 
of FS; and ii) the elaboration of a CDA (Clinical Document Architecture) are pivotal for covering 
the two critical aspects necessary for achieving full scalability of the service.
The CDA R2 (CDA, Release 2) standard by HL7 v3 (Health Level Seven, version 3) is a product of 
HL7 International, a not-for-profit organization dedicated to the production of interoperability 
standards in health care (82).  The CDA defines the structure of a clinical document and uses 
XML to label the different categories of information. XML is the standard for the structured 
information exchange between applications, regardless of the technological platform used, so 
that the CDA can be viewed from any computer using a web navigator.
The CDA for FS includes patient data, information about the context of the test, the result-
ing clinical parameters, the flow-volume and volume-time charts as well as the original signal 
captured by the spirometer. Likewise, it includes data about the origin of the request obtained 
from the providers’ electronic medical files. The clinical information is coded using SNOMED 
CT (Systematized Nomenclature of Medicine—Clinical Terms), which allows it to be processed 
automatically and incorporated into the patients’ medical files in a structured manner. The 
final CDA also includes certification of the quality control performed either through the al-
gorithm for automatic quality control or manually by an expert professional. As described in 
the Introductory Section, interoperability between the Linkcare® core module and external 
equipment and/or applications is implemented via web services.  
-	+	
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A complete description of the characteristics of the high quality FS service in primary care is 




display a scheme wherein all elements of the service in primary care (Fig 3) and in pharmacy 
offices (Fig 4) are identified and described in the figure legends.
We acknowledge that this PhD thesis has assessed efficacy and basic elements of the high 
quality FS service, but it has not validated the entire service process which is being partly 
implemented, as mentioned above, within the Synergy-COPD project and will be completed as 
part of the deployment of the PDMAR in Catalonia.        
The predicted beneficial clinical impact of the high-quality FS service has already been de-
scribed in the Introductory Section of this PhD thesis. Improvement should be expected in 
different areas, namely: i) enhancement of diagnosis and follow-up of patients with chronic 
respiratory disorders; ii) generation of novel reliable ways to assess bronchial hyper-respon-
siveness; iii) setting up of COPD case-finding programs and early disease prevention strategies; 
and, iv) decreasing duplicated testing due to the accessibility of reliable test results across the 
health systems.
Adoption of this type of service is strongly linked to policy decisions on early disease prevention 
strategies and, also, to the consolidation of novel models of reimbursement and incentives for 
chronic care. As extensively analyzed in NEXES(7), demonstration of efficiencies of the services 
and changes toward bundled payment models with shared risk among actors involved in the 
value chain are key elements for the extensive adoption of novel services into a coordinated 
care scenario.
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The high-quality FS service in the Basque Country was deployed in 2011 as part of the disease-
oriented programs for chronic patients aimed at early disease intervention and efficient man-
agement of high-risk patients(84). 
The service incorporates the web-based application assessed in manuscript 1 in combination 
with traditional training programs. Since 2011, it has been steadily deployed in the whole re-
gion, being currently used in 100 primary care units. By the end of 2012, the first year follow-up 
was successfully completed. The analysis of efficiencies comparing the remote support service 
against traditional ways to control quality of FS clearly indicated cost containment. The result 
triggered further deployment of the service at regional level up to its completion by 2014. 
The results of the Basque Country indicate that the approach has a high degree of transfer-
ability. The excellent level of acceptance among users (non-specialized professionals) seems 
to be due not only to the quality assurance but also because the service highly reinforces the 
quality and potential of FS for diagnosis.
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Scalability in Catalonia has evolved along with the development of this PhD thesis, as part of 
the PDMAR. It has been also modulated by the evolution of the Linkcare® platform. Compari-
son of the Catalan program with the deployment in the Basque country shows the following 
three major differences:


























Those services must be properly coordinated and validated. 
As mentioned above, all the additional developments, beyond the outcomes of this PhD thesis, 
are planned to be accomplished within 2013, as part of the Synergy-COPD project(68) and the 
PDMAR deployment plan (36).
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We believe that this PhD thesis provides the basis for such developments that will obviously 
require the build-up of additional applications and refinement of the existing ones. Moreover, 
protocols for validation of the system should be designed and be in place before full scalability 
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. The figure depicts the clinical 
process of a patient with respiratory symptoms attending a primary care visit. The flow is as 
follows: the general practitioner (GP) decides that the patient is a candidate for FS testing and 
both baseline and post-bronchodilator studies will be done by a non-specialized nurse. At the 
end of the testing, the results will be automatically assessed using the algorithm that will gen-
erate FS certification for quality.  The three possible outcomes are: i) the FS testing qualifies as 
high quality. It will be used by the GP for his/her decision-making process and the certified FS 
will be sent to the patient’s EHR and to the regional repository (shared EHR or HC3, Historia Cli-
nica Compartida de Catalunya); ii) the FS testing does not fulfill quality criteria. Then automatic 
feedback with specific information on the problem is forwarded to the nurse while the patient 
is still on site. Consequently, the nurse will have the opportunity to solve the problem and 
generate a high-quality FS test; and, iii) approximately 12% of the FS testing will be classified as 
undefined by the automatic algorithm and forwarded to the specialist for advice. The specialist 
will provide remote off-line recommendations directly to both the GP/nurse and the patient 
will be attended by the GP who will take the final decision on how to proceed. In two of these 






gram. The figure depicts the process of a citizen/customer attending a CPh where he/she sees 
a banner inviting participation in a respiratory health status assessment program. If the citizen 
decides to apply, then the CPh officer will administer the GOLD questionnaire to assess health 
status. If risk factors are identified, the citizen will be invited to perform a pre-bronchodilator 
Forced Spirometry (FS) testing carried out by the CPh officer. 
Regarding the quality of the FS testing, there are three possible outcomes: i) the FS testing is 
qualified as high quality and it will be certified as such by the automatic algorithm and for-
warded to the regionally shared EHR (or HC3, Historia Clinica Compartida de Catalunya); ii) 
the FS testing does not fulfill quality criteria. Then, automatic feedback with specific info on 
the problem is forwarded to the CPh while the patient is still on site. Consequently, the CPh 
will have the opportunity to solve the problem and generate a high-quality FS test; and, iii) 
approximately 12% of the FS testing will be classified as undefined by the automatic algorithm 
and forwarded to the specialist for advice. 
The specialist will provide remote off-line recommendations directly to the CPh officer and the 
certified FS testing will be forwarded simultaneously to the regionally shared EHR.  The citi-
zen’s flow in the case of high-quality FS testing can be as follows: i) Normal FS testing: the CPh 
officer will generate a report on paper giving tests results and advice about stopping smoking; 
ii) Abnormal FS results: the CPh officer will generate a report on paper advising the subject to 
contact his/her general practitioner, who will have access to the certified FS testing through 
the HC3; and iii) Undefined results (12% of the testing): the subject will be informed of the 




Besides the consolidation of the scalability program in Catalonia, the results of this PhD thesis 
open a new exciting avenue consisting of the generalization of the transfer of other functional 
testing and therapeutic tools from hospital-based specialized care to primary care with the 
remote support of specialists. 
Ongoing pilot studies in the area of sleep apnea and management of pulmonary hypertension 
are showing promising results that seem to confirm the potential for generalization of the 
approach. There is no doubt that any significant progress in this direction will require a proper 
analysis of the efficiencies generated by the new services, proposal for innovative reimburse-
ment modalities, followed by profound reorganizations of the existing hospital units providing 
these services. The process will generate completely new modalities of interactions with pri-











































































L’Espirometria Forçada com a prova de concepte
	
El desplegament de nous models de salut basats en la coordinació entre nivells assistencials 
constitueixen una prioritat a nivell europeu davant la necessitat de gestionar les disfuncions 
generades per l’elevat impacte sanitari i social de les malalties cròniques.
La transferència de la complexitat des de l’atenció sanitària especialitzada, en general de base 
hospitalària, a professionals d’Atenció Primària constitueix un dels elements centrals del canvi 
en el model de salut. 
Això implica el redisseny de processos clínics i la preparació del personal sanitari per al nou entorn.
L’ús eficient del potencial que ofereixen les Tecnologies de la Informació i la Comunicació (TIC), 
com a element facilitador de la col·laboració entre nivells assistencials i d’una major accessi-
bilitat del pacient, té un rol important en el desplegament i l’articulació dels Serveis d’Atenció 
Integrada (SAI) que configuren el nou model de salut. En aquest context, la transferència de 
les intervencions diagnòstiques especialitzades a l’atenció primària constitueix un àrea molt 
rellevant en el procés de canvi.
L’hipòtesi central de la present tesi doctoral és que la transferència de determinades proves 
diagnòstiques a l’atenció primària genera eficiències a nivell del sistema de salut. Els diferents 
estudis realitzats en la tesi es centren en l’espirometria forçada (EF), seleccionada, per les seves 
característiques, com una prova de concepte. Els objectius generals són explorar aquells fac-
tors que s’han identificat com a claus en la modulació del procés de la transferència de l’EF, 
així com definir estratègies per a la seva escalabilitat regional. La tesi s’estructura en base a 3 
objectius específics:
Objectiu 1 - Anàlisi de la transferència de la EF a Atenció Primària i a oficines de farmàcia.  
En el primer estudi “Telemedicine enhances Quality of Forced Spirometry in Primary Care” es 
va demostrar l’eficàcia en el temps (12 m) d’un servei centralitzat pel control de qualitat de 
l’EF efectuada per professionals no especialitzats de tres regions espanyoles. Es va demostrar 
que la col·laboració remota entre professionals de primària i especialistes de funció pulmonar 
tenen  un efecte positiu sostingut sobre la qualitat de l’EF realitzada per personal no expert. Es 
va observar una diferència significativa entre el grup d’intervenció (71.5% EF d’alta qualitat) i el 
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La investigació va generar informació valuosa per planejar de forma adient l’escalabilitat del 
programa a nivell regional. Els resultats d’aquest estudi, junt amb altres apartats de la tesi i 
d’altres investigacions en curs, facilitaran el redisseny del rol de les proves diagnòstiques en la 
gestió dels pacients crònics en un entorn d’atenció integrada.
Els estudis 2 (Early detection of COPD in customers of urban community pharmacies: a pilot-
study) i 3 (Spirometry in community-pharmacies: a novel strategy to reduce COPD  underdiag-
nosis) de la tesi responen de forma afirmativa a la següent pregunta: 
Poden les oficines de farmàcia tenir un rol rellevant en un programa de detecció de casos de MPOC?
Els resultats són clarament indicatius del potencial de les oficines de farmàcia com a agent 
sanitari en estreta col·laboració amb Atenció Primària. Cal senyalar que amdos estudis sola-
ment aporten informació sobre factibilitat. L’anàlisi d’eficiència es planeja com a una activitat 
més enllà d’aquesta tesi doctoral, en el marc del projecte EU Synergy-COPD i del Pla Director 
de Malalties de l’Aparell Respiratori (PDMAR) del Departament de Salut de la Generalitat de 
Catalunya. 
Objectiu 2 – Avaluació de requeriments per a l’escalabilitat regional a nivell de Catalunya 
En els estudis 4 (Encuesta de utilización de la función pulmonar en los hospitales públicos de 
Cataluña en 2009) y 5 (Estudio de la función pulmonar básica en los centros de atención pri-
maria de Cataluña. Atención Primaria) s’analitzà la situació i necessitats futures de les proves 
de funció pulmonar a Catalunya a nivell hospitalari i extra-hospitalari en el marc del PDMAR.
Els resultats obtinguts confirmen la necessitat de desplegar l’EF a l’Atenció Primària i 
d’incrementar l’homogeneïtat territorial en el que respecta a l’accés a les proves de funció pul-
monar per a pacients i professionals. Es confirma la necessitat del programa de transferència 
de l’EF plantejat en la tesi doctoral.
En un segon grup d’estudis en el Objectiu 2 de la tesi, efectuats en el marc del PDMAR, 
s‘analitzaren les necessitats i estratègies pel que fa a l’entrenament dels professionals no es-
pecialitzats tant en l’àmbit català, estudi 6 (Disseny d’un programa de formació basic para 
aconseguir espirometries de qualitat), com a nivell europeu, estudi 7 (HERMES Spirometry: the 
European Spirometry Driving Licence). 
Objectiu 3 – Contribucions tecnològiques a l’escalabilitat 
L’estudi 8 (Requerimientos técnicos de los espirómetros en la estrategia para garantizar el acceso 
a una espirometría de calidad) va aportar  un element essencial per assegurar l’interoperabilitat 
de les dades de l’EF al assegurar l’estandardització de la transferència d’informació utilitzant 
el protocol HL7 v3 i CDA (Clinical Document Architecture) amb estàndard R2. Efectuat amb el 
suport de l’Oficina d’Estàndards i Interoperabilitat del Departament de Salut de la Generalitat 
de Catalunya dins el Pla de Digitalizació de la Imatge Mèdica. L’estàndard de transferència de 
l’EF ha estat ja adoptat per alguns fabricants d’equips de medició i és un requeriment per als 
concursos públics a nivell regional. 
A més, a l’estudi 9 (Clinical Decision Support System to Enhance Quality Control of Forced Spi-
rometry) es va generar i validar un algoritme per el control automàtic de la qualitat de l’EF. 
Els resultats de la validació amb 778 corbes espiromètriques varen indicar que la sensibilitat 
i especificitat de l’algoritme era del 96.1 i 94.9%, respectivament. La validació de l’algoritme 
aportà un segon element tecnològic necessari  per a l’escalabilitat del programa de transfer-
ència de l’EF a Atenció Primària i a les oficines de farmàcia. L’algoritme ha estat integrat a la 
plataforma TIC de gestió de malalts crònics. La validació del procés clínic s’efectuarà dins del 
projecte EU Synergy-COPD i el pla d’escalabilitat a Catalunya es materialitzarà a curt termini 
en el marc del PDMAR.
		
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cació dels requeriments per a l’escalabilitat regional del programa de transferència de l’EF 






cialitzats com a component essencial d’un programa de transferència d’EF de qualitat a l’ 
Atenció Primària (manuscrits 6 i 7). 
6 Es van efectuar dos contribucions tecnològiques rellevants per assegurar la interoperabilitat 













La Espirometría Forzada como prueba de concepto
	
El despliegue de nuevos modelos de salud basados en la coordinación entre niveles asisten-
ciales constituye una prioridad a nivel Europeo ante la necesidad de gestionar las disfunciones 
generadas por elevado impacto sanitario y social de las enfermedades crónicas.
La transferencia de complejidad desde la atención sanitaria especializada, en general de base 
hospitalaria, a profesionales de Atención Primaria, constituye uno de los elementos centrales 
del cambio en el modelo de salud. Ello implica el rediseño de procesos clínicos y la preparación 
del personal sanitario para el nuevo entorno. 
El uso eficiente del potencial que ofrecen las Tecnologías de la Información y la Comunicación 
(TIC), como elemento facilitador de la colaboración entre niveles asistenciales y de una mayor 
accesibilidad del paciente, tiene un papel importante en el despliegue y articulación de los 
Servicios de Atención Integrada (SAI) que configuran  el nuevo modelo de salud. En este con-
texto, la transferencia de las intervenciones diagnósticas especializadas a la atención primaria 
constituye un área muy relevante en el proceso de cambio.
La hipótesis central de la presente tesis doctoral es que la transferencia de determinadas prue-
bas diagnosticas a la atención primaria genera eficiencias a nivel del sistema de salud. Los dife-
rentes estudios realizados en la tesis se centran en la espirometría forzada (EF), seleccionada, 
por sus características, como una prueba de concepto.
Los objetivos generales son explorar aquellos factores que se han identificado como claves 
en la modulación del proceso de la transferencia de la EF, así como definir estrategias para su 





En el primer estudio “Telemedicine enhances Quality of Forced Spirometry in Primary Care” se 
demostró la eficacia en el tiempo (12 m) de un servicio centralizado para control de calidad de la 
EF efectuada por profesionales no especializados de tres regiones españolas. Se demostró que 
la colaboración remota entre profesionales de primaria y especialistas de función pulmonar 
tiene  un efecto positivo sostenido sobre la calidad de la EF realizada por personal no experto. 
Se observó una diferencia significativa entre el grupo intervención (71.5% EF de alta calidad) 
y el grupo control (59.5% EF de alta calidad) durante los 12 meses del estudio (p<0.001). La 
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programa a nivel regional. Los resultados de este estudio, junto con otros apartados de la tesis 
y otras investigaciones en curso, facilitarán el rediseño del papel de las pruebas diagnosticas en 
la gestión de los pacientes crónicos en un entorno de atención integrada.
Los estudios 2 (Early detection of COPD in customers of urban community pharmacies: a pilot-
study) y 3 (Spirometry in community-pharmacies: a novel strategy to reduce COPD  underdiag-
nosis) de la tesis responden de forma afirmativa a la siguiente pregunta: 
Pueden las oficinas de farmacia tener un papel relevante en un programa de detección de casos 
de EPOC?
Los resultados son claramente indicativos del potencial de las oficinas de farmacia como 
agente sanitario en estrecha colaboración con Atención Primaria. Cabe señalar que ambos 
estudios solo aportan información sobre factibilidad. El análisis de eficiencia se planea como 
una actividad más allá de esta tesis doctoral, en el marco del proyecto EU Synergy-COPD y del 
Plan Director de Enfermedades de Aparato Respiratorio (PDMAR) del Departamento de Salud 
de la Generalitat de Catalunya. 
?&4,	W=,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En los estudios 4 (Encuesta de utilización de la función pulmonar en los hospitales públicos 
de Cataluña en 2009) y 5 (Estudio de la función pulmonar básica en los centros de atención 
primaria de Cataluña. Atención Primaria) se analizó la situación y necesidades futuras de las 
pruebas de función pulmonar en Catalunya a nivel hospitalario y extra-hospitalario en el 
marco del PDMAR. Los resultados obtenidos confirman la necesidad de desplegar la EF en 
Atención Primaria y de incrementar la homogeneidad territorial en lo que respecta al acceso a 
las pruebas de función pulmonar para pacientes y profesionales. Se confirma la necesidad del 
programa de transferencia de la EF planteado en la tesis doctoral.
En un segundo grupo de estudios en el Objetivo 2 de la tesis, efectuados en el marco del 
PDMAR, se analizaron las necesidades y estrategias en lo que respecta al entrenamiento de 
profesionales no especializados tanto en el ámbito catalán, estudio 6 (Diseño de un programa 
de formación básico para conseguir espirometrías de calidad), como a nivel Europeo, estudio 7 
(HERMES Spirometry: the European Spirometry Driving Licence). 
?&4,	#W	&	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El estudio 8 (Requerimientos técnicos de los espirómetros en la estrategia para garantizar el ac-
ceso a una espirometría de calidad) aportó  un elemento esencial para asegurar la interopera-
bilidad de los datos de EF al asegurar la estandarización de la transferencia de información uti-
lizando el protocolo HL7 v3 y CDA (Clinical Document Architecture) con estándar R2. Efectuado 
con el soporte de la Oficina de Estándares e Interoperabilidad del Departament de Salut de la 
Generalitat de Catalunya dentro del Plan de Digitalización de la Imagen Médica. El estándar de 
transferencia de la EF ha sido ya adoptado por algunos fabricantes de equipos de medición y 
es un requerimiento para los concursos públicos a nivel regional. 
Además, en el estudio 9 (Clinical Decision Support System to Enhance Quality Control of Forced 
Spirometry) se generó y validó un algoritmo para el control automático de la calidad de la EF. 
Los resultados de la validación con 778 curvas espirométricas indicaron que la sensibilidad y 
especificidad del algoritmo era del 96.1 y 94.9%, respectivamente. La validación del algoritmo 
aportó un segundo elemento tecnológico necesario  para la escalabilidad del programa de 
transferencia de la EF a Atención Primaria y a oficinas de farmacia. El algoritmo ha sido inte-
grado a la plataforma TIC de gestión de pacientes crónicos. La validación del proceso clínico 
se efectuará dentro del proyecto EU Synergy-COPD y el plan de escalabilidad en Catalunya se 
materializará a corto plazo en el marco del PDMAR. 
		
























































cializados como componente esencial de un programa de transferencia de EF de calidad a 
Atención Primaria (manuscritos 6 y 7).
6 Se efectuaron dos contribuciones tecnológicas relevantes para asegurar la interoperabi-
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Editorial
Quality of Forced Spirometry in Primary Care, Impact on the COPD Treatment
La espirometría forzada de calidad en Atención Primaria, impacto en el tratamiento de la EPOC
Felip Burgos
Servicio de Neumología, ICT, Hospital Clínic, Barcelona, Spain
Spirometry is an essential test in the diagnosis, monitoring and 
management of respiratory diseases. Likewise, the reduction of 
forced vital capacity (FVC) has been related with greater mortality in 
cancer, cardiac pathologíes1 and lower survival rates in adults with 
respiratory symptoms or disease.2,3 This goes to show that John 
Hutchinson in 1846 was right on the mark when he defined this 
parameter as “vital” capacity.
Respiratory diseases that run their course with airway obstruction, 
especially chronic obstructive pulmonary disease (COPD) and asthma, 
are extremely prevalent. Despite their morbidity and mortality and 
the important consumption of resources involved in their 
management, both diseases are underdiagnosed, up to more than 
70% in COPD as shown in a recent study in Spain.4
The diagnosis of COPD is based on the detection of airway 
obstruction and one of the most useful tools for its determination is 
the implementation of spirometry in Primary Care (PC). Several 
studies show the usefulness of spirometry to detect subjects at high 
risk for developing COPD,5,6 but few analyze the impact of spirometry 
in the treatment of COPD.7 In this issue of Archivos de Bronconeumología, 
M. Monteagudo et al8 analyze the impact of spirometry testing in the 
standard clinical practice of COPD in Primary Care and how it 
influences COPD treatment. Twenty-one centers intervened in this 
cross-sectional observational study with the participation of 801 
patients, for whom only 53% of spirometries were available, FEV1 
being the only parameter. Thus, it was impossible to correctly stratify 
the patients into degrees of severity, a limitation that was admitted 
by the authors of the study.
Once again, the underuse of spirometry in the diagnosis and 
follow-up of COPD is revealed. Only in half of the patients was COPD 
diagnosis confirmed by forced spirometry and there was evidence of 
great variability in its use between the 21 centers that participated 
in the study. This diversity was also studied in the audit that Pellicer 
et al9 carried out in 10 hospitals in the province of Valencia that 
diagnosed COPD. Fifty-four percent of the patients with COPD 
diagnosis did not undergo spirometry before hospital discharge. This 
study also states that COPD diagnosis in the hospital setting does not 
meet the minimal standard of acceptable quality of care, stating that 
there are great differences in the diagnostic management of this 
disease between the different specialists and levels of health-care.
M Monteagudo et al8 associated the use of spirometry with better 
patient control, although they did not associate it with an integral 
approach to the disease, as recommended by the clinical guidelines. 
Patients with spirometry presented more registered exacerbations 
but, however, a lower number of hospitalizations. This could explain 
why the authors defend better follow-up and registry of this group 
of patients. The majority of the patients had follow-up visits with 
their general practitioner in Primary Care, whereas 35% were 
controlled by the nursing staff. It was confirmed that being controlled 
by a pulmonologist and/or nurse was positively associated with 
follow-up spirometries.
Another aspect to highlight is that 38% of patients who were 
smokers had not received any type of anti-smoking advice and had 
less follow-up spirometries. Even lower is the percentage of patients 
who received “healthy lifestyle” advice on diet, exercise, etc. When 
the authors evaluated the treatment, they found a greater use of 
short-acting β-2-adrenérgics in patients without spirometry (60 vs 
52%) and (70 vs 63%) in the use of glucocorticoids. The authors could 
not analyze the quality of the spirometry, and it must be noted that 
in many cases only FEV1 is registered. Moreover, each spirometer had 
its own reference values and no data was provided as to whether the 
spirometers were subjected to any type of quality control. This all 
goes to show that, as the authors highlight, quality health care 
standards are far from being reached in COPD.10
In spite of national11 and international12 clinical guidelines 
recommending the use of forced spirometry as a diagnostic tool in 
COPD, it is not only underused in all healthcare settings, but many 
times it is not adequately utilized. This was demonstrated in the 
study by M. Monteagudo et al,8 where the minimal values of 
spirometry (FVC, FEV1 and FEV1/FVC ratio) could not be compiled, 
nor were data for bronchodilators, and in many instances it was not 
known which reference values were used while only percentage FEV1 
values were collected.
The healthcare challenge is early diagnosis of respiratory diseases, 
especially in those with greater prevalence like COPD and asthma. 
The dissemination of quality spirometry is an objective within our 
reach in the near future, but quality controls must be implemented 
in order for spirometry to be a reliable exploration, where both E-mail address: fburgos@clinic.ub.es
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numerical and graphic data can be accessed. We must strive for a 
more extensive use of spirometry in all healthcare settings, without 
sacrificing quality.
The growing impact of information and communication 
technologies (ICT) in medicine is a reality, and there is no doubt that 
spirometry will not lie outside these technological changes.13 It is 
necessary for spirometry to occupy its deserved place in clinical 
histories, due to both its historical and clinical use. Only by integrating 
lung function in computerized registers can we guarantee adequate 
quality control, and the expansion of spirometry as a basic tool for 
the evaluation of health.
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